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Abstract
The M il gene was originally identified through its role in infant acute 
myeloid and lymphoid leukaemias. M il also has a role in normal haematopoiesis as 
identified using mouse knockout models. Homozygous mutation of M il is embryonic 
lethal, which has limited research into its role in haematopoiesis.
To overcome this embryonic lethality, a conditional knockout mouse model 
of A/77 was established. In this model, exons 9 and 10 of M il were flanked by LoxP 
sites (‘floxed’), which recombined to induce deletion of exons 9 and 10 in the 
presence of the Cre recombinase. Deletion of exons 9 and 10 lead to complete loss of 
the MLL protein as detected by immunoblotting. By breeding mice homozygous for 
the floxed M il allele to mice that carried the Cre recombinase under the control of 
the Vav promoter, it was possible to delete M il within the haematopoietic system.
Analysis of foetal and adult haematopoiesis in the absence of M il was carried 
out using the new model. In embryos lacking M il, the foetal liver showed a marked 
reduction in the number of colony forming cells as well as both long and short term 
haematopoietic stem cells. When transplanted into lethally irradiated recipients 
with wild type competitors, M il deficient foetal liver cells were unable to contribute 
to reconstitution of the haematopoietic system.
In adult mice, removal of M il had no apparent effect on the steady state 
haematopoietic system. Populations of myeloid, lymphoid and stem cells were 
unaffected. However, in competitive repopulation assays, M il deficient bone marrow 
cells were unable to compete with wild type cells. This work suggests M il is needed 
for the correct development of foetal liver haematopoiesis and also to maintain self­
renewal potential in adult haematopoietic stem cells. However, it appears that M il is 
not needed to maintain adult haematopoiesis under homeostatic conditions.
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Chapter 1 
Introduction
1.1 Mil: The Mixed Lineage Leukaemia gene.
This study concentrates on the role of gene M il {M ixed Lineage Leukaem ia) 
in regulating haematopoiesis in foetal and adult mice. M il was first discovered due to 
its involvement in chromosomal translocations in infant leukaemia (Daser and 
Rabbitts, 2004; Djabali et al., 1992; Ernst et al., 2002). Animal models and 
biochemical studies have shown that the A///gene codes for a large protein involved 
in chromatin remodelling that the MLL protein has some role in regulating 
haematopoiesis in a normal context. This Chapter gives an overview of the processes 
that M il may be involved in regulating and an introduction to the MLL protein 
itself.
1.2 Haematopoiesis
Haematopoiesis is defined as the formation and differentiation of red and 
white blood cells. In mammals, the continuous process of blood cell self renewal 
requires a population of haematopoietic stem cells (HSCs) that are able to give rise to 
all the different lineages of blood cells throughout the lifespan of an individual. 
These multi-potent stem cells are thought to undergo asymmetric cell division to 
produce progenitor cells which can then divide and differentiate to produce the 
lymphoid, myeloid and erythroid cells of the haematopoietic system (Cumano and 
Godin, 2007; Shizura et al., 2005; Weissman et al., 2001).
1.3 Haematopoietic development in mice
Embryonic haematopoiesis has been extensively studied in mice, and two 
distinct extra and intra-embryonic waves of haematopoiesis have been identified. In 
the first wave, primitive haematopoiesis begins in the blood islands of the yolk sac at
17
embryonic day 7.5 (E7.5) (Bonnet, 2003; Cumano and Godin, 2007; Fujikawa et al., 
2003; Mikkola and Orkin, 2006; Wong et al., 1986). The first cells of haematopoietic 
origin to be produced in the embryo are found here and are thought to be derived 
from mesoderm cells of the primitive streak (Palis and Yoder, 2001). These are 
nucleated erythrocytes (so called primitive erythrocytes due to their resemblance to 
erythrocyte precursors in the adult bone marrow) that express foetal specific 
isoforms of haemoglobin (Cumano and Godin, 2007; Zhu and Emerson, 2002). At 
this time point, the yolk sac does not appear to contain haematopoietic stem cells 
capable of contributing to all adult haematopoietic lineages, as shown by 
repopulation assays (Cumano et al., 1996; Cumano and Godin, 2007; Godin and 
Cumano, 2002). However, it is possible that the yolk sac can support the expansion 
of definitive HSCs at later time points.
At E8.5, the first intra-embryonic haematopoietic precursors become 
apparent. These are situated in the paraortic splanchnopleura (P-sp) which then 
gives rise to the Aorta, Gonads, Mesonephros region (AGM) (Cumano et al., 1996; 
Godin and Cumano, 2002; Medvinsky and Dzierzak, 1996; Medvinsky et al., 1993). 
Cells which can give rise to long term reconstitution in Rag~2A x y c A mice have been 
detected in the AGM region by E l0.5 (Cumano et al., 1996; Godin and Cumano, 
2002; Medvinsky and Dzierzak, 1996; Muller et al., 1994). These cells, which reside 
in the ventral wall of the dorsal aorta, are thought to be the first definitive HSCs, 
which will eventually seed the foetal liver and then the bone marrow. There is also 
evidence to suggest that some definitive HSCs develop in the placenta (Gekas et al., 
2005; Mikkola and Orkin, 2006).
Between E9.5 and El 1.5, these HSCs transplant to the foetal liver, which 
becomes the primary site for haematopoiesis in the embryo (Cumano and Godin, 
2007; Mikkola and Orkin, 2006). Until haematopoiesis transplants to the bone 
marrow at E l5.5, the foetal liver is the main site of HSC expansion and 
differentiation. W hen cells from the foetal liver are transplanted into lethally 
irradiated mice, they are able to give rise to both long and short term haematopoiesis 
(Morrison et al., 1995; Rebel et al., 1996), showing the presence of HSCs that can 
function in the adult system. Following birth, the primary site of haematopoiesis is
18
the bone marrow, where HSCs reside in niches which are thought to protect their 
self renewal and multipotent capacities (Mikkola and Orkin, 2006).
1.4 Haematopoietic stem cells give rise to all the lineages of blood cells
In adult bone marrow, as in foetal liver, HSCs give rise to all the cells of the 
blood system. This small population of cells was originally identified through its 
ability to give rise to all mature blood cell lineages and to reconstitute the 
haematopoietic system when transplanted into lethally irradiated mice (Siminovitch 
et al., 1963; Smith et al., 1991; Spangrude et al., 1995).
The process by which HSCs divide and differentiate to give rise to mature 
cells is not known definitively, although several models have been proposed, (for 
review, see (Ema and Nakauchi, 2003).
One popular theory of HSC differentiation has been proposed by the group of 
Irving Weissman (Akashi et al., 2000; Kondo et al., 1997).In this model (see Figure
l.l,(Shizuru et al., 2005)) a subset of stem cells, the Long Term repopulating HSCs 
(LT-HSC) are capable of propagating haematopoiesis over the lifespan of an 
individual. These cells rest predominantly in the Go phase of cell cycle, and when 
transplanted into irradiated recipients, are able to maintain haematopoiesis for 
longer than 4 months (Forsberg et al., 2005; Forsberg et al., 2006). They can also 
reconstitute following serial transplantations into irradiated recipients, 
demonstrating their self-renewal capacity (Kiel et al., 2005). The LT-HSC gives rise 
to a population of more rapidly proliferating cells, the Short Term repopulating HSC 
(ST-HSC) which has a self-renewal lifespan of 6-8 weeks (Forsberg et al., 2006; 
Weissman, 2002) (Figure 1.1). The ST-HSC produces M ulti-Potent Progenitors 
(MPPs) which have a self-renewal lifespan of only two weeks (Figure 1.1). All of 
these stem cell types, although they have different self-renewal capacity, are 
multipotent and can give rise to the different mature lineages of the haematopoietic 
system.
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Figure 1.1. Haematopoiesis in Adult Mice.
LT-HSC -  Long-Term HSC, ST-HSC -  Short-Term HSC,
MPP - Multi-Potent Progenitor CLP -  Common Lymphoid 
Progenitor, CMP -  Common Myeloid Progenitor, GMP -  
Granulocyte/Monocyte Progenitor, MEP
Megakaryocyte/Erythrocyte Progenitor. Figure adapted from Shizura 
et al., 2005 with additional information from Zhong e t al. 2005 and 
Kiel e ta l 2005.
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1.5 Characterisation of foetal and adults HSCs
HSCs have been extensively characterised in both foetal and adult 
haematopoiesis. There are several characteristics in which foetal liver HSCs differ 
from adult bone marrow HSCs. Foetal liver HSCs expand rapidly and are actively 
cycling, whereas bone marrow HSCs are largely quiescent (Cheshier et al., 1999; 
Nygren et al., 2006). Foetal liver HSCs are also able to out compete bone marrow 
HSCs in transplantation experiments (Harrison et al., 1997; Rebel et al., 1996).
The transition from foetal to adult HSCs brings about a change in surface 
marker expression. Foetal liver HSCs, unlike adult bone marrow HSCs, express 
selected lineage markers, for example Macl, which is expressed on monocytes and 
granulocytes and is absent from HSCs in adult mice (Morrison et al., 1995). Foetal 
liver HSCs also express the marker AA4.1, which is normally expressed on B cells in 
adult mice. Adult HSCs also down regulate expression of CD34. There are several 
markers which foetal and adult HSCs share in common, however. Although some of 
these markers are not exclusively expressed on HSCs, they can be used in 
combination to purify the different HSC populations to a high degree. LT-HSCs, ST- 
HSCs and MPPs in both the bone marrow and foetal liver all express high levels of 
c-kit and Seal (Ikuta and Weissman, 1992; Spangrude et al., 1988) (Figure 1.1).
Markers which have been identified as differentially expressed between LT- 
HSC, ST-HSC and MPP in the foetal liver and bone marrow include CD38 (Randall 
et al., 1996; Zhong et al., 2005), T hy l.l (although this is not expressed by all strains 
of mice (Spangrude et al., 1988)), and the SLAM family members CD48 and CD 150 
(Kiel et al., 2005; Kim et al., 2006) The expression of these markers on the different 
HSC subpopulations is detailed in Figures 1.1 and 1.2. The tyrosine kinase receptor 
Flk2/Flt3 can also be used to differentiate between LT and ST-HSC in adult bone 
marrow cells, but not foetal liver (Christensen and Weissman, 2001).
Phenotypic characteristics of the stem cells can also be used to isolate them 
from other haematopoietic populations. For example, treatment of mice w ith 5- 
fluoruracil (5FU) results in ablation of the majority of haematopoietic cells in the 
bone marrow. This is because 5FU targets actively cycling cells. HSCs, however, are
21
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Figure 1.2. Identification of stem cells in foetal haematopoiesis.
The figure shows the model conceived by Irving Weissmans group. 
LT-HSC -  Long-Term HSC, ST-HSC -  Short-Term HSC, MPP - Multi- 
Potent Progenitor, CLP -  Common. Figure adapted from Shizura et al., 
2005 with additional information from Randall e t al, 1996 and Kim et 
a l 1996.
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predominantly quiescent and therefore immune to 5FU treatment. This means that 
HSCs are enriched in the bone marrow of mice following 5FU treatment, and can be 
purified in this manner (Ogata et al., 1995). HSCs are also more efficient at effluxing 
dyes using a multi-drug like transporter and this means that they can be purified by 
staining them with dyes such as Hoechst 33342 (Goodell et al., 1996). W hen the 
cells are analysed by flow cytometry, the HSCs form a so-called ‘side population’ of 
cells negative for Hoechst 33342, separating them from other haematopoietic cells, 
which are positive (Goodell et al., 1996).
Using these markers and characteristics in combination with Lineage 
markers, c-kit and Seal, it is possible to analyse the different populations of HSC in 
the bone marrow and foetal liver in some detail.
1.6 Techniques used in the analysis of HSCs and progenitors
In addition to the various markers that have been characterised for use in 
identifying HSCs by flow cytometry, several techniques have been developed to 
identify HSCs and progenitors by functionality. In  vitro  methods to identify HSCs 
include the Cobblestone Area Forming Cell Assay (CAFC Assay) and the Long term 
Culture Initiating Cell Assay (LTC-IC Assay). Both of these techniques involve 
plating HSCs identified via flow cytometry onto irradiated bone marrow stroma 
cells. The HSCs then form so called ‘cobblestone’ areas which can be quantified by 
counting the cobblestone foci after limiting dilution (Ploemacher et al., 1989). The 
LTC-IC is defined as cells which can still produce clonogenic progenitors after 5 
weeks in culture (de W ynter and Ploemacher, 2001) (Ploemacher et al., 1989).
In  vitro  assays for progenitor cell function predominantly take the form of 
methylcellulose colony forming assays. These assays measure the ability of 
individual progenitor cells to produce colonies when cultured in semi solid media 
containing cytokines to promote differentiation of the cells (Humphries et al., 1981; 
Johnson and Metcalf, 1977; Johnson et al., 1976). Different combinations of 
cytokines can be used to promote growth and assay progenitors of B cells, myeloid 
cells and erythroid or megakaryocyte cells. Following culture, each colony is 
counted as a Colony Forming Unit (CFU) thought to derive from one progenitor cell.
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W hen assaying myeloid progenitors, it is possible to differentiate between the 
colony types by morphology and so assess whether the colony was formed by an 
early myeloid progenitor (CFU Granulocyte, Erythroid, Megakaryocyte, 
Macrophage) or later progenitors (Bust Forming Unit Erythroid, CFU Granulocyte, 
Macrophage).
The definitive in  vivo  assay for HSC function is still considered to be the 
repopulation assay. This involves transplanting cells from the bone marrow or foetal 
liver of one mouse to the bone marrow of a lethally irradiated recipient. On 
transplantation, the ability of the cells to reconstitute all of the mature 
haematopoietic lineages is an indication of their function as stem cells. Cells that can 
give rise to reconstitution past 3 months post transplantation, and can serially 
transplant have been termed LT-HSC. Cells that can reconstitute all lineages, but 
only transiently, for up to 4 weeks, have been termed ST-HSC (Ikuta and Weissman, 
1992; Siminovitch et al., 1964; Spangrude et al., 1988). Transplantation assays have 
also been developed to compare the reconstitution capacity of mutant HSCs to wild 
type HSCs. These assays make use of the marker CD45 (Ly5), which is expressed on 
immature and mature haematopoietic cells (with the exception of mature 
erythrocytes and platelets). Different strains of laboratory mice express different 
alloantigens of CD45 -  either CD45.1 or CD45.2 (Spangrude et al., 1988). Mutant 
cells of one strain and wild type competitors of another strain, can be transplanted 
together into lethally irradiated recipients. It is then possible to measure the 
contribution of each population of cells to reconstitution using flow cytometry to 
analyse CD45.1 and CD45.2 expression. This technique has been very useful in 
establishing the roles of different genes in the regulation of HSCs using knockout 
mouse models (Hock et al., 2004a; Katsumoto et al., 2006; Lawrence et al., 2005b).
1.7 Differentiation of HSCs to mature lineages
Following the progression from LT-HSC to MPP and concomitant loss of 
self-renewal capacity, stem cells must differentiate to the mature lineages of the 
haematopoietic system. There is some discussion as to how this occurs. Following 
the model of Irving Weissman, differentiation of the HSCs progresses with the
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segregation of MPPs to committed progenitors of either the myeloid lineage or the 
lymphoid lineage. MPPs differentiate to become either common lymphoid 
progenitors (CLPs, IL-7R+/c-kitVScall0, CD34+), or common myeloid progenitors 
(CMPs, IL-7R/c-kitVScall0) (Weissman, 2002) (Figure 1.1).
The CMP differentiates to two further progenitor cells, the 
megakaryocyte/erythrocyte lineage restricted progenitor (MEP) and 
granulocyte/monocyte progenitor (GMP) (Akashi et al., 2000; Traver et al., 2001). 
These progenitors divide and differentiate to produce all the mature blood cell types 
of the myeloid, erythroid and megakaryocyte lineages. The CLP has the capacity to 
produce B and T-lymphoid cells and NK cells (Kondo et al., 1997). There is some 
disagreement in the literature as to whether this model is in fact correct, or whether 
there is more plasticity in some of the progenitor populations (Adolfsson et al., 2001; 
Adolfsson et al., 2005). However, this model is the most thoroughly researched at 
the present time (Adolfsson et al., 2001; Adolfsson et al., 2005; Forsberg et al., 2006).
1.8 Mature haematopoietic lineages: Lymphocytes
The lineages thought to be derived from the CLP include Natural Killer cells, 
and T and B lymphocytes. These cells are important in the response of the immune 
system to foreign antigens.
B lymphocytes function to produce antibody in response to external antigens 
and are an essential component of the adaptive immune system. Through 
progressive rearrangement of the light and heavy chain components of 
immunoglobulin genes, B cells can produce antibodies specific for an enormous 
number of antigens (Goldsby et al., 2003). B cells are thought to arise from CLP in 
the bone marrow (Kondo et al., 1997) and their subsequent development has been 
well characterised (Busslinger, 2004; Hardy and Hayakawa, 2001). A schematic 
detailing their development is shown in Figure 1.3. Following their production in 
the bone marrow and maturation in the spleen, they circulate the blood and lymph 
until they encounter their cognate antigen. Upon receiving additional signals from T 
Helper cells, they can begin to differentiate and begin secreting antibodies to mount 
an immune response to the encountered pathogen or irritant (Goldsby et al., 2003).
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CD43+
B220+
CD19+
BP1 +
lgM+
VDJ recombination 
Of Heavy Chain
VJ recombination 
Of Light chain
Figure 1.3. B cell development in the bone marrow.
The figure shows the progressive differentiation of B cells from 
common lymphoid progenitors (CLP) to immature B cells (Imm. B cell). 
The blue circles represent different B cell stages. Shown in black are the 
markers expressed by the cells at different stages of development. 
Shown in dark blue are times at which gene rearrangement of the 
heavy and light immunoglobulins occurs. Figure based on figures from 
Hardy and Hayakawa, 2001 and Busslinger, 2004.
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T cells are also an essential component of the adaptive immune system. 
Unlike B cells, which can recognise free standing antigens, T cells can only 
recognise antigens when they are presented on the surface of an antigen presenting 
cell w ith the Major Histocompatibility Complex (MHC). T cells develop in the 
thymus, which is initially populated by progenitor cells derived from HSCs in the 
bone marrow (Schwarz and Bhandoola, 2004; Schwarz and Bhandoola, 2006). Once 
in the thymus, these cells are known as thymocytes. The earliest thymocytes are 
negative for both CD4 and CD8. These progress to cells which are Double Positive 
(DP) for CD4 and CD8 (Goldsby et al., 2003). Following positive selection, 
thymocytes mature into T cells that are Single Positive (SP) for either CD4 or CD8. 
These cells are then released into the periphery. T cells positive for CD8 recognise 
antigen presented with MHC Class I molecules and develop into Cytotoxic T cells 
(Tc or CTL Cells) (Goldsby et al., 2003). Cytotoxic T cells are involved in killing virus 
infected cells and cancerous cells (Goldsby et al., 2003). CD4 positive cells recognise 
antigen presented with MHC Class II molecules and are known as Helper T cells 
(effector or Th cells). In response to contact w ith their cognate antigen and MHC 
Class II, they can secrete cytokines and activate B cells and Tc cells. Memory T cells 
can be either CD4 or CD8 positive and can recognise pathogens encountered during 
a previous infection to mount a swift immune response (Goldsby et al., 2003).
Natural Killer Cells are a form of lymphocyte which are part of the innate 
immune system. They are cytotoxic cells which are activated by cytokines or 
interferons. They can induce apoptosis in infected cells and are important in the 
response of the immune system to viral infections (Goldsby et al., 2003).
1.9 Mature haematopoietic lineages: Granulocytes and Macrophages
The cells of the myeloid lineage include granulocytes and macrophages. Both 
derive from the CMP, and then a further committed progenitor, the GMP 
(Granulocyte/Monocyte progenitor) (Akashi et al., 2000; Traver et al., 2001). 
Granulocytes (neutrophils, basophils and eosinophils) constitute up to 70% of 
circulating white blood cells and function in the defence against pathogens through 
phagocytosis and secretion of toxic substances (Goldsby et al., 2003). They are
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recognisable through their expression of high levels of Grl (Ly6G) and Macl 
(CDllb) (Taylor et al., 2003). Macrophages begin life as monocytes in the bone 
marrow which then differentiate in tissues and have the ability to phagocytose and 
kill infected cells and pathogens and to present antigens to T-cells (Goldsby et al.,
2003). Monocytes are recognisable by their expression of low levels of Grl and high 
levels of Macl (Taylor et al., 2003).
1.10 Mature haematopoietic lineages: Erythrocytes and Megakaryocytes
The other proposed derivative of the CMP is the MEP 
(Megakaryocyte/Erythrocyte Progenitor) (Akashi et al., 2000; Traver et al., 2001). 
The MEP is thought to give rise to erythroid cells and megakaryocytes cells. The 
cells of the erythroid lineage differentiate into enucleated erythrocytes. 
Erythrocytes consist mainly of haemoglobin, a complex molecule containing haeme 
groups whose iron atoms temporarily link to oxygen molecules in the lungs. The 
erythrocytes then distribute the oxygen around the body via the circulatory system 
(Goldsby et al., 2003).
Megakaryocytes are large cells responsible for producing platelets, which are 
involved in blood clotting. Megakaryocytes undergo endoreduplication that results 
in an increase in cell size (Zimmet and Ravid, 2000). Platelets are produced in and 
released from the cytoplasm of the megakaryocytes.
1.11 The genetic control of haematopoiesis: Initiation of primitive and 
definitive haematopoiesis
The renewal and differentiation of HSCs to progenitors and then mature cells 
is tightly regulated by a combination of factors. Some of these factors have been 
identified using mouse knockout and conditional knockout models. These include 
genes which are necessary for the establishment of primitive or definitive 
haematopoiesis, but whose expression is not necessary for adult stem cell self 
renewal.
In the earliest stages of primitive haematopoiesis, the transcription factors scl 
{Stem Cell Leukaemia) and lm o2 {LIM Domain O nly 2) are needed for the formation
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of primitive erythroid cells. W hen mouse null models were analysed for of these 
genes, scLAand Lm o2/' embryos died at E9.5-E10.5 (Robb et al., 1995; W arren et al.,
1994). Both scP 'and  lm o2A embryos were anaemic and showed an absence of yolk 
sac haematopoiesis (Robb et al., 1995; W arren et al., 1994). Chimaeric mice made 
using Scl or lm o2  deficient ES cells showed that these cells could not contribute to 
haematopoietic lineages in adult chimaeras, supporting a role for these genes in the 
establishment of haematopoiesis (Robb et al., 1996; Yamada et al., 1998). However, 
conditional deletion of Lm o2 in early lymphocytes had no effect on the production 
of mature B and T cells (McCormack et al., 2003) in adult mice, suggesting that 
Lmo2 is not essential for adult haematopoiesis. Likewise, conditional deletion of scl 
in the haematopoietic compartment of adult mice showed that scl is not needed for 
the proliferation and self- renewal of adult HSCs (Mikkola et al., 2003). These 
experiments showed that, whilst Lmo2 and scl are needed for the establishment of 
primitive haematopoiesis in the yolk sac, they are not needed for the maintenance of 
adult haematopoietic cells.
Several genes are necessary for the establishment and maintenance of 
definitive haematopoiesis in the foetal liver. The most important of these is the 
transcription factor R u n x l/A m ll {Runt related transcription factor 1 /A cute M yeloid  
Leukaemia 1). In the absence of R unxl expression, although yolk sac haematopoiesis 
is normal, no definitive haematopoietic cells are seen in the foetal liver. No 
haematopoietic cells were apparent in the AGM of R u n x lA mice, and it has since 
been shown that R u n xl expression is a defining marker of stem cells in the AGM 
region (Mukouyama et al., 2000; North et al., 2002). Conditional deletion of A m ll in 
the haematopoietic system of adult mice showed that, whilst it is necessary for the 
establishment of definitive haematopoiesis in the foetus, R u n x l it is not needed in 
adult HSCs (Ichikawa et al., 2004).
WTiilst R u n xl is needed for the establishment of definitive haematopoiesis, 
there are other genes which, whilst not being needed for establishing definitive 
haematopoiesis, are necessary for the proper expansion and maintenance of HSCs in 
the foetal liver. These include the transcription factors c-myb, GATA-2, and Pu.l. In 
c-m yb  deficient foetal embryos, although sites of HSC development appear to be
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functioning in the AGM, the only mature cells seen in the foetal liver are 
megakaryocytes and erythroid cells (Emambokus et al., 2003; Sumner et al., 2000). 
The foetal liver cells do not express high levels of c-kit and can form very few 
colonies in myeloid CFU assays, suggesting reductions in myeloid progenitors and 
stem cells. These results suggest that whilst c-m yb  is not necessary for establishing 
definitive haematopoiesis in the AGM, it is needed for the maintenance and self­
renewal of HSCs and progenitors in the foetal liver. Embryos deficient in G ATA-2 
had pan-haematopoietic defects and died at E10.5 (Tsai and Orkin, 1997). Embryos 
deficient in P u .l die at E18.5 due to haematopoietic failure (Kim et al., 2004). Stem 
cells as defined by flow cytometry were absent or severely reduced in P u .lv~ 
embryos, as were all myeloid progenitors (Kim et al., 2004). This suggests that P u.l 
is needed for proper expansion of HSCs in the foetal liver.
1.12 The genetic control of haematopoiesis: Regulation of Adult HSCs
Following the transition of haematopoiesis to the bone marrow, HSC 
proliferation and differentiation is tightly regulated. In the foetal liver, HSCs must 
undergo large scale expansion in order to populate the foetal liver. This means that 
HSCs in foetal liver are predominantly actively cycling cells (Harrison et al., 1997; 
Nygren et al., 2006). In the bone marrow, the opposite is the case- HSC proliferation 
must be restrained in order to preserve the stem cell pool for the life-span of an 
individual. This requires, in some instances, regulation of the HSCs by a different set 
of genes to that which control the onset of primitive and definitive haematopoiesis. 
Genes which were necessary for the establishment of primitive and definitive 
haematopoiesis, such as A m ll/R u n x l and scl are no longer needed for HSC self­
renewal (Mikkola et al., 2003). However, as in foetal liver haematopoiesis, 
transcription factors play a large role in regulating HSC self renewal. A large part of 
this role is played through the regulation of cell cycle and apoptosis genes to 
maintain the self renewal capacity of HSCs. Another class of genes strongly linked to 
HSC regulation are chromatin remodelling proteins of the Polycomb and Trithorax 
groups.
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One transcriptional repressor that is not needed for primitive haematopoiesis, 
but is crucial for the maintenance of adult HSCs is Tel/Etv6 ( Translocation-Ets- 
Leukemia). Although homozygous deletion of Tel/Etv6 is embryonic lethal, yolk sac 
haematopoiesis is unperturbed in the absence of Tel/Etv6. However, induced 
deletion of Tel/Etv6 in adult mice abrogates LT-HSC activity without affecting 
progenitor functions indicating that Tel/Etv6 is essential for their survival HSCs 
(Hock et al., 2004b).
Other transcription factors have been identified as being important for HSC 
self-renewal and are thought to act via an effect on HSC proliferation. GATA-2, in 
addition to its role in regulating foetal liver and AGM haematopoiesis, also regulates 
HSC proliferation in adult mice (Ling et al., 2004). Mice heterozygous for G ATA-2 
had reduced numbers of HSCs which had a competitive disadvantage against wild 
type cells in transplantation assays, and showed delayed recovery after 5FU 
treatment (Ling et al., 2004). This suggests that G ATA-2 is necessary for the normal 
self renewal of HSCs. The ETS transcription factor P u .l is also needed to maintain 
the proliferation and differentiation of HSCs in adult mice, as shown using 
conditional knockout mice (Iwasaki et al., 2005).
In contrast, mice deficient for the transcription factor MEF/ELF4 had a 
slightly higher number of BM HSCs as defined by flow cytometry. These cells were 
protected from cell cycle dependent toxicity due to a greater number of cells being 
in Go. This suggests that MEL1/ELF1 regulates the entrance of HSCs into the cell 
cycle at ready state, and prevents their over expansion (Lacorazza et al., 2006).
As expected, several genes involved in regulating cell cycle progression have 
also been identified as important regulators of stem cell self-renewal. Some cyclin 
dependent kinase inhibitors (CDKi) are thought to act to prevent HSC hyper or 
hypo proliferation. For example, p21c‘PI/wafl deficient mice have normal numbers of 
HSC but these HSC exhibit a serial repopulation defect and reduced resistance to 
5FU treatment (Cheng et al., 2000b). This suggests that p21ciP1/wafl is needed to 
maintain cells HSCs in Go. In contrast, HSCs from mice deficient for p l& nk4c have 
improved long-term engraftment, suggesting that p W 1*40 functions to limit stem cell 
self renewal (Yuan et al., 2004). Mice deficient in p27kiP1, had normal numbers of
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stem cells, and no transplantation defects in the HSC. However, they had increased 
numbers of progenitors that out competed wild type cells in transplantation assays 
(Cheng et al., 2000). Mice deficient for p l6 NK4A had normal numbers of HSCs when 
young. However, in old mice, the numbers of both LT and ST HSC were increased, 
in comparison to wild type (Janzen et al., 2006). Bone marrow cells from old 
p l6 NK4A / mice also performed better in competitive and serial transplantation 
experiments (Janzen et al., 2006). This suggests that expression of p i  ffNK4A is needed 
to regulate HSC pool size as mice age. The mosue models show that CDKis are 
closely involved in positively and negatively regulating HSC self renewal and 
proliferation. CDKis are thought to act through their inhibition of cyclin/CDK 
complexes, leading to prevention of the phosphorylation of Rb protein. 
Interestingly, conditional deletion in adult mice of Rb, led to no observed 
abnormalities in the numbers or repopulating capacity of HSCs (Walkley and Orkin, 
2006). This suggests that the mechanism by which CDKis work to regulate 
proliferation in HSCs and progenitors is not dependent on Rb.
Three genes that encode proteins from the Polycomb (PcG) repressive 
complex 1 (PRC1) have been shown to be important in HSC function. Mice deficient 
in m e ll8  had increased HSCs that had higher self-renewal activity and elevated 
expression of H oxb4compared with wild type controls (Kajiume et al., 2004). Foetal 
liver HSCs and progenitors deficient in another PcG gene, rae28 have impaired self­
renewal capacity and were unable to reconstitute the bone marrow of lethally 
irradiated recipients (Ohta et al., 2002). Mice null for B m il had ten times as few 
phenotypic HSCs as wild type mice, with initially normal levels of progenitor and 
mature blood cells (Park et al., 2003). Gene expression profiles of BM mononuclear 
cells from B m il null mice showed increased expression of p l f f1* ^  suggesting that 
B m il controls HSC renewal by releasing the cells from cell cycle arrest imposed by
plffnk4A
The transcription factor C/EBPa (CCAAT/Enhancer Binding Protein Alpha) 
is thought to play an antagonistic role to Bm il. Disruption of C/EBPa in adult mice 
leads to an increase in expression of B m il and enhanced repopulation capacity in 
HSCs (Zhang et al., 2004).
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Recently, an anti-apoptotic factor, M cl-1 (M yeloid Cell Leukaemia Sequence 
I) was shown to regulate apoptosis in HSCs. Opferman et al. (2005) showed that the 
survival of bone marrow progenitors in vitro requires expression of M cl-1 induced 
by early-acting cytokines. In vivo, after conditional deletion of M cl-1, progenitors 
and HSCs are gradually depleted.
The regulation of the self-renewal, proliferation and differentiation of the 
HSC pool is co-ordinately regulated by many factors, and involves measures to 
prevent inappropriate cell expansion and death.
1.13 The genetic control of haematopoiesis: Differentiation to mature 
lineages
Many different transcription factors work in concert and/or antagonistically 
to direct differentiation of HSCs to the different mature lineages of haematopoietic 
cells. Expression levels of the different transcription factors are particularly 
important as it is thought that, although some transcription factors are expressed in 
many lineages, only when their expression is above a threshold level will they drive 
progenitors down a particular developmental pathway.
Transcription factors important for erythropoiesis include GATA-1, Lmo2, 
FOG-1 (Friend o f  GATA-1) and scl/tall (Allen et al., 2006a; Cantor and Orkin, 2002; 
Mikkola et al., 2003; Tsang et al., 1998). As discussed above, Lmo2 and scl are 
necessary for primitive erythropoiesis. Conditional deletion of scl in adult tissues 
also led to anaemia and thrombocytopenia in the mice, and an inability of the bone 
marrow cells to form BFU-E, suggestive of blocks in erythropoiesis and 
megakaryopoiesis (Hall et al., 2003). Gata-1 and Fogl also regulate both 
erythropoiesis and megakaryopoiesis. Embryos deficient in Fogl die of anaemia and 
have blocked erythropoiesis and megakaryopoiesis (Tsang et al., 1998). Loss of Gatal 
leads to blocked maturation of erythrocytes and megakaryocytes and the failure of 
erythropoiesis (Orkin et al., 1998; Weiss and Orkin, 1995).
The two predominant transcription factors that are thought to regulate 
myelopoiesis are P u.l and C/EBFol (Laiosa et al., 2006; Orkin, 2000). CMPs and
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GMPs are absent in the foetal livers of E14.5 embryos lacking P u .l, although MEPs 
were present (Kim et al., 2004). Adult mice in which P u .l was conditionally deleted 
in HSCs after birth were unable to produce CMPs. However deletion of P u.l after 
GMP formation resulted in excess granulocyte production (Dakic et al., 2005; 
Iwasaki et al., 2005). This suggests that P u.l is needed for the formation of CMP but 
is also jieeded to restrict differentiation in the GMP. Adult mice in which C/EBPa 
was conditionally deleted produced very few GMPs, neutrophils, eosinophils and 
monocytes (Zhang et al., 2004). Conditional deletion of C/EBPa in the GMP 
population did not affect their capacity to produce colonies in vitro, suggesting that 
C/EBPa is needed for the formation of GMP, but not for the downstream 
differentiation of granulocytes and monocytes (Zhang et al., 2004).
Pu. 1, in addition to regulating myelopoiesis, plays a further role in lymphoid 
development. Loss of Pu.l results in an inability of HSCs to produce CLPs as well as 
CMPs (Dakic et al., 2005; Iwasaki et al., 2005). Another transcription factor needed 
for CLP formation is Ikaros (Allman et al., 2003) as evidenced by the fact that mice 
deficient in Ikaros have undetectable levels of CLPs.
Further differentiation of CLPs to mature B cells requires different levels of 
several transcription factors. Inactivation of transcription factors such as PAX5 
(Paired Box Gene 5), E2A and EBF (Early B cell Factor) (Bain et al., 1994; Isnard et 
al., 2000; Lin and Grosschedl, 1995; Nutt et al., 1999) all result in disrupted B cell 
development. Loss of EBF or Pax5 in adult mice leads to a block in B cell 
development at the ProB stage and loss of E2A leads to a loss of B cells early in 
development, before DJ immunoglobulin gene rearrangement (Bain et al., 1994; Lin 
and Grosschedl, 1995; Nutt et al., 1999) . Interestingly, Pax5 deficient B cells can be 
induced to differentiate to cells of the myeloid lineage, and express genes of 
different lineage-affiliated gene programs (Nutt et al., 1999). Therefore, Pax5 plays 
an essential role in B-lineage commitment by suppressing alternative lineage 
choices.
Correct maturation of T-cells requires transcription factors such as 
R u n xl/A m ll, c-m yb, E2A/HEB and GATA3 (Laiosa et al., 2006; Rothenberg and 
Taghon, 2005). A m ll/R u n x l is needed for the proper expansion of DN thymocytes,
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and also to suppress CD4 expression during the selection process for CD8 SP cells 
(Telfer et al., 2004; W oolf et al., 2003). c-m yb  is required during several stages of T 
cell development - transition through the DN stage in the thymus, survival of DP 
thymocytes, and differentiation of CD4+ thymocytes (Bender et al., 2004). E2A and 
HEB are partially redundant bHLH transcription factors, but in the absence of either 
protein, T cell differentiation is partially blocked before the transition from DP to 
SP cells (Bain et al., 1997; Barndt et al., 1999). GATA3 is the only transcription 
factor that appears to have a T cell specific role. It is needed for the formation of the 
earliest thymocytes, before the DN stage and has further roles in regulating the 
development of Th cells (Ting et al., 1996; Zhu et al., 2004). N otchl, a component of 
the N otch signalling pathway is also important for T cell development. In mice in 
which N o tch l has been conditionally deleted, T cell development is absent, and 
instead, B cell development occurs in the thymus (Radtke et al., 2004; Robey and 
Bluestone, 2004). This showed that N otch l signalling is needed to suppress B cell 
development in lymphoid progenitors in order for T cell development to occur. 
N o tch l signalling is also required for later stages of T cell development (Radtke et 
al., 2004; Robey and Bluestone, 2004). Another group of signalling proteins 
important for T cell development are those of the Vav family (Tybulewicz, 2005). 
These are cytoplasmic guanine nucleotide exchange factors for Rho-family GTPases 
and are phosphorylated in response to T cell antigen receptor signalling (Bustelo et 
al., 1992). Vavl deficient mice showed a partial block at the transition from DN to 
DP cells (Turner et al., 1997). Mice deficient in all three Vav family proteins (Vavl, 
Vav2, Vav3) show a 100-fold reduction in number of DP and SP thymocytes, in 
comparison to a normal number of DN thymocytes. This demonstrates the 
importance of the Vav family in regulating the DN to DP transition (Fujikawa et al.,
2003)
The genetic control of the differentiation of HSCs via committed progenitors 
to the mature lineages of the haematopoietic system requires careful coordination of 
a range of transcription factors, the levels of which can influence the cell fate of a 
specified progenitor.
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1.14 The Hox cluster: A family of genes involved in haematopoiesis
Another group of genes shown to play an important part in regulating 
haematopoiesis are the genes of the H ox family. The HOX proteins are transcription 
factors that are important in determining cell fate and body patterning in the 
developing embryo. They are orthologous to the HOM-C proteins in Drosophila 
(Grier et al., 2005; McGinnis and Krumlauf, 1992) (Figure 1.4) that were first 
discovered through the analysis of Drosophila mutants (Gehring and Hiromi, 1986). 
Mutation of genes from the HOM-C cluster gave rise to homeotic transformations in 
the flies, involving the transformation of one body part e.g. an antennae, to another 
e.g. a leg (Gehring and Hiromi, 1986). This meant that HOM-C genes were needed 
for specifying the body plan during embryological development (Gehring and 
Hiromi, 1986). Following the discovery of the HOM-C cluster in Drosophila, H ox 
genes were found to reside in similar clusters in mammalian genomes (Hart et al., 
1985; McGinnis et al., 1984).
The H ox genes code for transcription factors whose conserved motif is the 
homeodomain (Grier et al., 2005). This is a 61-amino-acid helix-turn-helix DNA- 
binding domain (Grier et al., 2005). Hox proteins may be involved in both 
transcriptional activation or transcriptional repression (Moens and Selleri, 2006; 
Owens and Hawley, 2002). In mammals, the H ox genes are organised in 4 clusters 
(see Figure 1.4 (Grier et al., 2005)), each containing 9-11 genes. They are expressed 
in precise temporal and spatial patterns during embryological development, and the 
importance of this expression is seen in the morphological abnormalities that can 
arise following targeted disruption of some of the H ox genes in mice. These include 
homeotic transformations of the skeleton, suggesting that their function is analogous 
to that of the HOM -C  genes in Drosophila (Chen and Capecchi, 1997; Davis and 
Capecchi, 1994; Davis et al., 1995; Kostic and Capecchi, 1994).
H ox genes are also expressed postnatally in adult tissues, including blood cells 
(Pineault et al., 2002; Sauvageau et al., 1994). A survey of the CD34+ populations 
(which included HSCs and progenitors) showed expression of several genes from the 
A, B  and C H ox  gene clusters (Sauvageau et al., 1994). It is thought that 3' genes of
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Grier et al., 2005.
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the H ox clusters are expressed in pluripotent progenitors, w ith 5' genes bring turned 
on in more committed progenitors (Lawrence et al., 1997; Sauvageau et al., 1994).
Evidence for the role of these H ox genes comes from over expression studies 
and mouse knockout models. These studies do not always present a clear picture of a 
particular gene’s role, due to a certain amount of redundancy between the H ox 
genes. At the earliest stages of haematopoiesis, mice deficient in Hoxb3 and Hoxb4 
produce HSCs and progenitors with a reduced proliferative capacity (Bjornsson et 
al., 2003), and over expression of Hoxb4 increases the regenerative capacity of HSCs 
(Antonchuk et al., 2001).
Several H ox genes appear to be involved in the regulation of progenitor cells. 
Knockout of Hoxa9 in mice leads to a reduction in myeloid, erythroid and B- 
lymphoid progenitors without a reduction in pluripotent progenitors (Lawrence et 
al., 1997). However, although the stem cell compartment appears normal, upon 
transplantation, it has a severe repopulating defect (Lawrence et al., 2005a). 
Knockout of Hoxb6 led to an increase in early erythroid progenitors, although 
peripheral blood counts remained unaffected (Kappen, 2000). Disruption of Hoxc8 
led to a reduction in erythroid and myeloid progenitors in some individuals, 
although this phenotype was not fully penetrant and was not cell intrinsic 
(Shimamoto et al., 1999).
It appears that several of the H ox genes have a similar function in regulating 
the pluripotent progenitor population, but that individual H ox genes play different 
roles in the further differentiation of progenitors. Ernst et al. (2004) looked at the 
colony forming ability of cells from embryoid bodies differentiated from M il 
deficient ES cells. These had reduced or absent expression of several H ox genes, and 
a much reduced ability to form myeloid colonies. W hen early progenitors from 
these embryoid bodies were transduced with individual H ox  genes, HoxA9, B4, A 10 
were able to rescue the phenotype and restore the ability of the cells to produce 
myeloid colonies. Subsequent differentiation, however, was influenced by the 
specific H ox gene expressed.
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1.15 Hox gene cofactors Pbxl and Meisl
Although HOX proteins have direct DNA binding capacity via the 
homeodomain, the sequence specificity of this binding is mediated by interaction 
with other homeodomain proteins such as PBX1 (Pre-B-cell leukemia Homeobox 1) 
and MEIS1 (Moens and Selleri, 2006). These cofactors can interact with a broad 
subset of HOX proteins and facilitate their binding to DNA (Moens and Selleri, 
2006). It came as no surprise, considering the importance of their interaction to 
HOX protein function, when it was found that these HOX co factors were needed 
for haematopoiesis to develop normally. Homozygous deletion of either M eisl or 
P bxl results in embryonic lethality in mice (DiMartino et al., 2001a; Hisa et al., 
2004a). Studies using M eisH  and Pbxl~A embryos show that they are both necessary 
for normal HSC function in the foetal liver. This evidenced by the fact that HSCs 
from both M e islA and P bxl A embryos have repopulating defects in transplantation 
experiments (DiMartino et al., 2001a; Hisa et al., 2004a).
1.16 The role of Hox genes and their cofactors in leukaemogenesis
In addition to their roles in normal haematopoiesis, its has been shown that 
several H ox genes and HOX cofactors play an active role in leukaemogenesis (Owens 
and Hawley, 2002). In human acute myeloblastic leukaemia, co-expression of 
Hoxa7, Hoxa9 and M eisl are frequently observed (Afonja et al., 2000; Lawrence et 
al., 1999). In some leukaemias H ox genes and their cofactors may become fused to 
other genes as a result of chromosomal translocations, resulting in the formation of a 
chimaeric protein (Owens and Hawley, 2002). For example, in some human AMLs, 
Hoxa9 can become fused to Nup98 resulting in a chimaeric protein with oncogenic 
potential (Nakamura et al., 1996; Owens and Hawley, 2002). The over expression of 
several H ox genes also leads to the expansion of haematopoietic progenitor cells in 
mouse and human cells (Owens and Hawley, 2002). This suggests that the 
transformation potential of H ox genes is through the deviation of their normal role 
in HSC and progenitor proliferation (Owens and Hawley, 2002).
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1.17 Mil -  a gene rearranged in infant leukaemia
One of the upstream regulators of H ox genes in both normal and leukaemic 
haematopoiesis is Mil. The M il gene was first identified through its role in infant 
and treatment-related secondary leukaemias (Djabali et al., 1992; Ernst et al., 2002; 
Zeleznik-Le et al., 1994). The most frequent cytogenetic abnormality found in these 
leukaemias is chromosomal rearrangement of the llq23  region. W hen the locus 
spanning the breakpoint in llq23  was cloned, the gene MLL (.ALL-1, HRX) was 
identified (Cimino et al., 1991).
In leukaemic cells the N-terminal portion of MLL becomes fused, through 
chromosomal translocation, to one of up to 50 possible partner genes. These fusion 
genes can be present in cases of both Acute Myeloid Leukaemia (AML) and Acute 
Lymphoid Leukaemia (ALL) (Daser and Rabbitts, 2004; Ernst et al., 2002; Hess,
2004). The fusion partners of MLL tend to be either transcriptional activators (e.g. 
Af9, Af4, ENL) or dimerising proteins (e.g. Gas7) (Dobson et al., 1999; Horton et al., 
2005; So et al., 2004; So et al., 2003). In primary murine haematopoietic cells, these 
fusion genes are often sufficient to induce immortalisation in  vitro and 
transformation to leukaemia in  vivo (Dobson et al., 1999; Horton et al., 2005; So et 
al., 2004; So et al., 2003).
It is thought that part of the action of MLL fusion proteins in leukaemia is 
through deregulated H ox gene expression (So et al., 2004). Murine cells 
immortalised with human MLL-ENL, a fusion gene which causes AML and ALL in 
infants, have upregulated expression of several H ox genes, notably genes at the 
posterior end of the Hoxa cluster, such as Hoxa7, Hoxa9, HoxalO  and H o xa ll 
(Horton et al., 2005; Zeisig et al., 2004). The H ox  genes have also been shown to be 
direct targets of MLL fusion proteins which induce activating histone methylation at 
H ox loci (Milne et al., 2005a).
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1.18 Mil is involved in Hox gene regulation in the context of normal 
development
Following the identification of the role of M il in leukaemogenesis, research 
focused on whether the normal MLL protein was also involved in H ox gene 
regulation and the developmental processes which are normally regulated by the 
H ox genes. The M il gene encodes a protein of 3639 amino acids (human), molecular 
weight 430kd that is homologous to the Drosophila protein Trithorax (TRX) 
(Mbangkollo et al., 1995). Trithorax is a member of the Trithorax group (trx-G) of 
proteins that positively regulate gene expression during Drosophila development. 
These proteins do not initiate, but instead, maintain correct temporal and spatial 
expression of their target genes in the HOM Complex (HOM-C). This is evidenced 
by the fact that flies mutant for trx-G genes have homeotic transformations (Hess,
2004).
To investigate whether M il regulated H ox gene development during 
mammalian development, in a similar mechanism to Trx, mouse knockout models of 
M il were established (Figure 1.5) (Ayton et al., 2001; Yagi et al., 1998; Yu et al.,
1995) In the first model, M il was truncated at exon 3 by insertion of a lacZ/Neo 
cassette (Yu et al., 1995). The resultant homozygous mutant mice died by E10.5. 
Both homozygotes and, to a lesser degree, heterozygotes show segmental 
abnormalities suggesting haploinsufficiency of M il (Yu  et al., 1998; Yu et al., 1995). 
The heterozygotes had abnormalities of the axial skeleton normally w ith H ox gene 
mis-expression (Yu et al., 1995). The homozygotes had gross abnormalities of the 
branchial arches (the structures which give rise to the bones of the face) again 
associated w ith Hox gene deregulation (Yu et al., 1998). Heterozygous embryos had 
shifted expression patterns of Hox genes in the embryo, and homozygous embryos 
were unable to maintain expression of H oxa7 in the somites following E9 (Yu et al., 
1998). This confirmed that M il was necessary for the maintenance of H ox gene 
expression during development, making it orthologous to Trx.
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In the second knockout model of M il' the gene was truncated at exon 8 by 
the insertion of a neomycin resistance cassette (Figure 1.5). Although embryos 
homozygous for this truncation did not have the branchial arch abnormalities seen 
in the Yu knockout, they did have deregulated H ox gene expression (Yagi et al., 
1998).
1.19 Mil regulates haematopoiesis during development
In addition to the other developmental abnormalities, knockout embryos of 
both the Yagi and Yu models had abnormal haematopoietic development (Hess et 
al., 1997; Yagi et al., 1998). Analysis of yolk sac cells from mice homozygous for the 
exon 3 truncation showed that the overall number of haematopoietic cells was 
reduced in the absence of MU (Hess et al., 1997). The majority of cells in M il 
deficient yolk sacs were c-kit positive as compared with a minority in wild type yolk 
sacs. In methylcellulose assays, the mutant cells had a decreased capacity to produce 
myeloid colonies, but produced comparable numbers of erythroid colonies to wild 
type (Hess et al., 1997).
In the second model where M il was truncated at exon 8 , the embryos 
survived to E14.5, allowing analysis of foetal liver cells (Yagi et al., 1998). 
Homozygous mutant foetal livers had comparable numbers of mature cells, 
including myeloid cells, to wild type foetal livers, although the total cell number 
was reduced. In colony forming assays, the number and size of both erythroid and 
myeloid colonies was reduced in comparison to wild type (Yagi et al., 1998).
To further test the contribution of M il m utant cells to haematopoiesis, 
mutant homozygous ES cells were used (Ernst et al., 2004a). These cells were 
derived from ES cells used in the Yu model. In stromal cultures, mutant ES cells 
were unable to give rise to B-lymphopoiesis. W hen transplanted into blastocysts, 
mutant ES did not contribute to mature NK cells, T-cells or B-cells in the adult 
RAG -2  chimaeras. AGM cells from mutant embryos were unable to reconstitute 
haematopoiesis in sublethally irradiated recipients, as compared to wild type AGM 
cells, which gave 75% reconstitution (Ernst et al., 2004a).
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W hen M il deficient ES cells were differentiated down the haematopoietic 
lineage in embryoid body experiments, the cells were deficient in producing 
haematopoietic colonies (Ernst et al., 2004b). Q-PCR showed that in the absence of 
M il induction of Hoxa7, Hoxa9, HoxalO, Hoxb4, Hoxb5, Hoxb6, Hoxb8, and Hoxc6 
was reduced in the embryoid bodies (Ernst et al., 2004b). Ectopic expression of 
Hoxa9, HoxalO  or Hoxb4 was able to rescue the reduction in colony frequency in 
M1H embryoid bodies, suggesting that the haematopoietic abnormalities in M il 
deficient embryos are due to H ox gene deregulation (Ernst et al., 2004b).
1.20 MLL regulates Hox gene expression via chromatin remodelling
More recent research has focused on elucidating the mechanism by which 
MU controls the expression of H ox and other genes. The M il gene codes for a large 
protein, with several different domains (Figure 1.5). Some of these domains are 
conserved with Drosophila TRX. These include the PHD fingers and the SET 
domain (Hess, 2004). It has been shown that the many of the domains of MLL act to 
regulate gene expression via chromatin remodelling. Chromatin remodelling is a 
means of controlling the transcriptional activation status of genes (Jenuwein and 
Allis, 2001; Kouzarides, 2007; Li et al., 2007).
Chromatin is the state in which DNA is packaged, and depending on its 
formation, it can influence gene transcription. For example, euchromatin is 
chromatin which is lightly packed and contains a higher proportion of genes which 
are being actively transcribed (Alberts et al., 1994). Heterochromatin is more tightly 
packed and contains fewer genes undergoing transcription (Alberts et al., 1994). 
Chromatin is composed of DNA strands wrapped around nucleosomes. Each 
nucleosome is composed of an octamer of four core histones (H3, H4, H2A, H2B) 
(Campbell and Reece, 2005). Each histone has two domains -  a central region that 
interacts with the DNA and a tail region that projects outwards (Campbell and 
Reece, 2005).
Modification of amino acids in histone tails can weaken or strengthen their 
interaction with DNA, leading to a more open or a more closed chromatin formation 
(and the formation of heterochromatin) (Jenuwein and Allis, 2001). For example,
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acetylation of amino acids in the histone tails can lead to a more open chromatin 
formation allowing access to the DNA of transcription factors (Jenuwein and Allis, 
2001). Methylation of lysine and arginine residues in the histone tails can also lead 
to gene silencing or transcriptional activity (Jenuwein and Allis, 2001; Lachner and 
Jenuwein, 2002; Lachner et al., 2003). For example, methylation of Lysine 4 of 
Histone 3 (H3K4) has been shown to induce a transcriptionally active state whereas 
methylation of H3K9 has been shown to repress transcription (Milne et al., 2002; 
Nakamura et al., 2002).
The MLL protein is involved in both histone acetylation and histone 
methylation, either by the direct function of its domains, or by recruitment of other 
proteins via protein-protein interactions. The functions of the different domains of 
MLL are discussed below.
1.21 AT Hooks
There are three AT hooks located near the N-terminus of the MLL protein. 
AT hooks have been identified in several proteins and are thought to be able to bind 
to AT-rich regions in the minor groove of DNA (Broeker et al., 1996b). Using 
recombinant protein purified from bacteria, it has been shown in in  vitro assays that 
the AT hook region of MLL can bind to cruciform DNA. This binding is not thought 
to be sequence specific but rather structure specific (Broeker et al., 1996a).
1.22 SNL1, SNL2
These short nuclear localisation domains confer a punctuate localisation 
pattern of the protein in the nucleus (Yano et al., 1997).
1.23 Methyl transferase Domain
The Methyltransferase (MT) domain is so called because this 100 amino acid 
region bares homology to the regulatory region of DNA methyltransferase 1 
(DNMT1). The MT domain contains a CxxC motif shared with other proteins that 
are able to recognise and bind CpG dinucleotide sequences (Birke et al., 2002). 
Accordingly, recombinant MLL MT domain protein has been shown to bind
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unmethylated CpG DNA in  vitro and to bind to unmethylated DNA in vivo in VP 16 
reporter assays (Allen et al., 2006b; Ayton et al., 2004; Birke et al., 2002).
The MT domain lies in a larger region termed the ‘repression domain’, so- 
called because it can repress transcription when fused to the GAL4 DNA binding 
domain (Zeleznik-Le et al., 1994). This repression is thought to mediated through 
recruitment of histone de-acetylases, which remove acetyl groups from core histone 
tails in chromatin, thereby making it transcriptionally inert (Xia et al., 2003). It is 
also thought that HDACs may be able to recruit repressive complexes (Xia et al., 
2003; Zeleznik-Le et al., 1994). The repression domain can also interact w ith the 
Polycomb Group proteins (PcG) HPC2 and BMI-1 (Xia et al., 2003). Exogenous 
expression of BMI-1 in reporter assays with the MT domain of MLL increase its 
repressive activity (Xia et al., 2003; Zeleznik-Le et al., 1994). This is significant 
because in Drosophila and mouse, PcG proteins act antagonistically to trx-G proteins 
to maintain silencing of HOM -C  and H ox genes (Hanson et al., 1999).
1.24 PHD Fingers
The Plant Homeodomain (PHD) fingers, which are also present in TRX, are 
believed to play some part in the transcriptional regulation/ chromatin remodelling 
activity of MLL. This is because most proteins that contain PHD fingers are 
components of transcriptional regulation/ chromatin remodelling complexes, 
suggesting that these domains are intrinsic to their function (Eguchi et al., 2003). 
Further to this, the third PHD finger of MLL has been shown to interact with 
nuclear cyclophilin CYP33 (Fair et al., 2001). This is, in turn, thought to mediate the 
binding of HDAC1 to the MT domain (Xia et al., 2003; Zeleznik-Le et al., 1994)
Recent work has also shown that PHD fingers can act as highly specialised 
methyl-lysine binding domains (Li et al., 2006; Mellor, 2006; Pena et al., 2006). The 
PHD fingers of the chromatin remodelling proteins Ing2 (Inhibitor of Growth 
family 2) and BPTF (bromodomain PHD finger transcription factor) bind specifically 
to tri-methylated H3K4 (H3K4me3) (Li et al., 2006; Pena et al., 2006). H3K4me3 has 
been shown to be a mark for active chromatin and is found at the 5' end of genes 
together w ith acetylated lysines, another mark of active chromatin. It is thought
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that the PHD finger of BPTF, a subunit of the NURF chromatin remodelling 
complex, recognizes H3K4me3 in coordination with the recognition of acetylated 
lysine by an adjacent bromodomain. This recognition helps target the chromatin 
remodelling complex to the active chromatin (Li et al., 2006; Wysocka et al., 2006). 
M il contains 4 PHD fingers with a bromodomain between the 3rd and 4th fingers. It 
has not been shown whether the PHD fingers of MLL can bind to nucleosomes, as 
for ING2 and BPTF. However, H3K4me3 is positioned w ithin a cage of 4 aromatic 
amino acids in the BPTF PHD finger and aromatic amino acids are present in similar 
positions in the 3rd MLL PHD finger, supporting the possibility that the 3rd PHD 
finger of MLL may have some nucleosome binding capacity. The proximity of the 
3rd PHD finger to the bromodomain in MLL would support this.
1.25 Bromodomain
Little is known about the function of the bromodomain in MLL, however 
bromodomains are found in many chromatin associated proteins and nearly all 
histone acetyl-transferase (HAT)-associated transcriptional co-activators. They have 
been shown to interact with acetylated lysines, and to interact with PHD domains in 
tethering transcriptional HATs to the chromatin (Li et al., 2006; Wysocka et al., 
2006). They may also be important for the assembly and activity of multiprotein 
complexes in transcriptional activation (Dhalluin et al., 1999).
1.26 Dimerisation Domains (FYRN and FYRC)
W ithin MLL, there are two sites for proteolytic cleavage (CS1 and CS2) and 
two dimerisation domains (FYRN and FYRC). MLL is cleaved before entry to the 
nucleus, at two protease recognition sites, CS1 and CS2 by Taspasel to generate an 
N-terminal fragment, N320 and a C-terminal fragment C l80 (Hsieh et al., 2003).(see 
Figure 1.6). The two fragments then interact through the FYRN domain of the N- 
terminal fragment and the FYRC domain of the C-terminal fragment. This 
dimerisation confers stability to the N-terminal fragment.
The N-terminal fragment of MLL contains mostly transcriptionally repressive 
domains, so fusion to the C-terminus, which contains the transactivating domain
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and the SET domain, gives the protein an activating effect on transcription (Martin 
et al., 2003). Permanent dimerisation of MLL using pharmacologically dimerisable 
MLL fusion protein converts it to a transcriptional transactivator. This leads to 
upregulation of Hox genes Hoxa7 and Hoxa9, which are upregulated in some MLL 
fusion leukaemias (Martin et al., 2003).
Further evidence for the importance of cleavage and dimerisation to MLL 
function came with the analysis of a mouse knockout model for Taspasel. In the 
absence of Taspasel, no cleaved MLL protein could be detected in murine 
embryonic fibroblasts, although full length MLL was present (Takeda et al., 2006). 
Mice deficient in Taspasel had classic homeotic transformations characteristic of 
H ox gene deficiency, and the majority of homozygous null mice died at 1-2 days 
postpartum. However, this late lethality suggests that the full length, uncleaved MLL 
protein must have some residual function, as in the absence of MLL function, 
embryos die prenatally (Takeda et al., 2006; Yagi et al., 1998; Yu et al., 1995).
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1.27 Transactivation domain
The C-terminal fragment of MLL contains a transactivation domain (TAD). 
This activation domain can promote expression in Gal4 fusion experiments (Prasad 
et al., 1995). It is thought that the activity of this transactivation domain is based on 
its interaction with the CREB-CBP complex (Ernst et al., 2001). CREB (Cyclic AMP 
Response Element-Binding) is a signal dependent transactivator which becomes 
phosphorylated at serine 133 in response to stimuli that result in increased 
intracellular cyclic AMP. Upon phosphorylation, CBP (Creb Binding Protein) binds 
to CREB which results in a rapid induction of gene expression. This is through the 
direct recruitment of the basal transcriptional machinery and also through the 
acetyltransferase activity of CBP (Ernst et al., 2001). MLL has been shown to interact 
w ith the CREB-CBP complex in vitro. Point mutations which prevent this 
interaction also abrogate the transactivation potential of the MLL TAD in in  vivo 
GAL4 fusion reporter assays (Ernst et al., 2001).
1.28 SET domain
The SET domain is perhaps the best characterised of all the MLL domains and 
is highly conserved with other MLL and SET family proteins. SET domains are 
found in many proteins demonstrated to mediate lysine-directed histone 
methylation (Lachner and Jenuwein, 2002).
The MLL SET domain has been shown to possess histone methyltransferase 
activity both in  vitro and in  vivo (Milne et al., 2002; Nakamura et al., 2002). The 
SET domain of MLL is responsible for maintaining H3K4 methylation on the 
promoter and enhancer regions of Hoxc8 and Hoxa9 (Milne et al., 2002; Nakamura 
et al., 2002). This, in turn maintains transcription of these genes. This is evidenced 
by the reduced expression and H3K4 methylation status in M il null fibroblasts 
(Milne et al., 2002; Nakamura et al., 2002).
Recent work has shown that the SET domain is not as critical for MLL 
function as previously thought. A mouse knockout model has been established in 
which the MLL SET domain is absent. In the absence of the SET domain the stability
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and expression of the MLL protein are unaffected (Terranova et al., 2006). Mice 
homozygous for the SET deletion mutant are healthy and there is no embryonic 
lethality. Although the mice show some homeotic transformations characteristic of 
H ox deregulation, and reduced expression levels of Hoxc8 and Hoxd4, the 
phenotype is far milder than that of full MLL knockouts. This suggests that either 
MLL gene regulation is not solely based on the SET domain or that other SET 
domain proteins may be able to compensate for its function (Terranova et al., 2006).
1.29 The MLL protein family take part in large chromatin remodelling 
complexes
The presence of so many different domains in MLL would suggest that the 
protein can interact with several other proteins to perform different functions. This 
is apparently the case. MLL has been shown to participate in very large super 
complexes of 24 or more proteins (Nakamura et al., 2002). The proteins of the MLL 
super complex fall into eight different groups. These include core components of the 
nucleosome remodelling complex, members of the HDAC Sin3A complex, which is 
associated w ith transcriptional repression, components of the basal transcription 
machinery TFIID complex, and components of the yeast SET1 complex such as 
WDR5 (Nakamura et al., 2002) (Dou et al., 2006). Another protein recently found 
to complex with MLL is the tumour suppressor Menin (MEN1). It is thought that 
Menin functions to recruit MLL to the promoters of genes such as p27kiP1 (Milne et 
al., 2005c).
1.30 The MLL family of mammalian SET domain proteins
Several homologues of MLL that also contain SET domains have been found 
in mammals. These are termed MLL2, MLL3 and MLL4. Like MLL, these proteins 
have been shown to take part in chromatin remodelling complexes, although the 
components of these complexes vary (Goo et al., 2003; Hughes et al., 2004; Mo et al., 
2006). MLL2 and MLL3 have both been shown to take part in complexes w ith H3K4 
methylation activity that can positively regulate the expression of target genes (Goo 
et al., 2003; Hughes et al., 2004; Mo et al., 2006). M112has also been has been shown
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to complex with Menin and WDR5, as for MLL (Dou et al., 2006; Hughes et al., 
2004; Milne et al., 2005c; Mo et al., 2006). MLL2 null mouse die before El 1.5 and 
have growth retardation, widespread apoptosis and neural tube defects (Glaser et al., 
2006). Expression of H oxbl collapsed in M112/" embryos and expression of Hoxb2 
and Hoxb5 was reduced in embryoid bodies differentiated from MLL2 null ES cells 
(Glaser et al., 2006). This suggests that MLL2 targets different a different set of H ox 
genes to MLL. However, there is some scope for redundancy between these proteins 
as both MLL and MLL2 complex with Menin, which in turn has been shown to bind 
to the H oxc8 locus (Hughes et al., 2004; Milne et al., 2005c).
1.31 Transcriptional targets of MLL
MLL functions as a chromatin remodelling factor w ith DNA binding capacity 
that can activate and repress transcription through histone modification, direct 
interactions w ith transcriptional activating complexes and DNA methylation. Some 
of the gene targets of this activity have been identified.
As discussed above, the H ox genes are well characterised targets of MLL. M il 
homozygous null embryos have deregulated H ox expression leading to segmental 
abnormalities and MU deficient foetal liver was shown to have reduced levels of 
HoxalO, Hoxa9, Hoxa7 and Hoxc4 (Yagi et al., 1998; Yu et al., 1995). MLL also 
regulates the expression of several H ox genes, particularly of the Hoxa cluster, 
during embryoid body formation (Ernst et al., 2004b).
In non-haematopoietic cells MLL has been shown to bind to the promoters of 
the cell cycle inhibitors p27Ai^ i and ]>\%In]c4c as part of a complex w ith Menin (Milne 
et al., 2005c). Expression of p27*^; and p \%Ink4c was also reduced in M il deficient 
immortalised fibroblasts, which grow at a faster rate than wild type immortalised 
fibroblasts. This suggests that MLL, as well as regulating H ox  gene expression, may 
play a role in the cell cycle in some cells by up-regulating cell cycle inhibitors.
Another recently identified target of MLL is Gata3. MLL has been shown to 
localise directly with and regulate H3K4 methylation at the Gata3 locus in murine 
Th cells (Yamashita et al., 2006). In M il heterozygous mice the ability of memory 
Th2 cells to produce Th2 cytokines was reduced. This was because abnormal H3K4
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methylation at the Th2 cytokine and Gata3 gene loci resulted in reduced expression 
of these genes (Yamashita et al., 2006).
Further analysis of specific cell types, e.g. haematopoietic cells, may yet 
reveal more MLL targets.
1.32 The need for a conditional mouse model of Mil: Aims of this 
project
Due to the embryonic lethality of M il deletion, there have not been any 
studies performed looking at the role of M il in adult haematopoiesis. The limited 
material available from MU deficient embryos has also limited the study of foetal 
haematopoiesis in the absence of M il and the exact nature of the haematopoietic 
defect is not known. In order to study the role of M il further, a new, conditional 
mouse model of M il was needed. This study describes the establishment of a new 
mouse model that uses the Cre-lox system to induce haematopoietic specific deletion 
of MLL in adult mice. A full knockout model was also established to enable further 
study of foetal liver haematopoiesis. The aims of this project were as follows:
1. To establish new conditional and constitutive mouse knockout models 
of Mil.
2. To further analyse foetal liver haematopoiesis and characterise any 
effects on foetal HSCs in the absence of MLL.
3. To characterise the role of MU in  regulating adult haematopoiesis and 
HSCs.
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Chapter 2 
Materials and Methods
2.1 Materials
Reagents used in this project were from the following companies;
Perkin Elmer Life Sciences; Gene Screen Membrane.
Invitrogen; 1 kb ladder, Penicillin-streptomycin solution (10000 p/10000 pg/ml), 
Dulbeccos Modified Eagle Media (DMEM), L-Glutamine solution (200 mM), 
lx  Phosphate Buffered Saline solution (lx  PBS), lx  Trypsin-EDTA, lOOx 
Minimal essential amino acids, Hepes Buffered Saline Solution (HBSS), MEM 
Alpha media, Karyomax Colcemid solution (10 pg/ml), G418 solution (50 mg/ 
ml)
Promega; pGemT-Easy kit, restriction enzymes, klenow.
Sigma; General chemicals and reagents, Foetal Calf Serum (FCS) for MEF media, 
gelatine powder, Hepes Buffered Saline solution (HBS), 
Phenol:chloroform:isoamyl alcohol 25:24:1 saturated w ith 10 mM Tris pH 
8.0, 1 mM EDTA, Genomic Red taq 
Hyclone; ES cell FCS
VWR; General reagents and chemicals, Giemsa solution , Eukit, Superfrost© slides 
Chemicon; ESGRO® (Leukaemia Inhibitory Factory)
NE Biosciences; Restriction enzymes, T4 DNA ligase 
BD Biosciences; Advantage GC Taq polymerase kit 
Upstate; Mil c-terminal antibody, Mil N-terminal antibody 
Cell signalling technology; Hsp90 anitbody 
Stem cell technologies; Methocult 3434, 3630 
Peprotech; GMSCF
Pharmingen; Biotin-conjugated mouse lineage panel (for sorting FL cell)
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Miltenyi; Lineage cell depletion kit, mouse (for sorting adult BM), MS and LS 
magnetic columns, anti-pe, anti-APC and anti-bio microbeads 
Roche; Proteinase K (recombinant, PCR grade)
National Diagnostics; 20x SSC (Sodium Chloride Sodium Citrate)
Amersham Biosciences; ECL reagent, Sheep anti-mouse HRP
2.2 Methods
All buffers used in this work are detailed in Table 2.1
2.2.1 DNA sequencing and analysis
Vectors pM11197.Al and pMLL197.2kb were sequenced by the Scientific 
Support services at the Wolfson Institute, UCL.
2.2.2 Culture of Mouse Embryonic Fibroblasts for ES cell feeder layers
The pluripotency of ES cells was maintained by growing the cells on a feeder 
layer of irradiated mouse embryonic fibroblasts (MEFs). Embryonic material from 
neomycin resistant Rag2 A embryos at day 13-14 was provided by Ursula Menzel at 
NIMR. Primary embryonic fibroblasts were plated out in MEF medium (DMEM, 
10% FCS, 5 ml penicillin/streptomycin solution, 2 mM L-Glutamine) and cultured at 
37°C, 5% CO2 .
The cells were expanded over 3 passages from 1 to 25 175mm flasks. All 
flasks were then trypsinised, using 1% trypsin plus EDTA. The cells were pooled and 
counted and then y-irradiated using a CIS Bio International 137Cs irradiator, w ith a 
dose of 3500 rads. Cells were aliquoted at densities of 4x106 and 2x107 and frozen at - 
80°C in MEF freeze media (50% MEF media, 40% FCS, 10% DMSO).
2.2.3 Gelatinization of Plates for ES cell culture
Prior to laying down the feeder layer, plates were gelatinized. A solution of 
0.1% gelatine in lx  PBS was left on the plates for up to an hour. The gelatine was 
removed and the plates left to dry before the feeder layer was seeded onto the plate 
or media added.
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Buffer or Media Components
lx TE 10 mM Tris-Cl,pH 7.5, 1 mM EDTA
caesium chloride/TE 
solution lg/ml CsCl added to lxTE
ES cell lysis buffer 0.1M NaCl, 1% SDS, 0.01M Tris-HCl, 0.001M EDTA, 0.5 mg/ml proteinase K Roche
Southern De- 
naturation buffer 1.5M NaCl, 0.5M NaOH
Southern 
Neutralisation buffer 1M Tris, 1.5M NaCl, pH 7.4
Southern Pre­
hybridisation solution
5xSSC, 0.5% SDS, 10% dextran sulphate, 1% Ficoll, 
1% polyvinylpyrrolidone, 1% BSA, 10 pg/ml 
denatured salmon sperm DNA
Hypotonic Solution 0.56% KC1 in ddH20
ES cell injection 
medium
90 ml DMEM plus HEPES, 10 ml ES cell FCS, 1.5 ml 
Penicillin/streptomycin solution, 1.5 ml L- 
Glutamine (2mM)
TNES lysis buffer 50mM Tris pH7.5, 50mM EDTA, 5% SDS plus 0.5mg/ml proteinase K
RBC lysis buffer 17 mM Tris (pH 7.2), 0.144 M NH4C1
2X SDS-DTT sample 
buffer
0.2 M DTT, 2% SDS, 10% glycerol, 0.125 M Tris- 
HCL, pH 6.8, 0.1% bromophenol blue
MACs buffer lxPBS, 0.5% BSA, 2 mM EDTA
FACs running buffer 0.05% sodium azide, lx PBS
FACS staining buffer 0.05% sodium azide, 0.1% BSA
Western Running 
Buffer 1.92M glycine, 250mM Tris base, 1% SDS
Western Transfer 
Buffer
1 x CAPS (N-Cyclohexyl-3-aminopropanesulfonic 
acid), pH 11
TBS-T Buffer 0.14M NaCl, 0.025M Tris, 0.003M KC1, 0.4 pi Tween 20/ ml, pH7.4
1 x Stripping Buffer 200mM Tris-HCl, pH 7.0, 0.1% SDS, 0.1 x SSC
Table 2.1. Buffers used in materials and methods.
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2.2.4 ES cell culture
PC3 ES cells (O’Gorman et al. 1997) at passage 14 were provided by Dimitris 
Kioussis, NIMR. Cells were routinely grown on a layer of irradiated mouse 
embryonic fibroblasts (MEFs) as a feeder layer. Feeder layers were laid down on 
gelatinized plates several hours before they were needed. Feeder layers were used in 
the densities shown in Table 2.2.
The ES cells were plated out onto MEF's and fed daily w ith ES cell medium ( 
450 ml DMEM plus 75 ml ES cell FCS (Hyclone), 3.5 pi p-mercaptoethanol (98% 
solution), 5 ml Penicillin/streptomycin solution, 5ml L-Glutamine (2mM), 50 pi LIF 
(107 units/ml, ESGRO), 5 ml minimal essential amino acids (100X)). Cells were split 
at ratio of 1:3 to 1:8 when confluent, as assessed by colony size and density. To split, 
the cells were trypsinised for 5 minutes at 37°C using lx  trypsin-EDTA, washed 
once in ES cell media and plated onto a fresh feeder layer.
2.2.5 Preparation of the targeting vector for electroporation into ES cells
For electroporation into ES cells, it was necessary that the targeting vector 
DNA be cleaned of any bacterial genomic DNA and proteins. For this reason, 
targeting vector DNA prepared from Escherichia coli using a Quiagen Maxiprep kit 
(according to manufacturers instructions) was further cleaned by performing a 
Caesium Chloride preparation. Briefly, 10 ml of caesium chloride/TE solution was 
added to 1-2 mg targeting vector DNA dissolved in 500 pi TE. 4 ml of 10 mg/ml 
Ethidium bromide solution was added and the mixture transferred to an 
ultracentrifuge tube. The tubes were capped and sealed and spun overnight at 57,000 
rpm, 20°C in an ultracentrifuge (Sorvall Discovery 100).
The following morning the tubes were removed and placed in a bench top 
clamp. A syringe needle was used to pierce the top of the tube to release any 
pressure, and then another needle and syringe were used to pierce the tube and 
extract the plasmid DNA. The DNA was transferred to a 15 ml tube, and 1 ml of 
NaCl-saturated isopropanol was added. After vortexing, the top layer was removed 
and the process repeated until the top layer was colourless. The bottom layer was
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Size of Dish Density of MEFs Volume of Media
96-well dish 2xl04 per well 50pl
24-well dish 1.3xl05 per well 500pl
60mm plate 2x106 4ml
10cm plate 4xl06 10ml
Table 2.2. Number of irradiated MEFs needed for feeder layers for ES 
cells.
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removed and transferred to a 50 ml tube. Three volumes of ddFEO were added to 
the DNA layer. Two volumes of 100% ethanol was added to this and the DNA left to 
precipitate for 10 minutes on ice. The tube was spun for 45 min at 4°C, 4000 rpm to 
pellet the DNA. The DNA was cleaned by spinning in 20 ml 70% ethanol for 15 min 
at 4000 rpm, the pellet dried and the DNA re-dissolved in sterile ddFhO water.
The purified targeting vector was linearised using an NsA site (shown in 
Figure 3.1), ethanol precipitated and re-suspended in sterile ddFhO, ready for 
electroporation into ES cells.
2.2.6 Electroporation of ES cells
The linearised targeting vector was electroporated into PC3 ES cells at 
passage 16. The day before electroporation, 10 x 10 cm dishes were laid down with 
MEFs in MEF media at the appropriate density. The MEF media was replaced with 
ES cell media the morning of the electroporation. A 6 cm plate of ES cells was grown 
to 50-100% confluency. The cells were fed with ES cell media at least an hour before 
they were needed for electroporation.
The ES cells were trypsinised as before, and a live cell count performed. The 
cells were re-suspended in electroporation buffer (HBS/ 7xlO'^/o p-mercaptoethanol) 
at a concentration of 107 cells/ml. 0.8 ml cells was mixed with 25 pg targeting vector 
DNA (re-suspended in sterile ddFhO) and the mixture transferred to a 4 mm 
electroporation cuvette. The cells were electroporated using an electroporator set at 
400 v, 25 pF. Following electroporation, the cells were immediately transferred to a 
15 ml tube containing 3.2 ml ES cell media.
400 pi of cells was added to each 10cm MEF plate, and the cells placed in a 
37°C/5% CO2 incubator. The following day, the media on all plates was changed to 
selection media (ES cell media plus 300 pg/ ml G418). The cells were left to grow 
under selection for the next 8-10 days, w ith a media change every 3 days.
2.2.7 Picking and Expansion of Selected ES cell clones
After 8-10 days of growth under selection, G418 resistant ES cell colonies 
were visible growing on the feeder layer. Each 10cm plate was examined for the
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presence of G418 resistant colonies and the media replaced with 1 x PBS. 96-well 
MEF plates in ES cell media were prepared before picking any clones (see Table 2)
Using a phase-contrast microscope, colonies of a suitable size were picked 
from the MEF plates using a P200 pipette. Each colony was transferred to a 96-well 
U-bottom plate containing 30 pi trypsin/ well. The colonies were trypsinised for 5 
minutes at room temperature and transferred to the pre-prepared 96-well MEF 
plate. Full 96-well plates were then transferred to 37°C/5% CO2 incubator. Between 
800-1000 colonies were picked in this way.
96-well plates were checked each day for confluent wells. Confluent wells 
were trypsinised and the cells were split to one DNA plate (gelatinised 96-well plate) 
and one freeze plate (96-well MEF plate). DNA plates were split to a further two 
DNA plates when confluent.
2.2.8 Freezing and of ES cell clones
Confluent 96-well plates of ES cells growing on MEFs were frozen at -80°C 
for future expansion. All wells of the plate were trypsinised with 50 pi trypsin per 
well, 50 pi ES cell media was then added to each well and the colonies made into 
single cell suspensions. 100 pi ES cell freeze medium (20% DMSO/80% ES cell FCS) 
was added to each well and the plates stored at -80°C.
2.2.9 DNA extraction from ES cell clones.
Confluent 96-well plates of ES cells growing on gelatine were lysed for DNA 
extraction. Media was removed from all wells and the wells washed once with 1 x 
PBS. 50 pi ES cell lysis buffer was added to each well and the plates incubated O/N 
at 37°C. Plates were then either frozen at -20°C for future use or DNA extracted 
directly.
To extract DNA, 100 pi ice cold isopropanol was added to each well. The 
DNA was left to precipitate at room temperature for an hour, after which the 
isopropanol was decanted off. 150 pi of 70% ethanol at room temperature was added 
to each well and then immediately decanted off. The wells were washed again with 
70% ethanol, and the plates were left to dry. DNA was re-suspended either in 50 pi
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1M Tris-HCl pH 7.5 or restriction digest buffer mix (according to manufacturer’s 
instructions), and shaken O/N at 37°C.
2.2.10 Analysis of ES Cell DNA from 96-well plates
To prepare genomic DNA for Southern blot analysis, restriction digests were 
set up directly in the 96-well plates following DNA preparation. The DNA in each 
well was digested with 60 units of enzyme in a 65 pi volume for at least 16 hours 
before being used for Southern Blot analysis.
2.2.11 Southern Blot Analysis
DNA extracted from 96-well plates of ES cell clones was analyzed by 
Southern Blot analysis. Southern Blots were prepared using a standard protocol. 
DNA Samples were run on an agarose gel of the appropriate concentration (0.7%- 
0.8%) O/N at 24 v. The samples were run against 1Kb ladder for size approximation.
The following day, the gel was photographed, w ith a ruler to mark the 
position of the ladder, and then washed in dH20 for 5 minutes. If large fragments 
were expected, the gel was de-purinated in 0.125M HC1 for 10 minutes. Gels were 
then washed again for 5 minutes in dH20. This was followed by 2 x 30 minute 
washes in de-naturation buffer, 1 x 5  minute wash in dH20, 2 x 30 minute washes in 
neutralisation buffer. Gels were washed again for 5 minutes in dH20.
Transfer apparatus was set up as follows: A sponge soaked in 10 x SSC was 
placed in a tray. On top of this, in order, were placed 3 sheets of 3MM filter paper, 
the gel (face down), a sheet of Gene Screen membrane, 3 more layers of 3MM filter 
paper, paper towels and weights. All filter paper and membranes had previously 
been soaked in 10 x SSC. The gel was transferred overnight.
Following transfer, the membrane was washed in 2 x SSC. The membrane 
was baked at 80°C for two hours and re-hydrated in 2 x SSC. The membrane was 
blocked in pre-hybridisation solution for 2 hours at 65°C with agitation. 70 ng of 
purified 32P d-CTP labelled probe was added to the pre-hybridisation solution and 
the probe left to bind O/N at 65°C. The probe (named the 3' probe) was obtained by 
digesting MLL genomic DNA, previously cloned into pBs, w ith BstXi/BgRl which
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released a 650 bp fragment from intron 13-14 of the gene. The blot was removed and 
washed the following day for 2 x 30 minutes in 3 x SSC/ 0.1% SDS, 2 x 30 minutes in 
0.3 x SSC/ 0.1% SDS. The blot was then placed in a phosphoimager cassette and 
visualised using a Typhoon 8600 phosphoimager.
2.2.12 Expansion of Positive ES cell Clones
Clones found to be positive for the 3' and 5* LoxP sites were thawed and 
expanded. Whole 96-well plates of clones were thawed at 37°C and transferred 
directly to 24-well MEF plates with ES cell media. W hen confluent, clones were 
expanded first to 6 cm dishes and then 10 cm dishes. 6 cm dishes were used for 
karyotyping. 10 cm dishes, when confluent, were trypsinised and split in 4. Three- 
quarters of the plate were frozen in 3 aliquots in ES cell freeze media.
The remaining quarter of the plate was used for DNA extraction for Southern 
Blot analysis using a standard Phenol: Chloroform extraction protocol. Briefly, cells 
were lysed with ES cell lysis buffer as before, in a 1 ml volume. 1 ml of 
phenol:chloroform:isoamyl was added to the lysates and the tubes were vigourously 
shaken for 1 minute. The tubes were then spun at 13,000 rpm for 5 minutes to 
separate the hydrophobic and hydrophilic layer. The top aqueous layer was 
transferred to a fresh tube and an equal volume of chloroform was added to it. The 
tubes were again spun at 13,000 rpm for 5 minutes and the top layer transferred to a 
fresh tube. 1 ml of 100% ethanol: 3M sodium acetate 25:1 was added to each tube 
and then the tubes were placed on dry ice for up to an hour. The tubes were then 
spun at 13,000 rpm for 10 minutes to pellet the DNA and the supernatant was 
removed. 1 ml 70% ethanol was added to each tube and the tubes were spun at 
13,000 rpm for 1-2 minutes. The ethanol was removed and the DNA pellets dried 
and resuspended in lx  TE.
2.2.13 Southern Blot Analysis of DNA from expanded clones
Southern Blot analysis was repeated using DNA from expanded clones. 
Southern Blots were performed as before using 5-10 pg DNA. Analysis was done
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using both the KpnI and NsA digests to ensure the presence of the LoxNeoLox 
cassette and the 5' LoxP site.
2.2.14 Karyotyping of ES Cells
Before using ES cells in blastocyst injections, it was necessary to karyotype 
them as culture of ES cells may result in aneuploidy in some cells. A 50-75% 
confluent 6cm plate of ES cells was used for karyotyping.
Cells were incubated in ES cell mediae plus 20 ng/ml Colcemid for 2 hours at 
37°C. The cells were then washed with 1 x PBS and trypsinised. After a second wash 
in 1 x PBS the cells were re-suspended in 5 ml hypotonic solution and incubated for 
6 minutes at room temperature. A few drops of fixative (3:1 methanol: acetic acid) 
were added to the hypotonic and the cells pelleted at 750 rpm for 5 minute. The 
hypotonic was removed and ice-cold fixative was added to the cells drop wise, to 
ensure an even suspension of cells. The cells were pelleted and washed in ice-cold 
fixative a further 3 times and finally re-suspended in an appropriate amount of 
fixative depending on the density of the suspension. Cells could be stored in fixative 
at -20°C for future use.
To make slides, Superfrost© slides were soaked in 5% acetic acid O/N and air 
dried. Fixed cells were dropped onto the slides using a Pasteur pipette and the 
metaphase spreads examined using a phase contrast microscope. Satisfactory spreads 
were left O/N at room temperature and stained the following day with 10% Giemsa 
stain for 20 minutes at room temperature. A coverslip was fixed to each slide w ith 
Eukit mountant. Metaphase spreads were examined using an oil immersion lenses 
and the chromosome counts made.
2.2.15 Blastocyst Injection
ES cell clones carrying the correct complement of chromosomes and positive 
for both LoxP sites and the Neo cassette were injected into C57B1/6 blastocysts by 
Dimitris Kioussis at NIMR. Cells were prepared for injection as follows: a 50-75% 
confluent 6 cm plate of ES cells was fed at least two hours before they were needed 
for injection. W hen the blastocysts were ready for injection, the ES cells were
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trypsinised and washed twice in ES cell media. The cells were resupended in 
injection media and taken on ice to be injected into blastocysyts. The blastocysts 
were implanted into pseudo-pregnant females and the resultant offspring analysed 
for levels of chimerism as shown by coat colour.
2.2.16 Mouse Genotyping
All chimeras and their descendents were housed at NIMR. Animal 
husbandry, re-derivations (necessary for transferral of the mice to clean animal 
facilities) and tail tipping were taken care of courtesy of staff at NIMR. DNA samples 
for genotyping were prepared from tail tips. Briefly, tips were digested O/N in 500 pi 
TNES lysis buffer plus 0.5 mg/ml proteinase K at 37°C or 55°C. The following day 
samples were spun at 13,000 rpm for 15 minutes and the supernatant transferred to a 
fresh microcentrifuge tube. 500 pi isopropanol was added to each tube and the DNA 
spooled out using an inoculating loop. DNA was washed once in 70% ethanol, re­
suspended in 1 x TE and shaken O/N at 37°C.
The DNA was then analysed by Southern Blotting or PCR. Southern Blotting 
was carried out as before, using a KpnI or NsA digest of 5-10 pg DNA and the 3' 
probe. PCR analysis was carried out using 3 combinations of primers. All primers 
and their binding sites in the different alleles are shown in Figure 4.2 and 4.8. 
Primers A and B were used to detected the presence of the Neo cassette. PCR 
reactions for genotyping the M il allele were set up using the Advantage GC2 PCR 
kit according to manufacturers instructions (BD-Biosciences). Genotyping for Cre 
transgenes was done using Genomic RedTaq (Sigma) according to manufacturers 
instructions. All primer combinations and the programmes used are shown in Tables
2.3 and 2.4.
PC3 ES cells are homozygous for the protamine-Cre transgene (O’Gorman et 
a l 1997), so that all offspring of successful chimaeras were heterozygous for this 
transgene. To detect the presence of the protamine-Cre transgene, a PCR using 
primers PC3CreF and PC3CreR was used (Tables 2.3 and 2.4).
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Primer Name Primer Sequence
LoxPF 5' TGCCCTAGGCCGACGTCGCATG 3'
LoxPR 5' TCGCCCGGGTAGTCGACCTGCA 3'
Intron5-
6MLLC
5' GGTCTCTAGAAGACAGGAGG 3'
PCR2a 5' CCCATGTACCTATCATCCAGC 3'
Exon5MLL 5' CAGTTGCTGGCTCAGAAGATGCC 3'
Intron5- 
6841OR
5' CACACCCATCTTAGGACTACCTCC 3'
B 5' GTCAGTGGTTGGTCACTGGG 3'
D 5' TGTCTCCTCTGTGATGATGCC 3'
A 5' GATCTCGTCGTGACCCATGG 3'
E2 5' GCCAGTCAGTCCGAAAGTAC 3'
F2 5' AGGATGTTCAAAGTGCCTGC 3'
G2 5' GCTCTAGAACTAGTGGATCCC 3'
PC3CreF 5' TTCCCGCAGAACCTGAAGATGTTCG 3'
PC3CreR 5' GCCGATTACGTATATCCTGGCAGC 3'
VavF 5' AGATGCCAGGACATCAGGAACCTG 3'
VavR 5' ATCAGCCACACCAGACACAGAGATC 3'
Table 2.3. Primers used for cloning and genotyping.
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PCR Primers Programme
Amplify LoxP LoxPF, LoxPR 94°C 3 min, (94°C 1 min, 63°C 1 min, 72°C 1 
min) x35 cycles, 72°C 10 min
Amplify 5' 
homology 
fragment
Exon5MLL, 
Intron5- 
6841OR
97°C 3 min, (97°C 30s, 63°C 1 min, 72°C 2 
min) x3 cycles, (96°C 30s, 63°C 1 min, 72°C 
2 min) x7 cycles, (96°C 30s, 62°C 1 min, 
72°C 2 min) xlO cycles, (96°C 30s, 61 °C 1 
min, 72°C 2 min) xlO cycles, 72°C 10 min
Amplify 3' 
homology 
fragment
Intron5-
6MLLC,
PCR2A
97°C 3 min, (97°C 30s, 63°C 1 min, 72°C 2 
min) x3 cycles, (96°C 30s, 63°C 1 min, 72°C 
2 min) x7 cycles, (96°C 30s, 62°C 1 min, 
72°C 2 min) xlO cycles, (96°C 30s, 61°C 1 
min, 72°C 2 min) xlO cycles, 72°C 10 min
Genotyping: 
Detect 3' LoxP
D,B 97°C 3 min, (97°C 30s, 63°C 1 min, 72°C 2 
min) x3 cycles, (96°C 30s, 63°C 1 min, 72°C 
2 min) x7 cycles, (96°C 30s, 62°C 1 min, 
72°C 2 min) xlO cycles, (96°C 30s, 61 °C 1 
min, 72°C 2 min) xlO cycles, 72°C 10 min
Genotyping: 
Detect the 
Neor
A, B 97°C 3 min, (97°C 30s, 63°C 1 min, 72°C 2 
min) x3 cycles, (96°C 30s, 63°C 1 min, 72°C 
2 min) x7 cycles, (96°C 30s, 62°C 1 min, 
72°C 2 min) xlO cycles, (96°C 30s, 61°C 1 
min, 72°C 2 min) xlO cycles, 72°C 10 min
Genotyping: 
Detect the 5' 
LoxP
E2,B 
E2, F 
E2, G2
97°C 3 min, (97°C 30s, 62°C 1 min, 72°C 2 
min) x3 cycles, (96°C 30s, 62°C 1 min, 72°C 
2 min) x7 cycles, (96°C 30s, 61 °C 1 min, 
72°C 2 min) xlO cycles, (96°C 30s, 60°C 1 
min, 72°C 2 min) xlO cycles, 72°C 10 min
Genotyping: 
Detect the 
PC3 Cre
PC3CreF,
PC3CreR
94°C 3 min, (94°C 40s, 62°C 40s, 72°C 30s) 
x30 cycles, 72°C 5 min
Genotyping: 
Detect the 
Vav-Cre
VavF, VavR 94°C 3 min, (94°C 40s, 62°C 40s, 72°C 30s) 
x30 cycles, 72°C 5 min
Table 2.4. PCR programmes used for cloning and genotyping
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A genotyping PCR was also used to genotype mice carrying the Vav-cre 
transgene. Primers VavF and VavR were used to amplify a band of 250 bp (Tables
2.3 and 2.4).
2.2.17 Mouse Husbandry
All mouse husbandry was carried out by staff in the animal facilities in 
NIMR. All animal husbandry and experimental procedures were carried out 
according to UK Home Office regulations and Institute guidelines.
2.2.18 Timed matings
W here embryos were needed, timed matings were set up by members of the 
animal house staff at NIMR. Up to three females were left w ith one male from 
approximately 5pm in the evening to 7am the next morning. The females were 
checked for the presence of a vaginal plug. Those that had plugged were considered 
pregnant and were separated from the male. The day that the plug was found was 
counted as E0.5. Pregnant mothers were sacrificed for embryos on the appropriate 
day.
2.2.19 Dissection of embryos and preparation of foetal liver cells
Pregnant females at the appropriate timepoint were killed using Schedule 1 
approved methods. The uteri were taken and placed in ice cold air buffered Iscoves 
Modified Dulbeccos Medium (AB IMDM). The embryos were dissected from the 
uterus and yolk sac and placed in ice cold AB IMDM in individual wells of 6-well 
plates. The fetal livers were removed from the embryos using dissecting forceps and 
the rest of the embryo removed to another dish. The heads of the embryos were 
used for genotyping. Each fetal liver was passed through a 70 pm cell strainer to 
produce a single cell suspension.
2.2.20 Removal of erythrocytes from single cell suspensions of 
hematopoietic cells
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W hen analysing cells from haematopoietic organs and blood, it was 
sometimes necessary to remove any erythrocytes present. Single cell suspensions 
prepared from bone marrow, spleen, thymus, blood or fetal liver were pelleted at 
1200 rpm for 5 minutes. The cells were resuspended in RBC lysis buffer and 
incubated at room temperature for 10 minutes. 10 ml of HBSS was then added to the 
tube and the cells were pelleted at 1200 rpm for 10 minutes. The cells were 
resuspended in the appropriate media.
2.2.21 Genotyping Embryos
Embryos were genotyped using the same PCR strategies that were used to 
genotype adult mice. Material from embryos e.g. the head was lysed in TNES lysis 
buffer plus 0.5 mg/ml proteinase K for 24 hours at 37°C or 55°C. DNA was then 
prepared as for tail lysates. PCRs were performed on the prepared DNA as for tail 
lysates.
2.2.22 Western Blotting to detect the MLL protein
All Western blotting was done by Samantha Hiew. The protocol was also 
optimized by Samantha Hiew. Whole-cell lysates for W estern blotting were 
prepared using 2X SDS-DTT sample buffer. 1 x 106 cells were taken from single cell 
suspensions from foetal liver and spleen and resuspended in 60pl sample buffer. The 
lysates were then sonicated for 1 minute w ith a 50% pulse and then boiled for 5 
minutes at 100eC. The samples were centrifuged at 13,000 rpm for several seconds 
and then if not used immediately, stored at -80 eC. The samples were loaded onto a 
SDS-PAGE gel with a 5% resolving gel and 4% stacking gel. The resolving and 
stacking gels were made according to standard protocols. Rainbow kaleidoscope 
ladder (Biorad) was used to assess protein fragment size. The gel was run at 50-65 v 
overnight in running buffer until the sample buffer had run off the end of the gel. 
The following day the protein was transferred onto PVDF membrane (Imobilon-P) 
in transfer buffer at 70 v/400 mA at 4eC for 5-6 hours.
Following transfer, the membrane was blocked for 1 hour with 5 % skimmed 
milk in TBS-T buffer. Two antibodies were used to detect the N-terminal and C-
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terminal fragments of the MLL protein. The N-terminal fragment runs at 
approximately 320 KD and the C-terminal fragment runs at approximately 180 kD 
(Hsieh et al., 2003). The anti-N-terminal antibody was raised against a maltose- 
binding protein (MBP) corresponding to human MLL amino acids 161-356 (clone 
N4.4) and the anti- C-terminal monoclonal antibody (Upstate) was raised against a 
maltose-binding protein (MBP) corresponding to human MLL amino acids 3084- 
3959 (clone 9-12). The binding positions of the antibodies are shown in Figure 2.1. 
The membrane was incubated overnight at 4eC with either MLLN4.4 (1:400) or MLL 
Clone9-12 (1:250) diluted in 5% milk/TBS-T. Proteins were detected using a sheep 
anti-mouse horse radish peroxidase (HRP) and a chemiluminescent reagent (ECL). 
Membranes were stripped in lx  stripping buffer, the blocking step was repeated and 
the membranes were re-probed with anti-HSP90 (1:2000) for 2 hours at RT as a 
loading control.
2.2.23 Counting Cells using Trypan blue
To obtain viable cell counts, trypan blue exclusion was used. Single cell 
suspensions were diluted in trypan blue and counted using a haemocytometer.
2.2.24 Analysis of data
All flow cytometric data was analysed using Summit 4.1, 4.2 or 4.3 
(Dakocytomation). All graphs were produced using either Microsoft Excel or 
Graphpad Prism 4. All statistical analyses were performed using Graphpad Prism 4 
software, according to the guide provided with the software. W hen comparing two 
data sets, a two-tailed non-paired t-test was performed to assess whether the sets 
were significantly different. Paired two-tailed t-tests were also used to analyse flow 
cytometric data from M il conditional mice. W here 3 data sets were analysed, One­
way anova with Tukeys multiple comparison test was performed.
2.2.25 Methylcellulose Colony-forming assays with foetal liver cells
Single cells suspensions were prepared from E l2.5 fetal liver. Following 
erythrocyte removal, 1.1 x 104 nucleated cells were added to 1.1 ml M3434
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Figure 2.1. Binding positions of the antibodies used for western blots of 
MLL.
The schematic shows the MLL protein. See Figure 1.5 for details of all the 
domains shown. The N-terminal antibody -  N4.4 - binds across the AT 
hooks. The C-terminal antibody -  9-12 -  binds across the SET domain.
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methylcellulose media (contains m-SCF, mIL-3, hIL-6, hEpo) plus GM-CSF at a 
concentration of 10 ng per ml. The cells were plated into 35 mm dishes and the 
cultures were placed in anther 10 cm dish containing a 35 mm dish of sterile 1 x PBS 
to prevent the plates from dessicating. The cultures were incubated at 37eC in 5% 
CO2 for up to 14 days. Colony Forming Units (CFUs) were scored after 7 and 14 days 
according to instructions from Stem Cell Technologies. Counts were made for CFU- 
Granulocyte, Macrophage (CFU-GM), CFU-Granulocyte, Erythrocyte, Macrophage, 
Megakaryocyte (CFU-GEMM) and Burst-Forming Unit Erythroid (BFU-E). The cells 
were then removed from the plate and then counted using trypan blue exclusion.
2.2.26 Cytospin analysis
To analyze the morphology of cells produced in CFU assays, cytopins were 
performed. Single cell suspensions were made and the cells washed twice in 1 x PBS. 
The cells were resuspended in MACs buffer at a concentration of 3 x 105 per ml. 100 
pi of cell suspension was centrifuged onto slides at 35 g for 5 minutes at low 
deceleration using a cytospin 3 machine (Shandon). The slides were then fixed and 
stained with May-Grunwald-Giemsa using a Shandon varistain 24-4 automated 
staining machine in the Haematology department at Great Ormond Street Hospital.
2.2.27 General protocol for the preparation of samples for flow 
cytometric analyses
For flow cytometry, samples from fetal and adult mice were prepared as 
follows. Single cell suspensions were prepared from foetal liver, adult bone marrow, 
thymus, spleen, mesenteric lymph node or blood. W here necessary, erythrocytes 
were removed by incubation in RBC lysis buffer. The cells were counted and 
aliquoted at a concentration of up to lx l0 7 cells per ml into either 5 ml round 
bottom FACS tubes or v-bottomed 96 well microtitre plates. The cells were washed 
once in staining buffer. All incubations and washes were performed with staining 
buffer, unless otherwise indicated. The cells were incubated with anti-Fcy lll/ll 
receptor mAh2 402 (1:5 dilution, produced in house) for 15 minutes on ice to prevent 
non-specific antibody binding. The cells were then incubated with the primary
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antibodies, at the specified dilution, on ice for 30 minutes. For details of all 
antibodies used, see Table 2.5. Isotype controls were routinely used for all 
experiments (Figure 2.2). W here a secondary antibody was used, the cells were 
washed once and incubated with the secondary antibody at the appropriate dilution 
for 15 minutes. The cells were then washed twice in running buffer. The cells were 
resuspended in 100-400 pi of running buffer and run on a Dakocytomation Cyan 
ADP flow cytometer. All samples were aquired using appropriate live gates (Figure
2.3). All flow cytometric data was analysed using Summit 4.1, 4.2 or 4.3 
(Dakocytomation).
2.2.28 Magnetic Activated Cell Sorting
W here it was necessary to sort for a population of cells expressing a 
particular marker, the Miltenyi Magnetic Activated Cell Sorting System (MACS) was 
used. The system was used according to the manufacturers instructions. Briefly, cells 
prepared from foetal liver or bone marrow were incubated w ith an antibody to the 
marker of interest (e.g anti c-kit APC, an ti-T erll9  PE, biotin-conjugated lineage 
markers). The cells were then washed and incubated w ith magnetic beads that 
bound to the conjugate present on the primary antibody (e.g Streptavidin beads, 
anti-APC, anti-PE beads). The cells were washed again and then passed down MACs 
MS or LS columns in the presence of a magnetic field. The column flow through was 
taken as cells negative for the marker in question, the cells attached to the column 
were taken as positive for the marker in question. The purity of all sorts was 
estimated following the sort by flow cytometry. W here necessary, cells were sorted 
twice to separate populations expressing different markers. For a detailed protocol, 
please see the manufacturers instructions (Miltenyi).
2.2.29 Analysis of foetal liver stem cells by flow cytometry
For analysis of fetal liver HSC populations, single cell suspensions were made 
from fetal livers from E l3.5 embryos. Total live cell counts were obtained for each 
foetal liver using trypan blue. Cells were stained with a biotin-conjugated Lineage 
antibody cocktail (CD3e (145-2C), CD45R/B220 (RA3-6B2), Ly6G and Ly-6C (RB6-
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Antibody Clone Isotype Supplier
W orking
Dilution
Anti-Seal-PE D7 IgG2a k
BD
Pharmingen 1:200
Anti-Mac 1- 
PE
M l/70 IgG2b k
BD
Pharmingen 1:200
Anti-Mac 1- 
FITC
M l/70 IgG2b k eBioscience 1:100
A nti-G rl-
APC
RB6-8CS IgG2b k eBioscience 1:300
A nti-Terll9-
PE
T erll9 IgG2b k
BD
Pharmingen 1:100
Anti-B220-
APC
RA3-6B2 IgG2a k eBioscience 1:100
Anti-CD 19- 
PE 1D3 IgG2a k
BD
Pharmingen 1:200
Anti-Ly5.2-
Bio
104 IgG2a k eBioscience 1:100
Anti-c-kit-
APC 2B8
IgG2b k eBioscience 1:100
Anti-Seal - 
FITC
D7 IgG2a k eBioscience 1:100
Anti-CD38-
PE 90 IgG2a k eBioscience 1:600
Anti-Ly5.2-
FITC
104 IgG2a k eBioscience 1:100
Anti-Ly5.1-
PE A20 IgG2a k eBioscience 1:200
Anti-CD4-PE H129.19 IgG2a k BD
Pharmingen 1:200
Anti-CD8-Tri CT-CD8a IgG2a k Caltag 1:100
Anti-IgG2A-
PE G155-178 IgG2a k
BD
Pharmingen 1:100
Anti-IgG2b-
FITC
27-35 IgG2b k BDPharmingen 1:100
Anti-IgG2b-
APC N/A IgG2b k eBioscience 1:100
Streptavidin-
PerCP N/A N/A
BD
Pharmingen 1:200
Table 2.5. Antibodies used for flow cytometric analyses.
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Figure 2.2. Isotype controls used for flow cytometry experiments. 
Representative histograms are shown for isotype controls to control 
for non-specific antibody binding. The blue plot is an unstained 
sample, the red plot is the isotype control stained sample.
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Figure 2.3. Live gates used for flow cytometric analyses. 
Representative dot plots showing gating for live cell populations in 
bone marrow, spleen, lymph node, thymus and foetal liver.
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8C5), and TER-119, Pharmingen). Lineage positive cells were depleted using 
magnetic sorting according to the manufacturer’s instructions (MACS, Miltenyi). 
Lineage negative cells were incubated with anti-Fcy III/II receptor mAb24G2 to 
prevent non-specific antibody binding and then incubated with c-kit-APC, Seal 
FITC, CD38 PE, 7AAD (to gate out dead cells) and Streptavidin-PrCP. Cells were 
analysed on a Dakocytomation Cyan ADP as before.
2.2.30 Reconstitution experiments using foetal liver cells
For reconstitution experiments with foetal liver, single cell suspensions were 
prepared from foetal livers (CD45.2/Ly5.2+) isolated from M11A and M lt/+ E l4.5 
embryos and frozen in 90% FCS and 10% DMSO. After genotyping using embryo 
material, the foetal liver cells were thawed into HBSS and pooled by genotype. The 
cells were then stained with c-kit APC and T e rll9  PE antibodies and c-kit+T erll9 ' 
cells were sorted using the MACS system, as described previously (Miltenyi). 
C57BL/6 Ly5.1 recipients were irradiated w ith a first dose of 5 Gy and a second dose 
of 4 Gy. They were then injected intravenously w ith 4 x 104 viable sorted foetal liver 
cells plus a radioprotective dose of 2 x 105 C57BL/6 Ly5.1+ bone marrow cells. All 
injections were performed by Owen Williams. Blood was taken from the recipients 
1 month post-transplantation and the reconstitution levels were assessed by 
analysing the number of Ly5.1 and Ly5.2 positive cells present using flow 
cytometry. After 4 months, the recipients were sacrificed and the bone marrow, 
spleen and thymus analyzed for the presence of Ly5.1 and Ly5.2 positive cells by 
flow cytometry.
2.2.31 Analysis of adult haematopoietic populations by flow cytometry
Haematopoietic cells in adult M il conditional mice were analysed by flow 
cytometry. 8 week old mice were killed using Schedule 1 approved methods. Spleen, 
thymus and mesenteric lymph nodes were taken from each individual. These were 
passed through 70 pM cell strainers to achieve single cell suspensions. The femurs 
and tibia were taken from each mouse and transferred to AB IMDM. Any muscle or 
skin was removed from the bones which were placed in fresh HBSS. The bone
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marrow was then flushed from the bones using a 25 gauge needle. Erythrocytes 
were removed from all samples by incubation in RBC lysis buffer as before. Viable 
cell counts were made, and aliquots of 1 x 106 cells from each sample were 
transferred to 96 well v-bottom microtitre plates. The cells were stained with 
different combinations of the following antibodies: anti-CD4-PE, anti-CD8-Tri, 
anti-c-kit-APC, anti-Scal-PE, Biotin-conjugated-Lineage panel, anti-B220-APC, 
anti-CD19-PE, anti-Grl-APC, anti-Mac 1-FITC, anti-IgG2a-PE, anti-IgG2b-FITC, 
anti-IgG2b-APC, anti-Ly5.2-FITC, anti-Ly5.1-PE, Steptavidin-PrCP. The cells were 
analysed on a Dakocytomation Cyan ADP flow cytometer as before.
2.2.32 Methylcellulose CFU assays using adult bone marrow cells
Single cells suspensions were prepared from bone marrow. For bone marrow 
Pre-B assays, 5.5 x 104 nucleated cells were plated into 1.1 ml M3630 
methylcellulose media (containing hIL-7) and CFUs were counted after 7 days. For 
bone marrow myeloid assays, 2.7 x 104 nucleated cells were plated in 1.1 ml M3434 
media and CFUs were scored after 10 days.
2.2.33 Reconstitution experiments using adult bone marrow cells
For competitive reconstitution assays w ith adult bone marrow cells, bone 
marrow was prepared from two mice for each genotype (MlFlox/+, M llFlox/\ M il 
conditional). Erythrocytes were removed by lysis w ith RBC lysis buffer and the cells 
counted and pooled for each genotype. All injections were performed by Henrique 
Veiga-Fernandes. For the 10:1 ratio, 2 x 106 cells from each genotype were mixed 
with 2 x 105 WT C57B1/6J Ly5.1+ bone marrow cells and injected into 5 lethally 
irradiated C57B1/6J Ly5.1+ recipients. For the 1:1 ratio, 1 x 106 cells from each 
genotype were mixed with 1 x 106 W T competitor cells. After 4 weeks, blood was 
taken from the recipients for the analysis of reconstitution levels, as before. After 4 
months, the recipients were sacrificed and bone marrow, spleen and thymus were 
taken for analysis as before.
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2.2.34 Analysis of recombination in Mil cKO bone marrow and fetal 
liver stem cells
To sort bone marrow stem cells for DNA preparation, single cell suspensions 
were prepared from the bone marrow of 3 M il cKO  mice and pooled. The cells were 
stained with a biotinylated Lineage antibody cocktail (CD3e, C D llb , CD45R/B220, 
Ly6G and Ly-6C, and TER-119, Miltenyi), and the lineage positive cells were 
depleted by magnetic sorting. The remaining cells were stained with c-kit-APC and 
Seal-PE. c-kit^Scal* cells were sorted from the population using a Beckman Coulter 
Epics Altra. DNA lysates were prepared from the cells and the DNA analyzed by 
PCR, using primers E2 and F to detect the floxed allele, and E2 and G2 to detect the 
deleted allele.
To sort c-kit+T erll9 ' fetal liver cells for DNA preparation, E13.5 fetal liver 
cells were stained with c-kit-APC and Terll9-PE. T e rll9 + cells were depleted and 
then c-kitw cells were selected by magnetic sorting. DNA was prepared from the 
resulting cells for PCR analysis as above.
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Chapter 3 
Successful Targeting of Murine 
Embryonic Stem Cells with an M il 
‘Floxed’ allele
3.1 Introduction
As shown in previous studies, homozygous deletion of M il results in 
embryonic lethality (Ayton et al., 2001; Yagi et al., 1998; Yu et al., 1995). This 
lethality had previously prevented the study of haematopoiesis in adult mice in the 
absence of Mil. It was therefore necessary to create a line of mice in which M il 
could be conditionally removed only in the haematopoietic system. By removing 
MU only in the haematopoietic system, it was hoped that the lethality of 
constitutively removing M il would be overcome, enabling the study of adult 
haematopoiesis in the absence of Mil.
It was decided that the most efficient way to facilitate conditional removal of 
M il was by utilizing the Cre-lox system. The bacterial recombinase Cre recombines 
DNA sequences flanked by so called loxP sites (Kuhn et al., 1995). loxP sites are 
unique, 34 bp long sequences of DNA, that are not normally present in mammalian 
DNA (Sauer, 1998). By flanking exons 9-10 of M il w ith loxP sites, it was possible to 
create a ‘conditional’ or ‘floxed’ allele of gene. In the presence of the Cre 
recombinase, the loxP sites would be recombined to excise exons 9 and 10 of Mil. 
Cre is not normally expressed in mammalian cells, so by breeding mice carrying the 
‘floxed’ allele to mice that express transgenic Cre under tissue specific promoters it 
was possible to produce mice where exons 9 and 10 of M il were excised only in 
certain tissues, such as the haematopoietic system (Kuhn et al., 1995).
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An Embryonic Stem (ES) cell targeting strategy was used to establish a mouse 
line bearing a ‘floxed’ allele of Mil. ES cells are pluripoitent cells derived from the 
inner cell mass of blastocysts. They can be cultured for many passages and still retain 
their pluripotency as shown by the fact that when they are reintroduced into 
blastocysts, they can contribute efficiently to the formation of chimaeras (Bradley et 
al., 1984). Using ES cells, mutations and foreign DNA can be introduced into the 
genome via gene targeting. This involves the homologous recombination of DNA 
sequences residing in the chromosome with newly introduced DNA sequences 
(Thomas and Capecchi, 1987). For example, as described here, a plasmid carrying 
introns 5-6 to 10-11 of MLL DNA, including the floxed exons 9 and 10 and a 
selection marker, was electroporated into PC3 ES cells (Figure 3.1). The floxed 
section of MLL was then integrated into the ES cell genome via homologous 
recombination (Figure 3.3). ES cells clones carrying the targeted allele were 
identified using the selection marker. These clones were karyotyped and injected 
into blastocysts to give rise to chimeric mice bearing the targeted M il allele.
3.2 Construction of targeting vector pM11197.Al
The first targeting vector used for targeting was constructed by Dr Suzana 
Hadjur. A pBluescript vector containing introns 5-6 to 10-11 of mouse 129sv M il 
genomic DNA was provided by Dr Terry Rabbitts (LMB, Cambridge) (pBS-Mll). 
pBS-Mll was linearised using a BgAl site in intron 10-11 of the M il genomic DNA 
and the sticky ends blunted. A LoxNeoLox cassette (a neomycin resistance cassette 
flanked by two loxP sites) was excised from the vector, pM197, using a SaR/N otl 
double digest and the fragment ends blunted. The LoxNeoLox cassette was blunt- 
end ligated into the blunted BgAl site of pBS-Mll. The resultant vector carrying was 
named pM11197.
pM11197 was digested with A adl in intron 6-7 of the Mil genomic DNA and 
the ends blunted. A DNA fragment containing a loxP site was amplified from the 
vector, pGEM30, using the primers LoxPF and LoxPR (Table 2.3, Table 2.4). The 
150bp fragment containing the loxP site was then digested with A ad I and Smal and 
the sticky ends blunted. The loxP site fragment was then blunt-end ligated into the
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blunted AaAl site of pMLL197. The final vector, containing a loxP site in intron 6-7 
and a LoxNeoLox cassette in intron 10-11 of Mil, was named pM11197.Al (Figure 
3.1).
After sequencing, two tandem loxP sites were found to have been ligated into 
the 5' A adl site Figure 3.1. It was thought that the presence of two loxP sites here 
would not interfere with the targeting strategy and the vector was used to target 
mouse ES cells.
3.3 Failure of targeting using pM11197.Al
Targeting of the M il locus in PC3 ES cells by electroporation (O’Gorman et 
al., 1997) was attempted using pM11197.Al (Figure 3.1). Over 800 clones were 
picked following selection in neomycin, and DNA prepared and screened by 
Southern Blot Analysis. Of 1000 neomycin resistant clones picked, 12 were found to 
be positive for the LoxNeoLox cassette using a Kpnl Southern blot strategy W hen 
these clones were screened for the 5' loxP site, none were found to be positive (data 
not shown). Homologous recombination had not been achieved at the 5' end of the 
targeting vector.
It was possible that the incomplete homologous recombination of the 
targeting vector in ES cells was due to a lack of M il homology flanking the 5' loxP 
site or to there being too much space between the loxP sites. To increase the chances 
of correct recombination, a second targeting vector was constructed where the 5' 
loxP site was brought closer to the LoxNeoLox cassette and extra MU homology was 
added to the 5' end of the targeting vector. In this second vector, exons 9 and 10 of 
Mil, which encode part of the first PHD finger of the protein, were flanked by loxP 
sites (Figure 3.2).
3.4 Construction of the second targeting vector pMLL197.2kb
To create the second targeting vector, pM11197 was used as the starting point. 
The 5' loxP site was amplified from pGEM30 as before and sub-cloned into pGEM-T 
Easy. An Aatll/Sm al digest was used to digest out the loxP site from pGEM-T Easy. 
The ends were blunted and the loxP site was this time ligated into a blunted NsA site
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Figure 3.1. Schematics of the vectors used for targeting.
A) The first targeting vector, pM11197.Al.Filled black rectangles 
denote exons, red triangles denote loxP sites and Neor denotes the 
Neomycin resistance cassette. pBS indicates the pBluescript vector 
backbone. The blue denotes vector DNA, the black line denotes M il 
genomic DNA
B) The second targeting vector M11197.2kb
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KCQNLQWMPSKASLQKQTKAVKKKEKKSKTTEKKESKESTAVKSPLEPAQKAAPPP
REE PAPKKS S SE PPPRKPVEEKSEEGGAPAPAPAPE PKQVSAPASRKS SKQVSQPA
AW PPQ PP S T APQKKE APKAVP SE PKKKQ PPPPEPGPEQS KQKKVAPRP SIPVKQK
Exon 9
PKDKEKPPPVSKQENAGTLNILNPLSNGISSKQKIPADGVHRIRVDFKEDCEAENV 
Exon 10 PHD 1
WEMGGLGILTSVPITPRWCFLCASSGHVEFVYCQVCCEPFHKFCLEENERPLEDQ
PHD 2
LENWCCRRCKFCHVCGRQHQATKQLLECNKCRNSYHPECLGPNYPTKPTKKKKVWI
CTKCVRCKSCGSTTPGKGWDAQWSHDFSLCHDCAKLFAKGNFCPLCDKCYDDDDYE
PHD 2
SKMMQCGKCDRWVHSKCESLSGTEDEMYEILSNLPESVAYTCVNCTERHPAEWRIiA
LEKELQASLKQVLTALLNSRTTSHLLRYRQAAKPPDLNPETEESIPSRSSPEGPDP
PVLTEVSKQDEQQPLDLEGVKKRMDQGSYVSVLE FSDDIVKIIQAAINSDGGQPEI
KKANSMVKSFFIRQMERVFPWFSVKKSRFWEPNKVSNNSGMLPNAVLPPSLDHNYA
QWQEREESSHTEQPPLMKKIIPAPKPKGPGEPDSPTPLHPPTPPILSTDRSREDSP
ELNPPPGIDDNRQCALCLMYGDDSANDAGRLLYIGQNEWTHVNCALWSAEVFEDDD
PHD 4
GSLKNVHMAVIRGKQLRCEFCQKPGATVGCCLTSCTSNYHFMCSRAKNCVFLDDKK
VYCQRHRDLIKGEWPENGFEVFRRVFVDFEGISLRRKFLNGLE PENIHMMIGSMT
Figure 3.2. Position of the PHD fingers in the MLL protein.
Exon 9 is highlighted in purple, exon 10 is highlighted in blue. The 
PHD fingers are underlined.
As shown above, exon 10 encodes a portion of the first PHD finger. 
The cysteine residues that form part of one of the zinc binding sites in 
the first PHD finger are highlighted in red. The sites of the PHD 
fingers were identified using information from Aasland e t al. 1995 
and Jose Saldanha (personal communication).
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in intron 8-9 of pMLL197. Sequencing was used to check the orientation and 
sequence of the loxP site and to confirm the presence of only one loxP site.
The additional M il 5' homology was PCR amplified in two fragments from 
genomic DNA extracted from PC3 ES cells (129sv background). A 5' fragment was 
amplified by PCR using primers Exon5MLL/Intron5-68410R and a 3' fragment was 
amplified using primers Intron5-6MLLC/PCR2A (Table 2.3, Table 2.4). Both 
fragments were sub-cloned into pGEM-T Easy and sequenced to check for mistakes 
that may have occurred during amplification. The 5' fragment was digested out of 
pGEM-T Easy using an Xbal/SaA double digest and ligated into pGEM-T Easy 
containing the 3' fragment using an Xbal site in the 3' M il sequence and a SaA site in 
pGEM-T Easy. This vector was termed pGEM-T Easyl.4+lKb.
The MLL homology in pGEM-T Easyl.4+lK bl.l was directionally cloned 
into the targeting vector using a blunt/sticky ended ligation. pGEM-T 
Easy 1.4+1Kb 1.1 was linearised using an A&/I digest. The sticky ends were blunted 
and the vector digested again with Aadl, to release the fragment of homology. 
pBluescript MLL 197 was linearised with BstXL and the ends blunted. The vector was 
then digested with A ad I. The homology from pGEM-T Easyl.4+lK bl.l was ligated 
into the 5' end of the vector using the A atll in MU and the blunted BstX1 to create 
the finished vector, pMLL197.2kb (Figure 3.1).
Restriction digest mapping was used to check that the resulting targeting 
vector was correct (all the components had been sequenced prior to assembly of the 
vector). In this targeting vector, the 5' loxP site and the 3' LoxNeoLox cassette flank 
exons 9 and 10 of M il (Figure 3.1).
3.5 Targeting of ES Cells with the Second Targeting Vector
ES cells were electroporated with the second targeting vector, pMLL197.2kb. 
The targeting strategy is shown in Figure 3.3.
Eight-hundred neomycin resistant clones were picked following 
electroporation of PC3 ES cells with vector pMLL197.2kb. DNA was extracted from 
two samples of each clone for Southern Blot analysis. An aliquot of cells of each 
clone was frozen and kept at -70eC.
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Figure 3.3. Targeting Strategy and Southern Strategy for identifying 
positive ES cell clones .
The figure shows the wild type M il allele before targeting, and the 
targeted allele after homologous recombination with the targeting 
vector has taken place. Also shown are the position of the restriction 
sites and probe used in K pn\ Southern Blot Analysis and the 
corresponding fragment sizes. Bsl- BstXX Ns- NsiX, R l- EcoRX, Kp- 
KpnX.
The filled black boxes denote exons, the red triangles denote LoxP 
sites, Neor denotes the neomycin resistance gene and the filled red 
box denotes the 3' probe.
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3.6 Southern Blot with Kpnl showed successful recombination of the 
LoxNeoLox cassette
DNA from over seven hundred clones was screened for the LoxNeoLox 
cassette using the KpiA Southern strategy shown in Figure 3.3. One gel per 96-well 
plate was run, as shown in Figure 3.4. The wild type allele gave a band of 5.7 kb and 
the targeted a band of 7.2 kb (due to the presence of the LoxNeoLox cassette) (Figure
3.4). Of approximately 500 clones screened, thirty-nine were found to be positive for 
the LoxNeoLox cassette.
3.7 Southern Blot with Nsil showed successful recombination of the 5' 
loxP site
The thirty-nine clones that were positive for the LoxNeoLox cassette were 
screened for the presence of the 5' loxP site using the NsA strategy shown in Figure 
3.5. DNA from clones identified as being positive for the LoxNeoLox cassette was 
digested with N sil and probed with the 3' probe. A representative blot is shown in 
Figure 3.6. Four clones showed successful recombination of the 5' loxP site as well as 
the LoxNeoLox cassette. These were clones M119.21, 3.102, 9.33 and 3.37.
Clones M119.21, 3.102, 9.33 and 3.37 were thawed from 96-well plates. All 
successfully expanded to 10 cm plates, from which genomic DNA and cells for 
freezing were prepared.
3.8 Karyotyping of positive clones
W hen cultured, ES cells often develop chromosomal aneuploidy (the 
acquisition of extra chromosomes in addition to the normal complement of forty) 
(Koller, 1992). W hen injected into blastocysts, aneuploid ES cells can lead to 
developmental abnormalities in the resultant chimeras. For this reason it was 
important to karyotype the clones before injection. For Clone M113.102, 50% of the 
cells were aneuploid (Figure 3.7). Clones M119.21, 9.33 and 3.37 were found to 
contain over 90% normal cells (Figure 3.7). These clones, when grown in culture,
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Figure 3.4. Southern Blot of DNA from G418 resistant clones. 
Genomic DNA from neomycin resistant ES cell clones grown in a 96 
well plate was digested with Kpnl and then probed with the 3' 
probe.
Clones positive for the LoxNeoLox are highlighted by red stars. Wild 
type band =5.7 kb. Targeted band = 7.2 kb
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Figure 3.5. N sil Southern for the different Mil alleles.
The different fragment sizes seen in Southern Blot Analysis using 
N sil digest are shown. Ns- Nsil. The filled black boxes denote exons, 
the red triangles denote loxP sites, Neor denotes the neomycin 
resistance cassette box and the red box indicates the 3' probe.
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Figure 3.6. Southern blot of DNA from clones positive for the 
LoxNeoLox cassette.
DNA was digested with N sil and probed with the 3' probe to look 
for the presence of the 5’ LoxP site. Wild type allele = 12 kb, 
incorrectly targeted allele (LoxNeoLox cassette only) = 13.55 kb, 
correctly targeted allele (plus the 5' LoxP) = 18 kb.
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Figure 3.7. Examples of karyotypes of ES cell clones.
A) Karyotype of Clone M113.37, showing a normal complement of 40 
chromosomes.
B) Karyotype of aneuploid clone M113.102 showing an abnormal 
complement of 41 chromosomes.
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looked healthy and had 5-10% differentiation as expected for healthy, pluripotent 
ES cells.
3.9 Southern Blot analysis on DNA from expanded clones showed the 
correct clones were picked
Following expansion of Clones M119.21, 9.33 and 3.37, DNA from the clones 
was used for Southern Blot analysis using the N sil and KprH strategies mentioned 
previously (Figures 3.3 and 3.5). This was to ensure that the correct clones had been 
picked and that these clones were not mixed clones of correctly targeted and wild 
type ES cells. Clones M119.21, 9.33 and 3.37 were found to be positive for the 5' loxP 
site and the LoxNeoLox cassette after expansion (Figure 3.8).
3.10 Blastocyst injection with clones M119.21 and M113.37 resulted in 
high percentage chimaeras
Clones M119.21 and M113.37 were chosen for injection into C57BL/6J 
blastocysts. All blastocyst injections were performed by Dimitris Kioussis at NIMR, 
London. The injected blastocysts were implanted into pseudo-pregnant females. 
Injection of both clones resulted in the birth of litters containing chimeras 
exhibiting a high percentage of chimerism. The level of chimerism was indicated by 
amount of agouti coat colour that the mice had (PC3 ES cells are derived from 129Sv 
mice that carry agouti coat colour, C57BL/6 blastocysts carry black coat colour). A 
high level of chimerism suggested that the ES cells injected were contributing 
successfully to the tissues of the mice.
3.11 The injected ES cells successfully contributed to the germline of 
chimaeras
Male chimeras with a high percentage of chimerism were bred to C57B1/6J 
females. All breeding pairs produced offspring with agouti coat colour, showing that 
the ES cells had successfully contributed to the germline of the chimeras. Chimeras
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Figure 3.8. Southern blots to confirm the genotype of the expanded 
ES cell clones.
A) Southern blot analysis of clones M113.37.3.102, 9.21, 9.33 using a
an N sil digest. Wild type band =12 kb, targeted band =18 kb.
B) Southern Blot analysis of the same clones using a KpiiL digest.
Wild type band = 5.7 kb, targeted band = 7.2 kb.
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derived from clone M119.21 gave rise to line M119.21, those derived from M113.37 
gave rise to line M113.37.
3.12 Discussion
Establishing a conditional knockout model of the gene Mil
This chapter describes the successful targeting of mouse ES cells w ith a 
‘floxed’ allele of M il and the subsequent contribution of ES cells carrying this allele 
to the germline of chimeras.
Failure of the first attempt at targeting is likely due to the region of Mil targeted
As described in Section 3.3, PC3 ES cells were first targeted with a plasmid 
which exons 7 to 10 of M il were flanked by a loxP site and a LoxNeoLox cassette 
(pM11197.Al, Figure 3.1). W hen neomycin resistant clones were screened after 
targeting, of over 800 clones, none were found to have recombined both the 5' loxP 
sites and the 3' LoxNeoLox cassette successfully. This was attributed to a possible 
lack of homology at the 5'end of the targeting vector and the large distance (2.55 kb) 
between the 5' loxP site and the 3' LoxNeoLox cassette. Previous work has shown 
that increased flanking homology can increase the likelihood of the recombination 
of non-homologous sequences (Koller, 1992; Thomas and Capecchi, 1987). It is also 
of note that this region of M il is very close to the breakpoint cluster region of the 
gene, where chromosomal translocations occur (Scharf et al., 2006). W hen designing 
genotyping primers in this region, it was found that the majority of primers designed 
could not be used because of homology to sequences from several chromosomes. 
This would suggest that both the 5' loxP site and the 3' LoxNeoLox cassette were 
situated in introns w ith a large number of repetitive elements. This may have meant 
that when the ES cells were targeted, the LoxNeoLox cassette was incorporated into 
other sites in the genome other than the M il locus, via homologous recombination 
with repetitive sequences. This may account for the large number of neomycin 
resistant clones that were picked that had not incorporated the LoxNeoLox cassette 
at the M il locus.
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The Second Targeting Vector - Targeting exons 9 and 10 of Mil
In the second, successful targeting vector, the loxP site and the LoxNeoLox 
cassette flanked exons 9 and 10 of M il which encode two cysteine residues that form 
part of the first loop of PHD finger 1 of MLL (Figures 3.1 and 3.2). PHD fingers are 
zinc finger containing domains that are predominantly found in chromatin 
remodelling proteins (Bienz, 2006; Pena et al., 2006). As discussed in the 
introduction, they are important for the binding of nucleosomes and other ligands 
by chromatin remodelling proteins. So, by targeting the first PHD finger of the MLL, 
it was possible that important protein-protein interactions would be abolished, or 
that the protein’s structure would be affected.
The second targeting vector was successfiilly used to target PC3 ES cells
Using the second targeting vector, PC3 ES cells were successfully targeted. 
Southern blot strategies where the probe bound externally to the targeted area of 
M il were used to ensure that the M il locus had been targeted correctly. Three clones 
were found that contained the correctly incorporated 5' loxP site and 3' LoxNeoLox 
cassette and that had a normal complement of chromosomes. Two of these clones 
were injected into blastocysts and both gave rise to chimeras showing high levels of 
chimerism. A high level of chimerism indicated that the ES cells used to create the 
chimera were healthy and able to contribute significantly to the embryo (Capecchi, 
1989). W hen the male chimaeras were bred to C57BL/6 females, which, like the 
blastocysts, had a black coat colour, the resultant litters contained agouti offspring, 
the parental coat colour from the PC3 ES cells, which were derived from a 129sv 
background (O'Gorman et al., 1997). This indicated that the targeted ES cells had 
contributed to the germline of the chimeras.
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Chapter 4 
Deletion of Exons 9 and 10 of M il 
Resulted in a Knockout Phenotype
4.1 Introduction
The previous chapter described the establishment of two mouse lines 
carrying an M il allele where exons 9 and 10 were flanked by a LoxP site and a 
LoxNeoLox cassette. This chapter describes the production of mice carrying floxed 
and deleted alleles of M il. In addition this chapter shows that the deletion of exons 9 
and 10 lead to the loss of MLL protein expression.
The floxed and deleted alleles of M il were produced using the PC3 Cre 
transgene which is present in PC3 ES cells (O'Gorman et al., 1997). The PC3 Cre 
transgene expresses the Cre recombinase under the control of the mouse protamine 
1 (PrmT) promoter (O’Gorman e t al. 1997). The P rm l promoter is active only during 
the terminal, haploid stages of spermatogenesis, so in those chimeras carrying the 
PC3 Cre transgene, Cre-mediated recombination occurred only in male 
spermatozoa. Therefore the offspring of male mice carrying the PC3 Cre transgene 
had different recombination events w ithin the targeted M il allele. As there are three 
LoxP sites in the targeted allele, three different recombination events can occur. 
These are termed Type I, Type II and Type III ( Figure 4.1) (Cohen-Tannoudji and 
Babinet, 1998). These different recombination events successfully occurred in male 
chimeras carrying the targeted M il allele, allowing the implementation of breeding 
strategies to propagate the different M il alleles.
W hen the deleted M il allele, lacking exons 9 and 10 was bred to 
homozygosity, it was embryonic lethal. Lysates prepared from embryos homozygous 
for the deleted allele showed an absence of MLL protein, indicating that a true 
knockout model of A///had been established.
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Figure 4.1. The different Mil alleles.
The different alleles that result from Cre-mediated recombination of 
the targeted allele.
The Cre recombinase recombines the LoxP sites (shown as red 
triangles). Black boxes denote exons, Neor denotes the neomycin 
resistance gene.
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4.2 Recombination by the PC3-Cre recombinase occurred in the 
germline of male chimaeras
Due to PC3 Cre mediated recombination in the male germline, the offspring 
of male chimeras could carry one of three possible recombinants of the targeted M il 
allele. A Type I recombination event would create the deleted allele (-), a Type II 
event would create the floxed allele (Flox), and a Type III event would create the 
deleted/Neo allele as shown in Figure 4.1. The offspring of male chimeras and 
C57B1/6J females were genotyped to look for the different recombined M il alleles. 
All mice were genotyped using DNA made from tail tips. Initially, the mice were 
genotyped by PCR to look for the presence of the wild type allele, the neomycin 
resistance cassette and the floxed allele. A PCR using primers A and B was used to 
detect the presence of the neomycin resistance cassette Figure 4.2. A PCR using 
primers D and B was used to detect the presence of the wild type and floxed alleles 
Figure 4.2. An example of the genotyping of a litter produced a chimera x C57B1/6J 
cross is shown in Figure 4.3.
Initially, it was necessary to identify animals that carried the ‘deleted’ allele 
using Southern blot analysis. DNA from mouse tail tips was digested with Afr/land 
probed with the 3' probe as before (Chapter 3.7). The expected fragment sizes 
produced from the different alleles are shown in Figure 4.4. A representative blot 
showing the genotyping by Southern blot of a litter of mice produced from a 
chimera x C57B1/6J cross is shown in Figure 4.5. A PCR strategy, using primers E2 
and B to detect the deleted allele, was optimised using DNA from M ltA mice 
identified in southern blot screening (Figure 4.2). As shown in Figure 4.6, the PCR 
using E2 and B was optimised to successfully detect the ‘deleted’ allele.
Recombination in the male germline of the chimeras had successfully 
produced M lfr^ and M lt/Flox mice, which could be used to produce constitutive and 
conditional knockout M il mice.
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Figure 4.2. Original PCR strategy employed for genotyping the 
offspring from chimeras.
Primers A and B were used to detect the presence of the neomycin 
resistance cassette.
Primers D and B were used to detect the presence of the floxed and 
wild type alleles.
Primers E2 and B were used to detect the presence of the deleted 
allele.
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Figure 4.3. Genotyping heterozygotes.
The mice genotyped were the offspring from breeding a male 
chimaeras to C57BL/6 females.
A) PCR with primers Dnew and Bnew to identify mice carrying a 
wildtype or floxed allele. Wild type band -  730 bp, floxed band 
920 bp. The third band present in PCRs for the floxed allele is a 
hybrid band where the floxed PCR product has bound to the WT 
PCR product. It disappeared upon denaturation of the DNA.
B) PCR with primers Anew and Bnew to identify mice carrying 
either the targeted allele or the deleted/neo allele. The band 
amplified from the Targeted and deleted/neo alleles was 1 kb.
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Figure 4.4. N sil and K pnl Southern Blot Strategies for detecting the 
different MU alleles.
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denoted the 3' probe.
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Figure 4.5. Genotyping by Southern blot of a litter of mice produced 
from a S chimera x ?C57BL/6J cross.
DNA was digested with N sil, as in Figure 4.4. The floxed (Flox) band 
was 16.2 Kb, the deleted (-) band was 14.7 Kb and the wild type band 
was 12 Kb
Figure 4.6 Optimisation of PCR using primers E and B to amplify the 
‘Deleted’ allele.
The genomic DNA was had previously been genotyped by Southern 
blot. The expected band for the deleted allele was 900 bp.
4.3 Removal of PC3-Cre transgene
The PC3 ES cells used here were homozygous for the PC3 Cre transgene 
(O'Gorman et al., 1997). Hence all mice bred from chimeras where the PC3 ES cells 
had successfully contributed to the germline were heterozygous for the PC3 Cre 
transgene. Before establishing breeding strategies to produce experimental mice, it 
was necessary to remove the PC3 Cre transgene. Offspring of the chimeras 
heterozygous for either the floxed or ‘deleted’ (A///7) alleles were back
crossed to wild type C57B1/6J mice. The resultant offspring were screened for the 
PC3 Cre transgene by PCR. A representative genotyping PCR showing genotyping 
for the PC3 Cre transgene is shown in Figure 4.7. Although some preliminary 
experiments were done using mice heterozygous for the PC3 transgene, the majority 
of experiments in this thesis were performed using mice negative for the PC3 Cre 
transgene.
4.4 Establishing breeding colonies for the two mice lines
To produce mice for experiments, two breeding colonies were established, 
one to propagate mice derived from M119.21 ES cells and one from M113.37 ES cells. 
MU/+ and M lF ox/+ mice from both M il strains were backcrossed to C57B1/6J mice to 
begin the process of producing congenic strains. Breeding pairs were also established 
to produce mice conditional for M il in the haematopoietic system -  this breeding 
strategy is described in Chapter 6.
4.5 Failure of original genotyping PCRs
The initial PCR srategies used to detect the different M il alleles were slightly 
unreliable in that they often failed due to undiagnosed reasons. For this reason, it 
was necessary to establish a new genotyping strategy. Primers E2 and F replaced 
primers D and B to detect the wild type and floxed alleles, and primers E2 and G2 
replaced primers E2 and B to detect the deleted allele. The new PCR strategy and 
the band sizes expected are shown in Figure 4.8. This strategy proved to be more 
reliable.
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Figure 4.7. Removal of the PC3 Cre transgene from the mouse lines. 
The figure shows the genotyping for a litter of mice from a M lPox/+ X 
C57B1/6J cross. The positive control was genomic DNA from PC3 ES 
cells, which were homozygous for the PC3 transgene. The expected 
band size was 350 bp
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Figure 4.8. New PCR Strategy for genotyping the different M il alleles. 
Using Primers E2 and F, the band sizes are : Wild type -  730 bp, floxed 
-  920 bp.
Using primers E2 and G2, the deleted band is 300 bp. A band of 1.8 kb 
is also amplified from the floxed allele by E2 and G2, but is not 
reliably amplified.
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4.6 MllFlo*/+ and Mll/+ mice have no apparent phenotypic abnormalities
It was important to establish that mice carrying the floxed allele had a 
normal phenotype to ensure that targeting introns 8-9 and 10-11 of M il had no 
effect on its function. M llF,ox/F!ox mice at 8-10 weeks of age were of normal weight 
(23.9 ± 2.3 for males, 19.4 ± 1.7 for females) compared to wild type mice (22.7 ± 2.2 
for males, 20.9 ± 2.3 for females) and had no obvious anatomical abnormalities. 
MlF‘ox/+ mice were of normal fertility, and were born in the expected mendelian 
ratios Table 4.1. The same was true of M llflox/flox mice.
M11A mice were also born in mendelian ratios, when crossed with C57B1/6J 
mice (Table 4.2).
4.7 Homozygous deletion of exons 9 and 10 of Mil is embryonic lethal
In previous models, homozygous interruption of the MLL protein was 
embryonic lethal (Ayton et al., 2001; Yagi et al., 1998; Yu et al., 1995). To assess 
whether this was true in our model, M lt/+ were crossed to produce M il mice. As 
shown in Table 4.3, in 5 litters from these crosses, no M11A mice were born, 
confirming the lethality of homozygous deletion of exons 9 and 10 of M il. To assess 
at which point of development M ltA embryos died, timed matings were set up using 
M ll/+ mice. As shown in Table 4.3, normal numbers of M ltA embryos were present 
up to E12.5. Figure 4.9 shows a representive PCR for a litter of E12.5 embryos, 
showing the presence of an M ltA embryo. After this point, the numbers of M llv' 
embryos were gradually reduced, with the biggest drop occurring between E l2.5 
and E14.5. At these timepoints, dead MUrA embryos were frequently seen (data not 
shown). Live M11'Aembryos frequently showed oedema and petechiae under the skin 
(data not shown). From E15.5 onwards, live M il'/' embryos were seen, but they were 
increasingly rare, only 2 live Mll~/~ embryos were seen from five litters.
4.8 Mil 7" embryos have no detectable MLL protein
The embryonic lethality seen in M lt^  embryos suggested that either the 1st 
PHD finger was integral to the function of MLL or that the levels of MLL were
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M113.37
Genotype Males Females Total
M lf/ttox 42% 48% 46% (n=22)
M1F+ 19% 25.9% 23% (n=13)
fyjjpox/flox 38% 25.9% 31% (n=15)
M119.21
Genotype Males Females Total
M lf/FIox 60% 42.9% 56% (n=15)
M lt/+ 15% 25% 22% (n=6)
fyfjjFlox/Flox 25% 14% 22% (n=6)
Table 4.1. M lfox/+ and M lt/+ mice are bom  in mendelian ratios.
Offspring from M lFlox/+ x M lfIox/+
Expected ratios are : M lfIox/+ 50%, M lt/+ 25%, M lfIox/Flox 25%
M119.21
Genotype Males Females Total
M1F- 45.5% 43.9% 43% (n=54)
M lt/+ 54.5% 56.1% 57% (n=73)
M113.37
Genotype Males Females Total
M & - 43.5% 41.4% 45% (n=50)
M tf/+ 56.5% 58.6% 55% (n=62)
Table 4.2. M lt^  and M1F/+ mice are bom  in mendelian ratios
Results of breeding pairs with M1F/+ x W T C57B1/6J. Expected ratios 
are : M U * 50%, M lt/+ 50%
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Percentage of Hve Embryos
M1T/+ M l^- M R/-
E10.5 (n=19) 10.5% 47% 42%
El 1.5 (n=16) 18% 62% 18%
E12.5 (n=28) 14.2% 50% 35.7%
E l3.5 (n=35) 31% 48.9% 20%
E14.5 (n=51) 31% 54.9% 13.7%
E15.5 (n-11) 27% 63.9% 9%
E16.5 (n=9) 22% 66.7% 11%
Postnatal (n=38) 52.6% 47.4% 0%
Table 4.3. Embryonic lethality in M ///_ embryos.
Expected Mendelian ratios were: M lt^  50%, M lt/+ 25%, M ///_ 25%. 
The table shows data pooled from M113.37 and M119.21 strains.
At earlier timepoints (E10.5, El 1.5), live embryos were considered to 
be those that had a heartbeat. At later timepoints, live embryos were 
those that showed blood in the umbilical chord and veins.
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Figure 4.9. Genotyping of a litter of embryos from a M R /+ x MLt/+ 
timed mating.
The wild type allele was detected using primers E2 and F and the band 
size was 770 bp.
The deleted allele was detected using primers E2 and G2 and the band 
size was 300 bp.
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Figure 4.10. M il-/- embryos show an absence of MLL protein.
Lysates made from foetal liver cells from M l//+, M lt/+ and A///7" 
embryos were run alongside lysates made from K562 cells (positive 
control). The blots were probed w ith either and anti-MLL N-terminal 
antibody (MLL-N) or and anti-MLL C-terminal antibody (MLL-C). 
The HSP90 antibody was used as a loading control.
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decreased. To ascertain the status of the MLL protein the absence of exons 9 and 10, 
protein lysates were made from the foetal liver cells of E l3.5 M lt/+, Mll~/+ and M il'/_ 
embryos. This analysis was done in collaboration w ith Samantha Y-L Hiew. W estern 
blotting was performed with the lysates using antibodies to detect the N-terminal 
the C-terminal MLL fragments. The binding sites for the antibodies are shown in 
Figure 2.1. The HSP90 antibody was used to ensure equal loading of the protein 
lysates. As can be seen in Figure 4.10, M11A embryos showed an absence of both 
MLL N-terminal and C-terminal protein fragments in comparison to M t/+ embryos. 
M lt/+ embryos also showed a decrease in the level of MLL protein. This result 
suggests that exons 9 and 10 of MLL are necessary either for the production or 
stability of MLL protein.
4.9 Discussion
Establishing two conditional and constitutive M il knockout mouse lines
This chapter describes the establishment of two mouse lines (M119.21 and 
M113.37) carrying a conditional and a constitutive knockout allele of M il. W hen 
chimeras derived from M il targeted ES cells were bred to C57BL/6J mice they 
produced offspring heterozygous for the targeted M il allele, showing that the ES 
cells had successfully contributed to the germline of the chimeras. As expected, the 
offspring of the chimeras carried different recombinants of the targeted allele, 
showing that all the LoxP sites were functional and that the PC3 Cre was inducing 
recombination during spermatogenesis (O'Gorman et al., 1997). This also meant that 
mice were born from both lines heterozygous for the floxed and deleted alleles of 
M il. These heterozygous mice were backcrossed to the C57B1/6J to breed mice 
heterozygous for the M il alleles but negative for the PC3 Cre transgene. Although 
the PC3 Cre transgene has not been shown to cause any phenotype, there is some 
very low level ectopic expression of the transgene in the brain (O'Gorman et al., 
1997). In addition, male mice carrying the floxed allele would undergo 
recombination during spermatogenesis, which would affect the breeding strategies.
I l l
For these reasons, it was necessary to remove the PC3-Cre transgene by 
backcrossing the mouse lines to wild type C57BL/6J mice.
Establishment of breeding colonies to produce mice for experiments
Breeding colonies for each of the lines have been established to propagate the 
floxed and deleted alleles, and to begin the creation of congenic lines. The chimeras 
produced from the PC3 ES cells (which were derived from mice w ith a 129sv 
background) were bred to C57B1/6J WT females. An important reason for doing this 
was that the C57B1 background has been used as a model in many studies of murine 
haematopoiesis (Gekas et al., 2005; Morrison et al., 1995; Spangrude et al., 1995; 
W orton et al., 1969). This is also true of previous A/Z/knockout studies (Ayton et al., 
2001; Yagi et al., 1998). However, as the original ES cells used here were derived 
from a 129sv background, this meant that the mice used for experiments in this 
work were of a mixed C57B1/6 and 129sv background. For this reason, in all 
experiments littermates were used as controls.
Mlp/nox Mll /+ mice have no apparent phenotypic abnormalities
As described, M1FIox/f1ox mice had no apparent abnormalities in terms of 
weight and fertility. More importantly, breeding the floxed allele to homozygosity 
was not embryonic lethal. This would suggest that targeting introns 8-9 and 10-11 of 
M il has no obvious effect on the function of the gene. M1F' mice in our model had 
no apparent abnormalities in terms of fertility and weight. In the first M il mouse 
knockout model, heterozygous females were hypofertile and heterozygotes of both 
sexes had retarded growth and reduced weight (Yu et al., 1995). However, as in the 
new model, in another M il knockout model, heterozygotes were of normal weight 
and fertility (Ayton et al., 2001).
The new model represents a true knockout model of Mil
Although M ltA mice were apparently normal, M11A mice were not detected 
after birth. The cause of death was not known. This showed that exons 9 and 10 
were needed for MLL function. This theory was supported by W estern blots using 
lysates made from foetal liver cells which showed a total absence of MLL protein in
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M ll^  embryos. W hy would deletion of exons 9 and 10 of the gene lead to a complete 
loss of MLL protein? As shown in Figures 3.2 , two cysteine residues belonging to 
one of the putative zinc binding sites of PHD finger 1 of MLL are removed following 
deletion of exons 9 and 10 (Aasland et al., 1995). It is possible that the removal of 
these residues and probable loss of zinc binding in this location may have gross 
consequences for protein folding and maturation. This may lead then to degradation 
of the protein.
No previous knockout model of M il has been directly shown to result in an 
absence of MLL protein in the resulting embryos (Ayton et al., 2001; Yagi et al., 
1998; Yu et al., 1995). This means that our new model is the first proven true 
knockout of M il. The phenotype of M ilA embryos in our model most closely 
resembled that of M ll/' embryos in Yagi e t a l, 1998, where MU is truncated at exon 
11 . W hen M ills truncated at exon 11, homozygous embryos die between El 1.5 and 
E14.5 and show oedema and bleeding under the skin. This closely resembles the 
phenotype seen in M ll/' embryos lacking exons 9 and 10. However, in the new 
model, lethality in M11A embryos occurs at a slightly later timepoint. The reason for 
this is not clear, although it may be attributable to differences in strain background.
In three previous M il knockout models, M11A embryos all exhibited different 
phenotypes, depending at which point MZ/was truncated at. The phenotype of the 
embryos also varied greatly. In the model by Ayton e t a l from 2001, the embryos 
died before the implantation stage (Ayton et al., 2001; Yagi et al., 1998). In the study 
of Yu e t al. the embryos died at E10.5 and showed severe branchial arch 
abnormalities (Yu et al., 1998). No such abnormalities were noted in the mice of 
Yagi e t al. or in our mice (Yagi et al., 1998). The reasons for these differences in 
phenotype are not clear. It is possible that in the model of Yu e t al., a dominant 
negative was created. In this targeting, a LacZ  cassette was inserted into exon 3 of 
M il creating a fusion protein, which is detectable by immunohistochemistry (Scharf 
et al., 2007). This may account for the increased severity of phenotype in embryos 
homozygous for this fusion.
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Mice carrying the floxed allele and the deleted allele can be used to study 
hematopoiesis in the absence of Mil
Mouse lines carrying deleted and floxed alleles of M il were successfully 
established. The later lethality in M llv' embryos in this model compared to previous 
models meant that fetal liver hematopoiesis in the absence of M il could be more 
extensively studied. The floxed allele was used to produce adult mice conditional for 
M il as discussed in Chapter 6.
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Chapter 5 
Mll^  Embryos Have Abnormal 
Foetal Liver Haematopoiesis
5.1 Introduction
It has been shown previously that MU deficient embryos exhibit 
abnormalities in yolk sac and foetal liver haematopoiesis. In MUA embryos these 
organs are reduced in cellularity and their cells have reduced colony-forming 
capacity (Hess et al., 1997; Yagi et al., 1998). Cells from the AGM (aorta-gonad- 
mesonephros) region of M il deficient embryos are also unable to repopulate the 
bone marrow of irradiated mice, in comparison to WT controls (Ernst et al., 2004a). 
These studies all suggest that M il is needed in a cell intrinsic manner for the proper 
progression of foetal haematopoiesis.
In previous mouse models of M il deletion, the early lethality of homozygous 
truncation of the gene has precluded a more thorough study of the role of M il in 
foetal haematopoiesis. In the model presented here, increased numbers of M lty~ 
embryos at E12.5, E13.5 and E14.5 allowed further investigation into definitive 
haematopoiesis in the absence of M il. These investigations have shown that whilst 
stem and progenitor cells are present in M1U' embryos, they are much reduced in 
number and do not have normal stem cell function in comparison to wild type cells.
5.2 Mil 7' embryos have reduced Foetal Liver Cellularity
To analyse foetal liver haematopoiesis in M11'A embryos in our mice, timed 
matings were set up between M lt/+ males and females. The females were taken at 
E13.5 and E14.5. At these time points, the foetal liver of M1U' embryos was visibly 
smaller before extraction (data not shown). To gain an accurate measurement of the 
reduction in foetal liver size, foetal livers were removed from M1U\ M ltA and M lt/+
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E13.5 (n=5-ll) and E14.5 (n= 6-8) embryos. Single cell suspensions were made and 
viable cell numbers obtained for each foetal liver.
Total foetal liver cellularity was reduced 2-fold in A///7' embryos compared to 
M llt/+ embryos (Figure 5.1). However, a 5-fold expansion in foetal liver size was seen 
in both M11A and M lt/+ embryos between E l3.5 and E14.5. This suggests that the 
haematopoietic cells that are present in A///7' foetal livers are able to undergo some 
degree of expansion.
5.3 Myeloid Progenitors are reduced in Mil/_ embryos
The reduced cellularity of the foetal liver in A///7' embryos, suggested that 
A///7' embryos in our model might possess a foetal liver phenotype similar to that 
seen before in other MU mouse models (Hess et al., 1997; Yagi et al., 1998).To assess 
this, the methylcellulose colony forming assays performed by Yagi e t al. 1998 were 
replicated to assess the ability of A///7' foetal liver cells to form myeloid colonies. 
Cells from E12.5 foetal livers from M ll^, M ltA and M lt/+ embryos were plated into 
methylcellulose w ith cytokines to induce myeloid colony growth (IL-3, IL-6, SCF, 
GM-CSF). After 7 days the colonies were counted and scored for the presence of 
Colony-Forming Unit Granulocyte, Macrophage (CFU-GM), Burst-Forming Unit 
Erythroid (BFU-E) and CFU- Granulocyte, Erythrocyte, Macrophage, 
Megakaryocyte (CFU-GEMM).
After 7 days in culture, the total number of myeloid CFUs was reduced 4-fold 
in cultures from M11A foetal liver cells compared to M lt/+ cells (Figure 5.2). Cell 
numbers in M ///_ cultures were reduced by 20 fold (Figure 5.2). Although there was 
a reduction in the total CFU number, there was no difference in the distribution of 
the different colony types between MU/~ and M lt/+ cultures (Figure 5.3). Many of 
the colonies in M llv~ cultures were smaller than in M lt/+ cultures, however, large 
colonies comparable to wild type colonies were also seen (Figure 5.4). The 
morphology of colonies in A///7' cultures also appeared normal (Figure 5.4). 
Cytospins of cells from A/Z77~ cultures showed maturing macrophages similar to those 
seen in M lt/+ cultures (Figure 5.5). The normal distribution and appearance of the 
colonies would suggest that the defect seen in A///7' cells lies in an early progenitor
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Figure 5.1. Foetal Liver cellularity is reduced in M IP^embryos. 
Expansion between E l3.5 and E14.5 in M il +/+, M1PA and A///7' fetal 
livers. Single cell suspensions were prepared from individual fetal livers 
and viable counts performed. P  values were calculated using lW ay 
ANOVA, with Tukeys multiple comparison test. (***) P < 0.001, (**) P  < 
0.01, (*) P  < 0.05. All samples were compared to M1P/+. The graph 
shows the mean (n=5-ll) and standard error of the mean of cell 
number in the fetal liver.
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Figure 5.2 Reduction in Myeloid CFU number from M Lt^foetal livers.
A. Myeloid CFU counts for E l2.5 fetal liver cells. Following the 
removal of erythrocytes, 1.1 x 104 fetal liver cells were plated in 
methylcellulose and CFUs were counted after 7 days.
B. The number of cells present in CFU cultures from E l2.5 fetal livers.
1.1 x 104 cells were cultured as above and after 7 days, single cell 
suspensions were made and viable counts performed.
/'values were calculated using lW ay ANOVA, w ith Tukeys multiple 
comparison test. (***) P  z  0.001, (**) P  < 0.01, (*) P  < 0.05. All samples 
were compared to M il WT. The bars show the mean and standard 
error of the mean.
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Figure 5.3 The proportions of different myeloid colony types are 
unchanged in M R embryos.
Proportion of different colony types produced by M R /+, M l and 
M il''’ E l2.5 fetal liver cells after 7 days culture in myeloid 
methylcellulose. CFU-GM = Colony-Forming Unit Granulocyte, 
Macrophage. CFU-GEMM = Colony-Forming Unit Granulocyte, 
Erythroid, Macrophage, Megakaryocyte. BFU-E = Burst Forming Unit 
Erythroid.
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Figure 5.4 Colony morphology in M Lt^ cultures.
The photographs show individual colonies from M7//_ and M lt/+ 
E12.5 foetal liver CFU assays at 7-9 days culture.
Photographs were taken at x 40 and x 100 magnification.
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Figure 5.5. The morphology of cells produced in M llr^ myeloid 
cultures.
The photographs show details from cytospins of fetal liver cells after 
12 days in culture in methylcellulose M3434. The cells were stained 
with May-Grunwald (Giemsa). Photographs were taken at x 100 and x 
200 magnification. The black arrows indicate maturing macrophages. 
The cytopins for both M lt/+ and M ///_ cultures showed that the 
cultures were predominantly composed of maturing macrophages.
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before the division between erythroid and other myeloid lineages. The presence of 
maturing macrophages in M11A cultures would also suggest that those progenitors 
present are able to differentiate as normal. These results suggest a significant 
reduction in the number of early myeloid progenitors present in M il KO  foetal 
livers.
5.4 Haematopoietic stem cell numbers are reduced in Mil 7' foetal livers
The reduction in total cell number in A///7' foetal livers could be a result of a 
defect in the Haematopoietic Stem Cell (HSC) compartment in the absence of M il. 
To assess this, flow cytometric analyzes were performed to examine the number of 
cells in the HSC pool in E l3.5 foetal livers. It has been shown that the different HSC 
populations in the foetal liver can be defined by flow cytometry using a combination 
of lineage markers and antibodies to c-kit, Seal and CD38 (Randall et al., 1996). The 
population defined as being negative for the expression of lineage markers (Lin-), 
but high for the expression of Seal and c-kit (LinScal+c-kit11 or LSK) has been 
shown to harbour the majority of the HSCs in the foetal liver (Reya et al., 2001). 
This population can be further defined by looking at the expression of the marker 
CD38. LSK foetal liver cells that express high levels of CD38 are highly enriched for 
Long Term HSCs (LT-HSCs), whilst those that express low levels of CD38 are 
enriched for Short Term HSCs (ST-HSCs) (Randall et al., 1996) Figure 1.2. Cells from 
the foetal livers of E l3.5 M ily~, M ltA and M1TA embryos were analysed by flow 
cytometry for the expression of these markers. Lineage depleted cells were stained 
with c-kit APC, Seal FITC, Streptavidin PrCP (to stain any remaining lineage 
negative cells), CD38 PE and 7AAD. The Lineage negative cells were gated for Scal+ 
cells, allowing the analysis of c-kit and CD38 expression in the Lin Scal+ population 
(Figure 5.6).
W hen the foetal liver stem cell compartment was analysed, a 2.5 fold 
reduction was seen in the number of LSK CD3810 (ST-HSC) cells in M11A foetal livers 
(mean = 1.5 ± 0.9 x 104 cells) compared to M lt/+ foetal livers (mean = 3.9 ± 1.3 x 104 
cells) (Figure 5.7). A 5.7-fold reduction was seen in the number of LSK CDSS1” (LT- 
HSC) cells in M ll/' foetal livers (mean = 0.78 ± 0.52 x 103 cells) compared to M lt/+
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Figure 5.6. Identifying LT-HSCs and ST-HSCs. Cells from E13.5 fetal 
livers were depleted of lineage positive cells by magnetic sorting. A 
small sample was also stained with Lineage markers for flow 
cytometric analysis, to estimate the percentage of Lineage negative 
cells present in the fetal liver. The Lineage negative cells were stained 
with c-kit, Sca-1 and CD38, 7AAD and Streptavidin-PerCP. Any dead 
cells and Lineage+ were gated out and Lin"Scal+ cells were analyzed 
for the expression of c-kit and CD38.
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Figure 5.7. ST-HSC and LT-HSC Numbers in M ltA fetal livers.
Cells from E l3.5 fetal livers were depleted of lineage positive cells by 
magnetic sorting. A small sample was also stained with Lineage 
markers for flow cytometric analysis, to estimate the percentage of 
Lineage negative cells present in the fetal liver. The Lineage negative 
cells were then stained with c-kit, Sca-1 and CD38, 7AAD and 
Streptavidin-PerCP. Any dead cells and Lineage+ were gated out and 
Lin-Scal+ cells were analyzed for the expression of c-kit and CD38.
(A) Number of ST-HSCs present in E l3.5 fetal livers. ST-HSCs were 
defined as Lin' Seal'c-kithlCD38l0.
(B) Number of LT-HSCs present in E13.5 fetal livers. LT-HSCs were 
defined as Lin'Scal tc-kithlCD38hl.
P  values were calculated using lW ay ANOVA, with Tukeys multiple 
comparison test. (***) P < 0.001, (**) P  < 0.01, (*) P < 0.05, ns = not 
significant. All samples were compared to M1P/+• The bars show the 
mean and standard error of the mean.
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foetal livers (mean = 4.5 ± 1.8 x 103 cells (Figure 5.7). The percentage of LT-HSC as a 
proportion of the foetal liver was decreased 3-fold in M11A foetal livers (mean = 
0.019 ± 0.017%) compared to M l't/+ foetal livers (mean = 0.064 ± 0.031%) (Figure 
5.8). However, the proportion of ST-HSC in Af7//_ foetal livers (mean = 0.54 ± 0.22%) 
was not significantly different to that seen in M lt/+ foetal livers (mean = 0.64 ± 
0.26%) (Figure 5.8). The proportion of the foetal liver cells that were negative for 
lineage markers was also not significantly different in A///7' foetal livers (mean = 24.9 
± 7.5%) compared to M lt/+ foetal livers (mean = 23.8± 4.9%) (Figure 5.9). This data 
confirms a major loss in the number of HSCs present in foetal livers lacking M il, 
suggesting that M il is important for HSC development. The reduction in the 
proportion of LT-HSC present would suggest that these cells are the most severely 
affected by the absence of M il.
5.5 Mil7- foetal liver cells are unable to reconstitute the haematopoietic 
system
Although LSK CD38W cells were present in M il KO  foetal liver, it was not 
known w hether these cells possessed normal stem cell function. To assess this, 
competitive repopulation assays were performed w ith c-kit+T e rll9  cells sorted from 
pooled, frozen foetal liver cells from E14.5 A///7'an d  M lt/+ embryos. 4 x 104 of the 
foetal liver donor cells (Ly5.2+) were mixed with a radioprotective dose of 2 x 105 
wild type congenic C57BL/6 Ly5.1+ bone marrow cells and transplanted into lethally 
irradiated recipients. Analysis of blood taken from the recipients at 4 weeks post 
transplantation showed that M lt/+ cells reconstituted short term haematopoiesis 
efficiently, as measured by the percentage of Ly5.2+ cells present in the periphery 
(Figure 5.10). By contrast, A/7/7cells were unable to give rise to any short term 
reconstitution (Figure 5.10). At 4 months post transplantation, the recipients were 
sacrificed and the bone marrow, spleen and thymus populations were analyzed for 
Ly5.2+ cells (Figure 5.10B, 5.11). The organs of mice transplanted with M lt/+ cells 
contained high levels of Ly5.2+ cells in all populations analyzed, demonstrating their 
ability to give rise to long term reconstitution (Figure 5.10B, 5.11). No Ly5.2+ cells
125
ST-HSC Percentage in
E13.5 Foetal Liver
©>
ns
iS
<Do
LL 0.5-
C<DOb.©
CL Mir1* m ii*'' Mir''
B  LT-HSC Percentage in
E13.5 Foetal Liver
O) 0.05*
0  0. 00'
Mir'
Figure 5.8. ST-HSC and LT-HSC Percentages in M lt^  fetal livers.
A) Percentage of ST-HSCs present in E l3.5 fetal livers. Lineage 
positive cells were depleted from E l3.5 fetal liver cells and then the 
cells were analyzed by flow cytometry using markers c-kit, Seal and 
CD38. ST-HSCs were defined as Lin' Scal+c-kithlCD38l0.
B) Number of LT-HSCs present in E l3.5 fetal livers. LT-HSCs were 
defined as Lin'Scal+c-kithlCD38hl.
P  values were calculated using lW ay ANOVA, w ith Tukeys multiple 
comparison test. (***) P z  0.001, (**) P <, 0.01, (*) P  <r 0.05, ns = not 
significant. All samples were compared to M1P/+- The bars show the 
mean and standard error of the mean.
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Figure 5.9. Percentage of MU-/- foetal liver cells negative for Lineage 
markers.
Cells were stained with an antibody mix containing Grl/Ly6G, B220, 
CD3, CD19 and T e rll9  and analysed by flow cytometry.
P  values were calculated using lW ay ANOVA, w ith Tukeys multiple 
comparison test. (***) P  z  0.001, (**) P  <. 0.01, (*) P  <r 0.05, ns = not 
significant. All samples were compared to M1P/+• The bars show the 
mean and standard error of the mean.
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Figure 5.10. Failure of M1P' fetal liver cells to reconstitute lethally
irradiated
recipients.
c -k itT erl 19 cells were magnetically sorted from frozen E14.5 foetal 
liver cell suspensions. After sorting, 4 x 104 viable cells were 
transplanted into lethally irradiated recipient mice with a 
radioprotective dose of 2 x 105 wild type bone marrow cells. Ly5.2+ 
cells represent the cells derived from donor foetal liver, Ly5.1+ cells 
represent cells derived from wild type bone marrow.
A) Representative dot plots showing the percentage of Ly5.2+ 
(donor) cells present in the peripheral blood of irradiated recipients 1 
month post-transplantation, as analysed by flow cytometry.
B) Table showing the number of irradiated recipients successfully 
reconstituted with either M ltA or M11~A fetal liver cells.
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Figure 5.11. Failure of M lt^  fetal liver cells to give rise to long term
reconstitution in lethally irradiated
recipients.
Representative dot plots showing the percentage of Ly5.2+ (donor) 
cells present in the hematopoietic organs of irradiated recipients 4 
months post-transplantation. Single cell suspensions were prepared 
from the hematopoietic organs of recipient mice and the cells 
analyzed by flow cytometry for Ly5.2 and Ly5.1. Ly5.2+ cells 
represent the cells derived from donor foetal liver, Ly5.1+ cells 
represent cells derived from wild type bone marrow.
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Figure 5.12. Failure of M ItA cells to contribute to the HSC 
compartment.
Representative dot plots showing the percentage of Ly5.2+ (donor) 
cells present in the bone marrow HSC compartment of irradiated 
recipients 4 months post-transplantation. Bone marrow cells were 
stained with Lineage markers, c-kit, Seal and Ly5.2 antibodies and 
the cells analysed by flow cytometry. The lineage positive cells were 
gated out and c-kit and Seal expression was analysed on the Lin'cells. 
Gates were set on the c-kithlScal+ (LSK) cells. The percentage of 
Ly5.2+ (donor foetal liver) cells in the LSK population was then 
analysed.
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were detected in mice transplanted with M1U' donor foetal liver cells demonstrating 
that M11A cells were unable to give rise to any long term reconstitution (Figure
5.1 OB, 5.11). Analysis of the bone marrow stem cell compartment also showed an 
absence of Ly5.2+ cells in mice that had received M ilv~ cells, showing that the 
absence of mature Ly5.2+ cells was not due to a block in differentiation of the stem 
cells (Figure 5.12). These results suggest that whilst HSCs are present in M7//_ foetal 
livers, they are unable to function as self renewing stem cells when in competition 
w ith wild type HSCs.
5.6 Discussion
Similarities in the haematopoietic phenotype between this model and previous KO 
models of Mil
In this chapter, abnormalities in foetal liver haematopoiesis have been 
analysed in a new mouse model of M il. Previous studies w ith MU knockout models 
have shown defects in haematopoiesis in the yolk sac, AGM (Aorta-gonad- 
mesonephros) region and the foetal liver in the absence of M il (Ernst et al., 2004a; 
Hess et al., 1997; Yagi et al., 1998). In two of these models, cells from M ltA yolk sacs 
(Hess, 2004) or foetal livers (Yagi et al., 1998) produced fewer colonies in myeloid 
CFU assays compared to M lt/+ cells. The data presented here is consistent w ith this, 
in that reduced numbers of colonies were seen in M11A foetal liver cultures. The 
colony assays performed in this study, using cells from E12.5 foetal livers, were 
based on those performed in a previous study of an M il mouse knockout (Yagi et al., 
1998). W hen these cells were cultured, a 4- fold reduction in colony number was 
seen compared to wild type (Yagi et al., 1998). This bears striking similarity to the 
results in this study where a 5-fold reduction in colony number was seen. In the 
present study, no difference was seen in the proportions of the different colony 
types in M11'A cultures compared to M1U/+. This is in contrast to previous studies 
which saw reduced proportions of CFU-GEMM and CFU-GM produced (Hess et al., 
1997; Yagi et al., 1998). The reason for these differences is not clear, although they
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could be attributable to differences in the strain background of the mice, or to the 
levels of different cytokines used in the CFU assays.
The similarities between the foetal liver phenotype seen in M llh embryos 
presented here and in previous studies support the protein evidence suggesting that 
deletion of exons 9-10 of MU results in a null allele.
Mil is not needed for the establishment of definitive haematopoiesis in the embryo
The presence of myeloid progenitors in the foetal liver shows that, although 
M il is needed for the proper progression of definitive haematopoiesis, it is not 
needed for its establishment. The presence of haematopoietic stem cells, as 
characterised by flow cytometry would support this. M il is therefore not needed for 
the formation of HSCs in the AGM, the proposed site of origin for definitive HSCs 
(Godin and Cumano, 2002; Mikkola et al., 2003).
Mil7' foetal liver stem cells are able to give rise to a limited amount of expansion
Although the stem cell compartment was severely reduced, those stem cells 
that were present in M lth foetal livers were able to undergo some level of expansion, 
as shown by the size increase between E13.5 and E14.5 M llv~ foetal livers. It is not 
clear what cell populations are responsible for this expansion in MUh foetal livers 
but it is likely to be erythroid cells. By E l4.5, approximately 80% of the wild type 
foetal liver is made up of late stage erythroblasts and mature erythrocytes 
(Katsumoto et al., 2006). Further analysis of foetal liver cells for the markers CD71 
and Ter 119, which are expressed on erythroblasts (CD71, Ter 119) and erythrocytes 
(Ter 119) would give more information as to w hether the expansion seen in MUrA 
foetal livers is due to erythroid progenitors (Katsumoto et al., 2006; Socolovsky et al., 
2001).
Foetal liver myeloid progenitors are severely affected by Mil disruption although 
this defect is not due to a block in differentiation
Although foetal liver expansion was seen in M1U foetal livers, a profound 
defect was seen in myeloid CFU assays. Some myeloid differentiation could occur in 
the absence of MU as shown by the normal colony morphology and the presence of
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maturing macrophages in M ltA cultures. Further characterisation of the cells produced 
in M llv cultures is necessary to assess whether an absence of Mil leads to any abnormal 
differentiation .The lack of any obvious block in differentiation would suggest that the 
reduction in colony number in M liA cultures is due either to a reduced number of 
myeloid progenitors in the foetal liver or to a reduced capacity for those progenitors 
present to proliferate in response to cytokines.
As described above, there was no difference in the proportion of the different 
colony types produced in myeloid CFU cultures from M11A cultures compared to 
M lt/+ cells. Myeloid cell differentiation from HSCs occurs through a series of 
populations of progressively more differentiated progenitors (Akashi et al., 2000; 
Kawamoto, 2006; Traver et al., 2001). Although there is some disagreement as to 
where the first myeloid progenitor arises, the work from Irving Weissman’s 
laboratory has defined this as the Committed Myeloid Progenitor, or CMP. It has 
been shown, through in  vitro  colony forming assays, stromal culture assays and in  
vivo  reconstitution assays that the CMP, is to give rise to lymphoid cells, but can 
give rise to erythroid, megakaryocyte and myeloid cells Figure 5.13 (Akashi et al., 
2000; Traver et al., 2001). It is thought that two further progenitor cells are derived 
from the CMP - the Granulocyte/Monocyte Progenitor (GMP) which give rise to 
granulocytes and erythrocytes, and the Megakaryocyte/Erythrocyte progenitor 
(MEP), which gives rise to megakaryocytes and erythrocytes. You would therefore 
expect that a block in differentiation at either the GMP or the MEP stage would 
result in a reduction in the production of CFU-GM or BFU-E respectively in CFU 
assays. The equal reduction in all colony types in M11'A cultures would suggest that 
the defect is at the level of, or before, the CMP.
The reduction in myeloid CFU produced could be due to a reduction of 
myeloid progenitors in the foetal liver, or a block in proliferation. Flow cytometry 
could be used to assess whether myeloid progenitors are reduced in MUrA foetal 
livers. The CMP, MEP and GMP populations in the foetal liver can be identified by 
differential expression of the markers CD34, c-kit and FcyR (Traver et al., 2001). 
Further analysis by in  vitro  culture of foetal liver cells in media containing myeloid
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Figure 5.13. The development of myeloid cells.
The figure shows the model conceived by Irving Weissmans group 
(Akashi e t al., 2000, Traver e t al,. 2001)
CMP -  Common Myeloid Progenitor 
GMP -  Granulocyte/Monocyte Progenitor,
MEP -  Megakaryocyte/Erythrocyte Progenitor
Shown below the cells are the markers used for isolation of the 
indicated populations.
Figure reproduced from Shizura et al., 2005.
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cytokines, followed by cell proliferation assays could also show whether the myeloid 
progenitors have reduced proliferation capacity in response to cytokines.
Mil"7" foetal liver stem cells are not fully functional
The reduced numbers of cells and, in particular, the lower proportion of LT- 
HSC present in A///7- foetal liver suggested that M11A HSCs, whilst present, had 
reduced function. W hen these cells were used to reconstitute lethally irradiated 
mice in competition with WT bone marrow cells, they failed to give rise to any long 
or short term reconstitution. The absence of MZ/7'cells in the periphery of recipients 
at 4 weeks showed that A///7'ST-HSCs and/or progenitors were not able to give rise 
to haematopoiesis post transplantation. The absence of M ll/~ cells in primary and 
secondary haematopoietic organs of recipients at 4 months showed that A/7/7~ LT- 
HSCs were also unable to give rise to haematopoiesis. The transplantation assays also 
suggested that the defect in A///7' HSCs was cell intrinsic and not due to 
abnormalities in the A/7/7' foetal liver niche. Otherwise, M ilL/* HSCs, whilst being 
present in reduced numbers in the foetal liver, would have been able to give rise to 
normal levels of reconstitution when transplanted into a normal stromal 
environment.
The exact nature of the defect in HSCs lacking M il has not yet been 
elucidated. However, there are several possible explanations. For example, it is 
possible that A///7' HSCs are incapacitated in their ability to home to the bone 
marrow and other haematopoietic niches when transplanted. HSCs normally reside 
in specific regulatory microenvironments in the foetal liver, bone marrow and other 
haematopoietic organs- so called ‘niches’ (Chute, 2006; Zhang et al., 2003). The 
HSCs are tethered to the niche cells via multiple cell adhesion molecule-ligand 
interactions. For example, in the bone marrow niche, haematopoietic stem cells 
reside in the endosteal lining of the bone marrow cavity, and are attached to 
specialised osteoblasts via a homotypic N-cadherin interaction (Calvi et al., 2003; 
Zhang et al., 2003). The niche is thought to provide a microenvironment that 
supports the HSCs and prevents their differentiation (Chute, 2006; Takubo et al., 
2006; W ilson et al., 2004). W hen haematopoietic stem cells are transplanted into
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irradiated recipients, it is necessary for the cells to home to these niches where they 
can then begin to propagate the haematopoietic system. This is evidenced by the fact 
studies showing that inhibition of the receptors and ligands necessary for the 
tethering of HSCs to the niches results in reduced homing and a reduction in HSCs 
in the bone marrow (Papayannopoulou et al., 2001; Potocnik et al., 2000; Sugiyama 
et al., 2006). It is possible that the reconstitution defect seen in M R / HSCs could be 
due to a defect in their ability to home to the bone marrow niche. The ability of M R  
A HSCs to transfer from the AGM to the foetal liver, and the results presented in 
Chapter 6 would suggest that this is not the case. However, to assess w hether M R1' 
HSCs are compromised in their homing capacity, it would be necessary to perform 
homing assays, in which the foetal liver HSCs are labelled w ith a fluorescent dye 
(e.g. carbofloxyfluorescein diacetate, succinimidyl ester) and then transplanted into 
irradiated mice. The bone marrow of the long bones of the recipients can then be 
analysed 6 to 18 hours post-transplantation by flow cytometry or fluorescent 
microscopy to assess the homing efficiency of the donor cells (Wilson et al., 2004; 
Zhang et al., 2006).
It is interesting that the phenotype seen in M RA foetal livers is similar to that 
seen in several other mouse gene knockout models. Of particular interest, is the 
similarities seen between the phenotype in the M RA foetal livers and those seen 
when different H ox genes and their cofactors are deleted. For example, mice 
deficient in H oxa9 have normal numbers of LSK cells in the bone marrow, but in 
competitive reconstitution assays, these cells are severely compromised (Lawrence et 
al., 2005b). Mice deficient in the H ox cofactors P b xl and M eisl establish foetal liver 
haematopoiesis, but the cells present have reduced myeloid CFU potential and are 
again compromised in competitive reconstitution assays (DiMartino et al., 2001b; 
Hisa et al., 2004b). In M R  deficient foetal liver, stem cells populations are present, 
but these stem cells are not able to function as normal in CFU assays and 
competitive reconstitution experiments.
Several studies have shown that MLL binds to the promoters and coding 
regions of H ox genes and promotes gene activation through the methylation of 
Histone3 Lysine4 (Milne et al., 2002; Milne et al., 2005b). The induction of several
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H oxA, H oxB  and H oxC  cluster genes was severely reduced in embryoid bodies 
derived from M il null ES cells (Ernst et al., 2004b), and M il null embryos show 
disrupted H ox expression (Yagi et al., 1998; Yu et al., 1995). H ox gene expression 
was also severely reduced in murine embryonic fibroblasts derived from M il KO  
embryos in our model (unpublished results, S. Y-L. Hiew and H. J. M. Brady).
It is possible that the stem and progenitor cell defects that we see in foetal 
haematopoiesis maybe due to a reduction in H ox gene expression in the absence of 
M il. At this stage of development, it is thought that the expression of multiple H ox 
genes are needed to drive proliferation of stem and progenitor cells, and that M il 
maintains this expression (Bjornsson et al., 2003; Ernst et al., 2004b; Lawrence et al., 
2005b; Lawrence et al., 1997). In the absence of M il, although stem cells are 
produced in the foetal liver, they are not able to expand as normal, either in the 
foetal liver or post transplantation, both situations where the expansion of stem cells 
is required.
It has been shown in other cell types that M il activates H ox gene 
transcription through H3K4 methylation and also through its interaction w ith 
H4K16 histone deacetylases such as MOF (Dou et al., 2005) The phenotype of the 
mouse model of another histone acetyl-transferase, M onocytic Leukaem ia Z inc- 
finger (MOZ) bears a striking similarity to the phenotype seen in MU'- embryos 
(Katsumoto et al., 2006). Embryos deficient in M O Z  die by E15.5, and have a 
reduction in foetal liver size. W hen the foetal liver cells were analysed, they were 
found to have reduced numbers of myeloid progenitors, both by colony analysis and 
flow cytometry. Like M llh foetal livers, the ratio of lineage-committed CFUs was 
not affected. As in M llh foetal livers, the LSK population was severely reduced 
although present, but w hen M O Z  deficient foetal liver cells were transplanted, they 
could not reconstitute lethally irradiated recipients. The expression of Hoxa9, a 
target of MU, was also reduced. The common phenotype shared by M il and M O Z  
deficient embryos suggests a possible interaction between the two proteins. As yet, 
MLL complexes have not been analysed in haematopoietic cells, so it is possible that 
MLL may interact with different proteins, including M OZ, in this context.
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It is probable that MLL activates transcription of an unidentified set of target 
genes in early haematopoietic cells. M il targets have been identified in other cell 
types, for example embryonic fibroblasts (Milne et al., 2005b; Scharf et al., 2006; 
Scharf et al., 2007; Schraets et al., 2003), but have not been analysed in 
haematopoietic cells, w ith the exception of embryoid bodies (Ernst et al., 2004b). 
The new exon 9-10 deletion mouse model presents a unique opportunity to analyse 
M il targets in a haematopoietic specific context. Microarray analysis can be 
performed using M il1' foetal liver cells compared to M lth cells to identify genes 
whose expression is altered in the absence of MIL Identification of these targets may 
elucidate the mechanism by which M il is involved in stem cell regulation.
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Chapter 6
In the absence of Mil, homeostatic 
haematopoiesis is unaffected, but 
M il deficient stem cells cannot self- 
renew when transplanted
6.1 Introduction
The defects in stem cell self renewal and progenitor growth seen in M il 
deficient foetal livers would suggest that M il plays an important role in foetal 
haematopoiesis. To assess w hether this role was also needed in adult haematopoiesis, 
it was necessary to establish a line of mice in w hich MLL expression was abrogated 
only in haematopoietic tissues, leaving MLL expression intact in the rest of the 
mouse. This would overcome any embryonic lethal effects of M il deletion. The 
creation of a mouse conditional for M il could be achieved by breeding mice carrying 
the floxed allele of M il to mice which carry the Cre recombinase under the control 
of different tissue specific promoters (Porret et al., 2006). Several strains have been 
developed for the study of genes important for haematopoiesis. The most widely 
used expresses the Cre recombinase under the control of the promoter for the M xl 
gene (Hock et al., 2004b; Ichikawa et al., 2004; Opfer et al., 2005; Zhang et al., 2006). 
The M xl promoter is normally silent, but can be transiently activated upon 
application of interferon a  or p or a synthetic double stranded RNA (polyinosinic- 
polycytidylic acid or pI-pC). Activation of the promoter results in Cre mediated 
deletion in all cells. This model has been extensively used as it results in high levels 
of deletion in all haematopoietic cells including early stem cells. A more tissue
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specific Cre shown to induce deletion in early haematopoietic cells is the Tie2 Cre, 
where Cre is under the control of the Tie2 promoter, a gene which is expressed in 
haematopoietic stem cells and endothelial cells (Kisanuki et al., 2001; Schlaeger et 
al., 2005).
Several models have also been developed that enable Cre mediated deletion 
in selected haematopoietic lineages. The Lck-Cre transgene can be used to induce 
LoxP mediated deletion in CD4+ and CD8+T-cells (Hennet et al., 1995). The CD19 
Cre and m bl Cre transgenes can be used to induce deletion in pro-B and pre-B cells 
respectively (Hobeika et al., 2006; Rickert et al., 1997). The Lys2M Cre and C D llb  
Cre transgenes can be used to induce deletion in macrophages and granulocytes 
(Clausen et al., 1999; Ferron and Vacher, 2005). These mouse strains enable the 
study of the function of genes specifically in mature lineages of cells, whilst 
preventing any stem cell associated defects.
In this study, mice carrying the Vav Cre transgene have been used to create 
MU conditional knockout mice. This transgene utilises the promoter elements of the 
Vav gene. The Vav promoter drives expression in haematopoietic cells of all 
lineages, including functional stem cells, from the foetal liver through to adult 
haematopoiesis (Almarza et al., 2003; de Boer et al., 2003; Ogilvy et al., 1999). Using 
this approach, Cre is continually expressed throughout haematopoietic development 
resulting in high levels of recombination in mature B lymphoid, T lymphoid and 
myeloid cells (de Boer et al., 2003). In this study, mice carrying a floxed allele of M il 
were bred to mice carrying the Vav Cre transgene to produce mice conditional for 
M il in the haematopoietic system. These mice were then analysed to assess the 
contribution of M il to  adult haematopoiesis.
6.2 Establishment of Mil conditional mouse lines
Vav Cre transgenic mice were kindly provided by Dimitris Kioussis and 
Alexandre Potocnik, NIMR, Mill Hill (de Boer et al., 2003). The mice had been 
backcrossed onto and were congenic for the C57B1/6J background. The Vav Cre 
transgenic mice were bred to M ltA mice to produce M1FA VavCre mice. These mice 
were then bred to M1Flox/Flox mice to give rise to M il maK/~ VavCre mice. These mice, in
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w hich M il should be absent in the haematopoietic system, were termed ‘M il 
conditional mice’. M il conditional mice were born live w ith no apparent 
abnormalities.
6.3 High levels of recombination were seen in the haematopoietic cells 
of Mil conditional mice
To ensure that M il was being efficiently deleted, the levels of recombination 
were assessed in the different haematopoietic organs of M il conditional mice. 
Southern blot analysis confirmed that exons 9 and 10 of the gene were efficiently 
recombined in DNA lysates prepared from whole bone marrow, spleen, thymus and 
lymph node of M il conditional mice (Figure 6.1). MLL protein was also undetectable 
in spleen lysates from M il conditional mice, confirming abolition of MLL expression 
(Figure 6.2). To analyse the levels of deletion in haematopoietic stem cells, LSK cells 
were sorted from the bone marrow of MU conditional mice by a combination of 
magnetic activated cell sorting and FACS. PCR analysis of DNA prepared from the 
cells showed efficient recombination of the floxed allele, although some residual 
unrecombined DNA remained (Figure 6.3). These results showed that the Vav Cre 
transgene was efficient in inducing recombination in adult haematopoietic cells.
6.4 Homeostatic haematopoiesis in adult mice is unaffected by the 
absence of Mil
To determine w hether the haematopoietic system in M il conditional mice 
was affected by the absence of M il, cells from the bone marrow, spleen, thymus and 
lymph nodes were analysed by flow cytometry. M lFlox/+ mice were used as littermate 
controls, since these were comparable to wild type mice in similar assays (Figure 
6.4). For all experiments, 8 week old males and females were used. There was no 
difference in the mean total cell number of the spleen and thymus between M il 
conditional and M1Flox/+ control littermates (Figure 6.5). The populations of myeloid 
(Figure 6.6, 6.7), and lymphoid cells (Figures 6.8, 6.9, 6.10) were analyzed in the 
primary and secondary haematopoietic organs of M il conditional and M lFlox/+ mice.
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Figure 6.1. High levels of recombination were seen in the 
haematopoietic organs of M il conditional mice.
Southern Blot analysis of DNA prepared from the bone marrow (BM), 
spleen (S) and thymus (T) of M il conditional mice. DNA from M llFIox/+ 
VavCre mice was used as a control. Mil conditional mice are represented 
by M il cKO. The DNA was digested with Kpn\ and incubated with the 
3' probe shown in Figure 4.4. The floxed and the wild type bands ran 
at the same size (5.7 kb) and the deleted band was 9.2 kb. No floxed 
band was visible using DNA prepared from Mil conditional mice 
haematopoietic organs indicating very high levels of recombination. 
DNA prepared from the tail of the M il conditional mouse shows the 
presence of the floxed band, as expected.
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MLL-N 
MLL-C 
Hsp90
Figure 6.2. MLL protein is absent from the spleen cells of MU 
conditional mice.
Western Blot of MLL protein in the spleens of M il conditional mice. 
Whole cell lysates made from splenocytes were run with K562 cell 
lysates as a positive control. MLL N-terminal (MLL-N) and MLL C- 
terminal (MLL-C) antibodies were used to detect the presence of the 
MLL fragments as before. An antibody against Hsp-90 was used as a 
loading control.
M il cKO denotes M il conditional.
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Flox Allele Deleted Allele
Figure 6.3. Recombination in MU  conditional HSCs.
Recombination of the floxed allele in M il conditional LSK and lineage 
positive cells. Lineage positive cells were depleted from bone marrow 
cells by magnetic sorting. c-kithlScal+ (LSK) cells were sorted from the 
lineage negative cells by FACS and DNA was prepared from them. 
PCR analysis was then performed on the DNA using primers E and F 
and E and B. Genomic DNA from an M lfIox/~ mouse and an M1. 
embryo were used as positive and negative controls. Flox allele - 900 
bp, deleted allele - 250 bp.
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Figure 6.4. Haematopoiesis is comparable to wild type in A /Z^^m ice. 
Flow cytometric analysis of the haematopoietic system of MlFIox/+ 
control mice showed that they were comparable to wild type animals. 
For all charts, n = 2-3. All mice were 8 week old males. The graphs 
show the mean and the Standard Error of the Mean (SEM).
A) B cell and T cell numbers in the spleen. B cells were defined as 
B220+ and T cells were defined as CD4+ or CD8+.
B) B cell and myeloid cell percentages in the bone marrow. B cells 
were defined as above, myeloid cells were defined as Grl+ Macl+.
C) LSK (HSC) cell percentages in the bone marrow.
D) T cell numbers in the thymus. T cells were defined as above.
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Figure 6.5. Cell numbers in the haematopoietic organs of M il 
conditional mice are equivalent to controls.
Single cell suspension were prepared from the spleen, bone marrow 
(BM) and thymus of MlFlox/+ (FloxZ+)din& M il conditional (M il cKO) 
mice. Erythrocytes were removed and live cell counts taken. For the 
thymus, n=3-4, for the spleen and bone marrow, n=3-6. All mice were 
8 week old females. The graph shows the mean and SEM.
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Figure 6.6. Myeloid cell populations are unaffected in the absence of 
MU.
Representative dot plots showing flow cytometric analysis of myeloid 
cells in the bone marrow (BM) and spleen (S). Granulocytes were 
defined as G rlhl M acl+ and monocytes were defined as G rl]o M acl+.
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Figure 6.7. Myeloid cell populations are unaffected in the absence of 
MU.
Flow cytometric analysis of the myeloid cell populations in the bone 
marrow and spleen of M il conditional mice. For all charts, n = 3-4. 
Flox/+ denotes M lflox/+ control mice, M il cKO  denotes M il conditional 
mice. The graphs show the mean and the SEM.
Granulocytes were defined as G rlhl M acl+ and monocytes were 
defined as G rllc M acl+.
A) Granulocyte and monocyte populations in the bone marrow of M il 
conditional mice. Percentages are shown as the cell numbers obtained 
were not accurate.
B) Granulocyte and monocyte numbers in the spleens of M il 
conditional mice.
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Figure 6.8. B lymphoid populations are unaffected in the absence of 
MU.
Flow cytometric analysis of the B cell populations in the bone 
marrow and spleen of Mil conditional mice. For all charts, n = 4. The 
graphs show the mean and the SEM
A) Representative histograms showing flow cytometric analysis of B 
cell populations in bone marrow (BM), Spleen (S) and Lymph Node 
(LN).
B) B cell populations in the bone marrow and lymph node of MU 
conditional mice. Percentages are shown as the cell numbers obtained 
were not accurate.
C) B cell numbers in the spleen of M11 conditional mice. B cells were 
defined as B220+CD19+.
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Figure 6.9. T lymphoid populations are unaffected in the absence of 
MU
Representative dot plots showing flow cytometric analysis of T cells in 
the and spleen (S), lymph node (LN) and thymus (T) of M il 
conditional mice. In the spleen and lymph node the numbers of CD4+ 
and CD8+ cells were analysed. In the thymus, CD4+CD8+ cells were 
also analysed.
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Figure 6.10. T lymphoid populations are unaffected in the absence of 
MU.
Flow cytometric analysis of the T cell populations in the spleen, 
lymph node and thymus of Mil conditional mice. For all charts, n = 1 
male and 3 females. The graphs show the mean and the SEM. Flox/+ 
denotes M lflox/+ control mice, M il cKO denotes M il conditional mice.
A) Numbers of CD4 and CD8 single positive cells in the thymus and 
spleen of M il conditional mice.
B) Percentage of CD4 and CD8 single positive cells in the mesenteric 
lymph node of M il conditional mice. Percentages are shown as the 
cell numbers obtained were not accurate.
C) Numbers of CD4 and CD8 double positive cells in the thymus.
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No significant differences were found between M il conditional and M llFIox/+ mice in 
any of the major blood cell populations, when the data sets were compared, both 
w ith paired and un-paired t-tests. This surprising result suggests that M il is not 
required to establish normal steady-state haematopoiesis postnatally. M il is also not 
required for the differentiation of mature haematopoietic cells.
6.5 Foetal liver haematopoiesis is perturbed in Mil conditional foetal 
livers
The phenotype seen in the haematopoietic system of M il conditional mice 
was somewhat unexpected. The VavCre transgene is expressed in definitive 
haematopoietic cells from an early stage of development, which means that M il 
should be absent in M il conditional fetal liver cells as well as bone marrow (Ogilvy 
et al., 1999; Okada et al., 1998). To see if this was the case, hematopoiesis in M il 
conditional fetal livers was analysed and compared to M11~A fetal liver hematopoiesis. 
To ensure that recombination of the ‘floxed’ allele was occurring in foetal liver, 
DNA was prepared from M il conditional c-kit+T e rll9 ' foetal liver cells from E13.5 
embryos. PCR analysis of this DNA showed high levels of recombination (Figure 
6.11). Stem cells from M il conditional, M1F0X/+, M1FIox/FIox, and M llFlox/~ E l3.5 foetal 
liver were analyzed by flow cytometry, using LSK markers and CD38 as described in 
Chapter 5.4. Surprisingly, there was no significant difference in the number of ST- 
HSCs or LT-HSCs in M il conditional foetal livers compared to control M1FIox/Flox or 
MIF1™/* (Figure 6.12). To further analyze haematopoiesis in M il conditional embryos, 
myeloid CFU assays were performed with cells from E l2.5 foetal livers as before. A 
2-fold reduction in colony number was seen in M il conditional cultures compared 
with M lFIox/~ (Figure 6.13A). A 2-fold reduction in cell number was also seen (Figure 
6.13B). Southern blot analysis of DNA extracted from methylcellulose cultures 
showed high levels of recombination of the floxed allele in M il conditional cultures 
(Figure 6.14). The reductions in colony number and cell number were not as great as 
that seen between M1F'and M //Acultures, where there were 3.5-fold and 10-fold 
reductions, respectively (Figure 5.2).
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Figure 6.11. The M il floxed allele is efficiently recombined in the 
foetal liver of AH1 conditional embryos.
Recombination of the floxed allele in M il conditional fetal liver cells. 
c-kit+T e rll9 ' cells were sorted from E13.5 fetal livers by magnetic 
sorting and DNA prepared from them. Primers E and F2 were used to 
amplify the floxed allele (900 bp) and primers E and G2 were used to 
amplify the deleted allele (250 bp).Tail DNA from a M lFlox/~ mouse 
was used as positive control.
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Figure 6.12. M il conditional foetal livers have normal numbers of 
haematopoietic stem cells.
A) Number of LT-HSCs present in M il control (Flox/Flox or Flox/+) 
M lfiox/- ancj M il conditional {M il cKO) E l3.5 fetal livers.
Lineage positive cells were depleted from E l3.5 fetal liver cells and 
then the cells were analyzed by flow cytometry for the markers c-kit, 
Seal and CD38. LT-HSCs were defined as Lin'Scal+c-kithlCD38hl.
B) Number of ST-HSCs present in M il conditional E l3.5 fetal livers. 
ST
HSCs were defined as Lin"Scal+c-kithlCD38l0.
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Figure 6.13. Myeloid CFU are reduced in M il conditional foetal liver.
The graphs show the mean and the SEM.
A) Myeloid CFU counts for M il cKO  E12.5 fetal liver cells. Following 
the removal of erythrocytes, 1.1 x 104 fetal liver cells were plated in 
methylcellulose and CFUs were counted after 7 days.
B) The number of cells present in CFU cultures from E l2.5 fetal livers. 
1.1 x 104 cells were cultured in methylcellulose and after 7 days, single 
cell suspensions were made and viable counts performed.
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Figure 6.14. High levels of recombination were seen methylcellulose 
cultures of M il condtional foetal liver cells.
Southern Blot analysis of DNA prepared from cells in methylcellulose 
cultures of the foetal livers of from a litter of embryos. All embryos 
were genotyped by PCR using material from the head. Mil conditional 
embryos are represented by M il cKO. The DNA was digested with 
K pn\ and incubated with the 5' probe shown in Figure 4.4. The floxed 
and the wild type bands ran at the same size (5.7 kb) and the deleted 
band was 9.2 kb.
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6.6 Reduced colony-forming capacity in Mil conditional bone marrow 
cells
Although there was no phenotype in M il conditional foetal liver stem cells as 
analyzed by flow cytometry, a functional defect was seen when the cells were 
cultured in methylcellulose. Similarly, in adult M il conditional bone marrow there 
was no reduction in LSK stem cells as analysed by flow cytometry (Figure 6.15). To 
assess w hether progenitor cells were functional in M il conditional adults, CFU 
assays were performed w ith cells from M il conditional, M1F1ox/FIox and M lF ox/+ bone 
marrow. W hen cultured in lymphoid conditions, M il conditional cells produced a 
significantly lower number (3-fold) of Pre-B cell CFUs compared to control cells 
(Figure 6.16A). A significant reduction in the number of CFUs (1.6-fold) was also 
seen when the cells were cultured in myeloid conditions (Figure 6.16B). In M il 
conditional myeloid cultures, a significant decrease was seen in the proportion of 
BFU-E and CFU-GEMM compared to M lFlox/+ cultures. The proportion of CFU-GM 
was not significantly decreased however (Figure 6.17). These results would suggest 
that, although haematopoiesis is able to proceed in the absence of M il, there are 
defects in both lymphoid and myeloid bone marrow progenitors.
6.7 Bone marrow cells from Mil conditional mice have a profound 
reconstitution defect
The reduction in CFUs produced from M il conditional progenitor cells 
suggested that M il conditional stem cells may also have had some hidden functional 
defects. To assess this, competitive repopulation assays were performed to test 
w hether bone marrow stem cells lacking M il would be able to compete w ith M il 
wild type stem cells. Ly5.2+ bone marrow cells from M il conditional, M lFlox/~ and 
MlF,ox/+ mice were transplanted into lethally irradiated recipients w ith C57BL/6J 
Ly5.1+ wild type competitor bone marrow cells in a 1:1 ratio or 10:1 ratio. 4 weeks 
post-transplantation, blood from the recipients was analyzed for the presence of 
Ly5.2+ and Ly5.1+ cells in the periphery. W hen transplanted at a 1:1 ratio, M il 
conditional bone marrow cells gave very low levels of reconstitution (0.9 ± 0.5%
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Figure 6.15. Bone marrow HSC number is unaffected in the absence 
of M R
Flow cytometric analysis of the HSC population in the bone marrow 
of M il conditional mice. For all charts, n = 3-4 females. The graphs 
show the mean and the SEM.
A) Representative dotplots showing flow cytometric analysis of the 
LSK population in bone marrow. LSK cells were defined as Lin' 
Scal+c-kithl.
B) LSK population in the bone marrow of M il conditional mice. 
Percentages are shown as the cell numbers obtained were not 
accurate.
0.30%
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Figure 6.16. Reduced CFU numbers in M il conditional bone marrow.
The graphs show the mean and the SEM.
A) Pre B CFU counts for M il Flox/+ and M il conditional {M il cKO) 
bone marrow cells. 5.5 x 104 cells were plated in methylcellulose and 
CFUs were counted after 7 days.
B) Myeloid CFU counts for M il Flox/+ and Mil conditional (Mil cKO) 
bone marrow cells after 10 days in culture in methylcellulose. 2.7 x 104 
cells were plated in methylcellulose and CFUs were counted after 10 
days.
159
CHIBFU-E
CZ3CFU-GEMM
IZUCFU-G M
Flox/+ or Flox/Flox M il cKO
Figure 6.17. M il conditional bone marrow cells produced reduced 
frequencies of BFU-E and increased frequencies of CFU-GM.
Myeloid CFU counts for M ilFlox/+ and M il conditional (Mil cKO) bone 
marrow cells after 10 days in culture in methylcellulose. 2.7 x 104 cells 
were plated in methylcellulose and CFUs were counted after 10 days. 
The graph shows the proportions, in percentages, of BFU-E, CFU- 
GEMM and CFU-GM in methylcellulose cultures of bone marrow 
cells after 10 days of culture. The frequency of BFU-E was 
significantly reduced {p = 0.0125) and the frequency of CFU-GM 
significantly increased (p = 0.014) in M il conditional {M il cKO) 
cultures compared to Ml?lox/+ and M l?10*™0*. For both M il conditional 
and M il Floxcontrols, n = 5.
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Ly5.2+ cells in the peripheral blood) compared to M lFlox/+ cells (37.6 ± 2.7%) (Figure 
6.18). M il conditional cells also gave very low levels of reconstitution when 
transplanted at a 10: ratio (10.35 ± 2.6%) compared to M lF ox/+ cells (81.7 ± 1.0%) 
(Figure 6.18).
At 4 months post-transplantation, the recipients were sacrificed and the bone 
marrow, spleen and thymus analysed for the presence of Ly5.2+ cells. W hen 
transplanted at a 1:1 ratio w ith wild type cells, M il conditional cells gave less than 
1% long term reconstitution, compared to a mean of 68 ± 12% reconstitution with 
M lF ox/+ cells (Figure 6.19, 6.20). W hen transplanted at a 10:1 ratio, M il conditional 
cells gave rise to 2 ± 2% reconstitution, compared to 87 ± 7% reconstitution with 
M lF ox/+ cells (Figures 6.19, 6.20). This reconstitution defect affected all 
haematopoietic lineages, as shown in Figures 6.21 and 6.22. This included the HSC 
compartment (Figure 6.22) suggesting that the lack of reconstitution of the mature 
lineages by M il conditional cells was not due to a block in HSC differentiation.
A significant reconstitution defect was also seen in M il heterozygous cells 
(M lF ox/~), particularly in the ability of these cells to reconstitute the T cell 
compartment (Figures 6.18- 6.22). These results show that, while M il deficient 
haematopoietic stem cells are able to generate steady state haematopoiesis, their 
ability to proliferate and self-renew is greatly compromised when they are placed in 
competition w ith wild type cells.
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Figure 6.18. M il cKO  bone marrow cells have a severe short term 
repopulating defect.
Reconstitution at 4 weeks post transplantation by M il conditional (M il 
cKO) bone marrow when mixed with wild type competitors in 1:1 
ratio and 10:1 ratios. The graph shows the percentage of Ly5.2+ cells 
present in the peripheral blood of recipients. For all samples, n=5, 
except Flox/+ 1:1, where n=4. The graphs show the mean and the 
SEM.
(***) P  < 0.001, (**) P< 0.01, (*) P  < 0.05. All samples were compared to
Mifiox/+.
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Figure 6.19. M il cKO  bone marrow cells have a severe long term 
repopulating defect.
Reconstitution at 4 weeks post transplantation by M il conditional 
(.M il cKO) bone marrow when mixed with wild type competitors in a 
10:1 ratio. Representative flow cytometric plots showing 
reconstitution levels in the organs of recipients. Single cell 
suspensions were prepared from spleen, bone marrow and thymus 
and Ly5.1+ and Ly5.2+ cells were analysed by flow cytometry.
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Figure 6.20. MU cKO  bone marrow cells have a severe long term 
repopulating defect.
Reconstitution at 4 months post-transplantation by M il conditional 
{M il cKO) bone marrow when mixed with wild type competitors in 
1:1 ratio and 10:1 ratios. For all samples, n= 4-5, except Flox/+ 1:1, 
where n= 3. The graphs show the mean and the SEM. (***) P < 0.001, 
(**) P< 0.01, (*) P  <0.05. All samples were compared to M lFIox/+.
A) Reconstitution levels in the spleens of recipients as shown by the 
percentage of Ly5.2+ cells present.
B) Reconstitution levels in the thymuses of recipients.
C) Reconstitution levels in the bone marrow of recipients.
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Figure 6.21. M il cKO  bone marrow cells have a severe long term 
repopulating defect affecting all haematopoietic lineages.
Long term contribution, as shown by the percentage of Ly5.2+ cells, to 
the lineages of the spleen. B cells were defined as B220+CD19+, T cells 
as CD4+ or CD8+ and myeloid cells as G rl+M acl+. The graphs show the 
mean and the SEM
For all samples, n= 3-5. (***) P  < 0.001, (**) P< 0.01, (*) ^ < 0 .0 5 . All 
samples were compared to M lfIox/+.
A) Reconstitution levels when cells were transplanted at a 1:1 ratio 
w ith WT competitors.
B) Reconstitution levels when cells were transplanted at a 10:1 ratio 
w ith W T competitors.
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Figure 6.22. M il cKO  bone marrow cells have a severe long term 
repopulating defect affecting all haematopoietic lineages.
Long term contribution, as shown by the percentage of Ly5.2+ cells, to 
the lineages of the bone marrow. B cells were defined as B220+CD19+, 
HSCs as Lin'Scal+c-kithl and myeloid cells as G rl+M acl+. The graphs 
show the mean and the SEM
For all samples, n= 3-5. (***) P  < 0.001, (**) P< 0.01, (*) P  < 0.05. All 
samples were compared to M lflox/+.
A) Reconstitution levels when cells were transplanted at a 1:1 ratio 
w ith W T competitors.
B) Reconstitution levels when cells were transplanted at a 1:1 ratio 
w ith WT competitors.
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6.8 Discussion
Establishment of a line of mice conditional for Mil in haematopoietic tissues
This chapter describes the establishment and characterisation of a line of mice in 
which M il is absent in haematopoietic tissues due to Cre mediated deletion driven by the 
Vav Cre transgene. The Vav promoter has been shown to drive Cre expression in all 
mature lineages of haematopoietic cells, including eryhroid, myeloid and lymphoid cells 
(de Boer et al., 2003). PCR analysis of bone marrow lineage positive cells and LSK cells, 
and foetal liver c-kit+Terl 19 cells showed some residual flox allele, suggesting that there 
are still some M il heterozygous cells present in the haematopoietic system. However, no 
floxed DNA was detectable when cells from the haematopoietic organs and 
methylcellulose cultures of M il conditional mice and embryos were analyzed by 
Southern blot. MLL protein was also absent from spleen lysates of M il conditional mice. 
This means that the vast majority of cells in the haematopoietic system of M il conditional 
mice have no functional copy of Mil. Therefore, while it is possible that cells that have 
not deleted M il are contributing to haematopoiesis in M il conditional mice, their 
contribution seems to be negligible.
Mil is not needed for bone marrow homeostasis and the formation and maintenance 
of HSCs
It was surprising to see no effect on the development of mature lineages in 
the bone marrow of adult mice in the absence of M il. A similar effect has been 
reported for other genes known to be important for foetal liver haematopoiesis 
w hen deleted in adults. For example, the A m ll and Scl genes are essential for the 
initiation of definitive haematopoiesis in the embryo. However, when these genes 
are knocked out conditionally using the Cre-Lox system, no effect is seen on adult 
HSCs (Ichikawa et al., 2004; Mikkola et al., 2003). It has been suggested that these 
genes are necessary to form the first definitive HSCs but are not needed for their 
maintenance. This is not the case with M il, however, as definitive haematopoiesis 
does occur in M11A embryos in the absence of M il but it is severely reduced.
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Differences in phenotype between Mil conditional and Mil 7' embryos
Although recombination levels appear to be high in the foetal livers of M il 
conditional embryos, the haematopoietic cells exhibit a far less severe phenotype 
than that seen in M IR  embryos. In particular, the reduction of the HSC pool that is 
seen in M Ry~ embryos, is not seen in M il conditional embryos. There are two 
possible reasons for this difference. The first is that the Vav Cre transgene is active 
after the point where M il expression is critical. A previous study of M il knockout 
embryos has shown that MU is needed for the proper formation of the first definitive 
haematopoietic stem cells in the AGM (Ernst et al., 2004a). It is possible that there 
are also defects in the AGM in the M IR  embryos presented here. This would result 
in fewer HSCs seeding the foetal liver and have a knock on effect on foetal liver 
haematopoiesis. Although Vav is expressed in the AGM (Okada et al., 1998), it is not 
known if the Vav Cre transgene is active in the AGM. It is possible that in MU 
conditional mice, M11 is deleted after the point at which it is necessary for producing 
normal numbers of stem cells to seed the foetal liver.
Another possibility is that the few cells that escape M11 deletion in 
conditional embryos, either in the AGM or the early foetal liver, are able to give rise 
to sufficient stem cells to establish foetal liver and then adult haematopoiesis 
successfully. It would be impossible to detect the presence of these cells as continued 
expression of the Cre throughout development would mean that their progeny 
would be homozygous for the M11 deletion.
MU is needed for in vitro expansion of lymphoid and myeloid progenitors
Although no reduction was seen in the number of HSCs in MU conditional 
embryos, a defect was seen in myeloid progenitors. A similar situation was also 
observed in the bone marrow of MU conditional mice, where the number of HSCs 
was equivalent to controls, but the number of colonies formed in both myeloid and 
Pre-B CFU assays were reduced. So, MU does have a critical function in progenitor 
cell expansion of both the myeloid and lymphoid lineages. This function is apparent 
in in  vitro  culture, but is not reflected in the production of mature myeloid and B- 
lymphoid cells in  vivo. This supports the data from M IR  embryos, suggesting that
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M il is necessary for the expansion of progenitor cells in response to cytokines, as is 
seen in methylcellulose colony forming assays. Preliminary analysis by flow 
cytometry in M il conditional mice suggested that the numbers of Pre B cells in the 
bone marrow were normal in comparison to controls (data not shown). This would 
suggest that the defect seen in Pre B CFU assays is not due to a reduced input, but to 
an intrinsic defect in the Pre B cells to produce colonies. Further analysis by flow 
cytometry of the CMP population in the bone marrow will confirm whether this 
population is also normal in M il conditional mice. If this is the case, the reduction in 
CFU numbers may be attributable to a defective response of the cells to cytokines or 
a proliferative defect.
Mil deficient stem cells suffer are unable to self-renew in competitive repopulation 
assays
The hidden defect in M il deficient progenitor cells led to further examination 
of the HSC compartment in these mice. W hilst the HSC population showed no 
apparent abnormalities under homeostatic conditions in M il conditional mice, these 
cells crashed spectacularly when transplanted with wild type competitors into 
lethally irradiated recipients. Even when transplanted at a 10:1 ratio, they 
contributed to less than 10% of the major haematopoietic lineages 4 months post 
transplantation. The reconstitution defect extended to all mature lineages analysed, 
suggesting that the lack of reconstitution was due to a defect in the HSCs. This 
defect appeared to affect both long and short term stem cells, as out competition of 
the M il conditional cells was seen at both 4 weeks and 4 months post transplantation 
(Christensen and Weissman, 2001; Spangrude et al., 1995).
It has been noted that the transplantation of HSCs into irradiated recipients 
leads to increased cell cycle activity of the cells, and proliferative stress (Allsopp et 
al., 2001; Cheng et al., 2000b; Spangrude et al., 1995). Under these conditions, it is 
thought that sufficient stem cells need to remain quiescent to enable stem cell self 
renewal capacity to be maintained post transplantation. It is possible that M il 
deficient mice have a higher proportion of cycling BM HSCs, which would lead to 
an inability to self renew when placed under proliferative stress.
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There are several other genes which, when deleted, appear to have no or 
even a positive effect on the numbers of HSCs present in the bone marrow. 
However, when these stem cells are transplanted, particularly when in competition 
w ith wild type cells, they are unable to give rise to effective reconstitution or to 
serially transplant. These genes include the cyclin dependent kinase (CDK) 
inhibitor, p 2 1 ciP^wafl. Mice deficient in p 2 1 ciP1/waf have apparently normal 
haematopoiesis and normal numbers of stem cells. However, the stem cell pool 
contains fewer quiescent cells, and in serial transplantations, these cells show a self 
renewal defect. This suggests that p 2 1 ciP1/waf is needed to maintain stem cells in a 
quiescent state upon proliferative stress (Cheng et al., 2000b). Mice deficient in G fi- 
1, a transcriptional repressor which is thought to positively regulate expression of 
p 2 1 ciPUwat\ have slightly elevated numbers of LT-HSC, with a higher proportion or 
the cells in cycle. However, when these cells are transplanted in competition with 
wild type cells, very poor levels of reconstitution were seen from the Gfi- fA cells 
(Hock et al., 2004a). These two genes are of particular interest as G f i - 1 has been 
shown by luciferase reporter assays to be a target of HoxalO, and by micro array 
analysis, a target of H oxa9 (Ferrell et al., 2005; Magnusson et al., 2007). H oxa9 has 
been identified as a direct target of MU and H oxalO  is down regulated in embryoid 
bodies derived from M1H ES cells (Ernst et al., 2004b; Milne et al., 2005a; Milne et 
al., 2002; Milne et al., 2005b). The H oxa9 knockout mice share some phenotypes 
w ith the M il conditional mice -  they have normal numbers of HSCs but these have 
greatly reduced repopulation capacity when transplanted with wild type 
competitors (Lawrence et al., 2005b). This similarity in phenotype between Hoxa9, 
G fi-1 and p 2 1 ciP1/waf deficient HSCs, suggests a common causality by down regulation 
of p 2 1 ciP1/wafl as shown in the model presented in Figure 6.23. This would also suggest 
that the phenotype seen in MU deficient stem cells is due to a failure to self renew 
under proliferative stress, caused by the down regulation of p 2 1 ciP1/waf and an 
inability of the stem cells to remain quiescent. Analysis by Q-PCR of the levels of 
Hoxa9, HoxalO\ G fi-1 and p 2 1 c,P1/waf in M11 deficient stem cells may confirm if this is 
indeed the case. Cell cycle analysis would also reveal w hether the cell cycle profile 
of M11 deficient HSCs was abnormal, resulting in fewer cells residing in Go.
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It is interesting to note that the phenotypes seen in mature myeloid and 
lymphoid cells in the above knockout models are quite divergent. The p 2 1 ciP1/wafl 
deficient mice have no apparent abnormalities in the lymphoid or myeloid 
compartments, whereas 677/ deficient mice have no granulocytes and reduced 
numbers of lymphoid cells and progenitors (Cheng et al., 2000b; Hock et al., 2004a). 
The H oxa9 mice also have reduced numbers of myeloid and lymphoid cells 
(Lawrence et al., 2005c; Lawrence et al., 1997). These differences in phenotype 
would suggest that after HSC differentiation, the functions of these proteins 
diverges, and they may no longer be part of the same pathway.
It is also possible that M il may be directly responsible for the regulation of 
CDK inhibitors. For example, in M il deficient immortalised fibroblasts, MLL has 
been shown to cooperate w ith the tumour suppressor Menin to regulate the 
transcription of p27 (Milne et al., 2005c). It is possible that M il may be active in 
regulating other CDKis such as p 2 1 ciP1/wafl in a cell context dependent manner (Figure 
6.23). Therefore, the identification of M il targets in HSCs would prove whether this 
is the case and also identify other genes contributing to the knockout phenotype.
The effect of Mil deletion is dose dependent
The reduced repopulating capacity of heterozygote (M llFlox/~) cells shows that 
the dosage of M il is also important. Although the heterozygous cells had an 
intermediate phenotype in the reconstitution of all haematopoietic cell types, the 
most profound effect was seen on the T cell compartment. The reconstitution of all 
T cells was more severely reduced in comparison to M lFlox/+ control cells, and 
reconstitution in the thymus was only 20% when the cells were transplanted in a 1:1 
ratio w ith wild type cells (Figure 6.20B). This suggests a further role for M il 
specifically in the expansion of T cells.
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Figure 6.23. A Possible mechanism for the function of M il in the 
control of HSC self renewal.
MLL may positively regulate control of the expression of multiple Hox 
genes. The targets of these H ox genes include Gfi-1, which in turn 
regulates the expression of p 2 1 ciP1/wafl. p 2 1 ciP1/wafl acts to maintain the 
quiescent state of long term HSCs. M il may also directly control the 
expression of cyclin dependent kinase inhibitors.
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Chapter 7 
Overall Conclusions and Future
Directions
In this project two new mouse models of M/7 were successfully established. A 
null mouse model was established in which homozygous deletion of exons 9 and 10 
of M il resulted in an absence of MLL protein. A later lethality in MU~A embryos than 
was observed in earlier M il mouse models allowed a more detailed examination of 
foetal haematopoiesis in the absence of Mil. A conditional model was also 
established which utilized the Vav Cre transgene. M il conditional mice lost 
expression of MLL in a tissue specific manner in the haematopoietic system. 
Analysis of foetal and adult haematopoiesis in these mice has revealed the following 
findings:
• M il is not needed to establish definitive haematopoiesis but is needed 
for normal foetal liver haematopoiesis.
• Deletion of M il did not abrogate normal haematopoiesis in adult mice.
• M il foetal and adult stem cells cannot compete with wild type cells in 
competitive reconstitution assays.
• M il is needed for the proper expansion of progenitor cells in vitro.
• The M il phenotype is dose dependent.
Mil conditional mice: a useful model for future investigations into Mil 
function
The new conditional mouse model for M il provides a useful tool for studying 
the role of M il in a variety of processes. Further work is still needed to clarify the 
exact role of M il in the regulation of adult haematopoietic stem cells, including
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analysis of the downstream targets in M il conditional mice and cell cycle analysis of 
M il deficient HSCs. Further work is also needed to assess whether M il is needed 
outside of normal homeostatic haematopoiesis, during the response to 
immunological challenge. The apparent role of M il in regulating GATA-3 and 
cytokine production in memory Th2 cells (Yamashita et al., 2006) would suggest 
further roles in the T and B lymphoid response to infection. This is supported by the 
effect on repopulation of the T cell compartment by M il heterozygous cells seen 
here.
The new conditional model can be crossed to other tissue specific Cre 
expressing mice, to assess whether M il functions outside of the haematopoietic 
system. For example, there is growing evidence for a role for MU in 
neurodevelopment. M il has been linked to H4 acetylation in the adult brain and 
neuronal differentiation (Kim et al., 2007; Wynder et al., 2005). Using transgenic 
mice expressing Cre under the control of central nervous system specific promoters, 
e.g. the Glial Fibrillary Acidic Protein (GFAP), a mouse model where M il is 
conditional in the central nervous system could be established (Zhuo et al., 2001). 
This could be used to further investigate the role of M il in neural development. 
Other tissue specific Cre transgenes could be used to elucidate the role of M il in 
other cell types and processes. The new conditional model described here represents 
an exiting opportunity to explore the function of M il in murine development.
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